BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001;344:495-500. [PMID: 11172192 DOI: 10.1056/NEJM200102153440706] [Cited by in Crossref: 1673] [Cited by in F6Publishing: 1758] [Article Influence: 76.0] [Reference Citation Analysis]
Number Citing Articles
1 Ito T, Nguyen VH, Tanaka T, Park H, Yeh ML, Kawanaka M, Arai T, Atsukawa M, Yoon EL, Tsai PC, Toyoda H, Huang JF, Henry L, Jun DW, Yu ML, Ishigami M, Nguyen MH, Cheung RC. Poor Diagnostic Efficacy of Noninvasive Tests for Advanced Fibrosis in Obese or Younger Than 60 Diabetic NAFLD patients. Clin Gastroenterol Hepatol 2023;21:1013-1022.e6. [PMID: 35654298 DOI: 10.1016/j.cgh.2022.05.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Ferrer MD, Reynés C, Monserrat-mesquida M, Quetglas-llabrés M, Bouzas C, García S, Mateos D, Casares M, Gómez C, Ugarriza L, Tur JA, Sureda A, Pons A. Polyunsaturated and Saturated Oxylipin Plasma Levels Allow Monitoring the Non-Alcoholic Fatty Liver Disease Progression to Severe Stages. Antioxidants 2023;12:711. [DOI: 10.3390/antiox12030711] [Reference Citation Analysis]
3 Liu CH, Fang YJ, Liu CJ, Su TH, Huang SC, Tseng TC, Wu JH, Chen PJ, Kao JH. Splenic Arterial Pulsatility Index to Predict Hepatic Fibrosis in Hemodialysis Patients with Chronic Hepatitis C Virus Infection. J Clin Med 2023;12. [PMID: 36902807 DOI: 10.3390/jcm12052020] [Reference Citation Analysis]
4 Takeuchi H, Sugimoto K, Kakegawa T, Tomita Y, Takahashi H, Wada T, Abe M, Yoshimasu Y, Matsubayashi J, Nagao T, Itoi T. The usefulness of a newly developed full-core biopsy needle in liver biopsy. Hepatol Res 2023;53:247-57. [PMID: 36355636 DOI: 10.1111/hepr.13856] [Reference Citation Analysis]
5 Duseja A, Singh SP, De A, Madan K, Rao PN, Shukla A, Choudhuri G, Saigal S, Shalimar, Arora A, Anand AC, Das A, Kumar A, Eapen CE, Devadas K, Shenoy KT, Panigrahi M, Wadhawan M, Rathi M, Kumar M, Choudhary NS, Saraf N, Nath P, Kar S, Alam S, Shah S, Nijhawan S, Acharya SK, Aggarwal V, Saraswat VA, Chawla YK. Indian National Association for Study of the Liver (INASL) Guidance Paper on Nomenclature, Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD). J Clin Exp Hepatol 2023;13:273-302. [PMID: 36950481 DOI: 10.1016/j.jceh.2022.11.014] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Liu W, Li X, Wang T, Xiong F, Sun C, Yao X, Huang W. Platinum Drug-Incorporating Polymeric Nanosystems for Precise Cancer Therapy. Small 2023;:e2208241. [PMID: 36843317 DOI: 10.1002/smll.202208241] [Reference Citation Analysis]
7 Liu Y, Chen Z, Wang Y, Hallisey MR, Varela BL, Siewko A, Tocci D, Wang C, Xu Y. Noninvasive Positron Emission Tomography Imaging of SIRT1 in a Model of Early-Stage Alcoholic Liver Disease. Mol Pharm 2023. [PMID: 36827644 DOI: 10.1021/acs.molpharmaceut.2c00904] [Reference Citation Analysis]
8 Ramai D, Pannu V, Facciorusso A, Dhindsa B, Heaton J, Ofosu A, Chandan S, Maida M, Lattanzi B, Rodriguez E, Bhagat VH, Samanta J, Barakat MT. Advances in Endoscopic Ultrasound (EUS)-Guided Liver Biopsy. Diagnostics (Basel) 2023;13. [PMID: 36832272 DOI: 10.3390/diagnostics13040784] [Reference Citation Analysis]
9 Liu Z, Li W, Zhu Z, Wen H, Li MD, Hou C, Shen H, Huang B, Luo Y, Wang W, Chen X. A deep learning model with data integration of ultrasound contrast-enhanced micro-flow cines, B-mode images, and clinical parameters for diagnosing significant liver fibrosis in patients with chronic hepatitis B. Eur Radiol 2023. [PMID: 36735040 DOI: 10.1007/s00330-023-09436-z] [Reference Citation Analysis]
10 Wood-Trageser MA, Lesniak D, Gambella A, Golnoski K, Feng S, Bucuvalas J, Sanchez-Fueyo A, Demetris AJ. Next-generation pathology detection of T cell-antigen-presenting cell immune synapses in human liver allografts. Hepatology 2023;77:355-66. [PMID: 35819312 DOI: 10.1002/hep.32666] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Nakashima M, Nakamura K, Nishihara T, Ichikawa K, Nakayama R, Takaya Y, Toh N, Akagi S, Miyoshi T, Akagi T, Ito H. Association between Cardiovascular Disease and Liver Disease, from a Clinically Pragmatic Perspective as a Cardiologist. Nutrients 2023;15. [PMID: 36771454 DOI: 10.3390/nu15030748] [Reference Citation Analysis]
12 Zha J, Huang S, Xia T, Chen Z, Zheng T, Yu Q, Zhou J, Cao P, Wang Y, Tang T, Song Y, Xu J, Song B, Liu Y, Ju S. A fully automated hybrid approach to assessing liver fibrosis and necroinflammation on conventional MRI: A multi-center cohort Study.. [DOI: 10.21203/rs.3.rs-2475668/v1] [Reference Citation Analysis]
13 Giri S, Agrawal D, Gopan A, Varghese J, Tripathy T. Diagnostic outcome and safety of plugged liver biopsy in high-risk patients: a systematic review and meta-analysis. Acta Radiol 2023;:2841851231151513. [PMID: 36694955 DOI: 10.1177/02841851231151513] [Reference Citation Analysis]
14 Kalkan Ç, Yılmaz Y, Erdoğan BD, Savaş B, Yurdcu E, Çalışkan A, Keskin O, Gencdal G, Zeybel M, Törüner M, Bozdayi AM, Idilman R, Yurdaydin C. Non-invasive fibrosis markers for assessment of liver fibrosis in chronic hepatitis delta. J Viral Hepat 2023. [PMID: 36651603 DOI: 10.1111/jvh.13806] [Reference Citation Analysis]
15 Lee Y, Bae S, Kim JH, Kwak M, Jeon SY, Kim T, Yim SY, Lee YS, Jung YK, Seo YS, Yim HJ, Yeon JE, Byun KS. Diagnostic Efficacy of Serum Asialo α1-Acid Glycoprotein Levels for Advanced Liver Fibrosis and Cirrhosis in Patients with Chronic Hepatitis B Compared to That in Healthy Subjects: A Prospective Study. J Clin Med 2023;12. [PMID: 36675640 DOI: 10.3390/jcm12020712] [Reference Citation Analysis]
16 Fujita S, Sano K, Cruz G, Fukumura Y, Kawasaki H, Fukunaga I, Morita Y, Yoneyama M, Kamagata K, Abe O, Ikejima K, Botnar RM, Prieto C, Aoki S. MR Fingerprinting for Liver Tissue Characterization: A Histopathologic Correlation Study. Radiology 2023;306:150-9. [PMID: 36040337 DOI: 10.1148/radiol.220736] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Yoshizawa E, Yamada A. MRI-derived proton density fat fraction. Jpn J Med Ultrasonics 2023. [DOI: 10.3179/jjmu.jjmu.r.221] [Reference Citation Analysis]
18 Donath H, Wölke S, Knop V, Heß U, Duecker RP, Trischler J, Poynard T, Schubert R, Zielen S. Liver Assessment in Patients with Ataxia-Telangiectasia: Transient Elastography Detects Early Stages of Steatosis and Fibrosis. Can J Gastroenterol Hepatol 2023;2023:2877350. [PMID: 36941982 DOI: 10.1155/2023/2877350] [Reference Citation Analysis]
19 Nepal P, Crowley C, Harisinghani M. Conventional liver imaging in hepatitis. Comprehensive Guide to Hepatitis Advances 2023. [DOI: 10.1016/b978-0-323-98368-6.00018-5] [Reference Citation Analysis]
20 Ogawa E, Nguyen MH. Hepatitis C: epidemiology, natural history, and diagnosis. Comprehensive Guide to Hepatitis Advances 2023. [DOI: 10.1016/b978-0-323-98368-6.00015-x] [Reference Citation Analysis]
21 Ichikawa H, Yasuda E, Kumada T, Takeshima K, Ogawa S, Tsunekawa A, Goto T, Nakaya K, Akita T, Tanaka J. Intra-individual comparison of liver stiffness measurements by magnetic resonance elastography and two-dimensional shear-wave elastography in 888 patients. Ultrasonography 2023;42:65-77. [PMID: 36366945 DOI: 10.14366/usg.22052] [Reference Citation Analysis]
22 Michel M, Wahl A, Anders M, Alqahtani SA, Kremer WM, Galle PR, Labenz C, Grimm D, Sprinzl M, Schattenberg JM. Significant liver fibrosis is a predictor of poor health-related quality of life in people living with HIV. Qual Life Res 2023;32:401-11. [PMID: 35996039 DOI: 10.1007/s11136-022-03232-w] [Reference Citation Analysis]
23 Song J, Liu Y, Chen J, Yang J, Wen J, Gao J, Shao C, Wang W, Tang YD. Fibrosis-4 stage of liver fibrosis predicts cardiovascular outcomes in acute coronary syndrome patients with and without type 2 diabetes mellitus. Diabetes Res Clin Pract 2023;195:110206. [PMID: 36502890 DOI: 10.1016/j.diabres.2022.110206] [Reference Citation Analysis]
24 Liu Y, Song J, Wang W, Zhang K, Yang J, Wen J, Meng X, Gao J, Wang J, Shao C, Tang YD. Association between liver fibrosis and thrombotic or bleeding events in acute coronary syndrome patients. Thromb J 2022;20:82. [PMID: 36578015 DOI: 10.1186/s12959-022-00441-8] [Reference Citation Analysis]
25 Canivet CM, Boursier J. Screening for Liver Fibrosis in the General Population: Where Do We Stand in 2022? Diagnostics (Basel) 2022;13. [PMID: 36611384 DOI: 10.3390/diagnostics13010091] [Reference Citation Analysis]
26 Kamada Y, Munekage K, Nakahara T, Fujii H, Sawai Y, Doi Y, Hyogo H, Sumida Y, Imai Y, Miyoshi E, Ono M; Japan Study Group of NAFLD (JSG-NAFLD). The FIB-4 Index Predicts the Development of Liver-Related Events, Extrahepatic Cancers, and Coronary Vascular Disease in Patients with NAFLD. Nutrients 2022;15. [PMID: 36615725 DOI: 10.3390/nu15010066] [Reference Citation Analysis]
27 Gök K, Takmaz T, Köse O, Tüten N, Bostancı MS, Özden S. Effectiveness of the Fibrosis-4 Score in Predicting Intrahepatic Cholestasis of Pregnancy. eamr 2022;38:299-303. [DOI: 10.4274/eamr.galenos.2022.30092] [Reference Citation Analysis]
28 Sim KC, Kim MJ, Cho Y, Kim HJ, Park BJ, Sung DJ, Han NY, Han YE, Kim TH, Lee YJ. Radiomics Analysis of Magnetic Resonance Proton Density Fat Fraction for the Diagnosis of Hepatic Steatosis in Patients With Suspected Non-Alcoholic Fatty Liver Disease. J Korean Med Sci 2022;37:e339. [PMID: 36536543 DOI: 10.3346/jkms.2022.37.e339] [Reference Citation Analysis]
29 Zerbato JM, Avihingsanon A, Singh KP, Zhao W, Deleage C, Rosen E, Cottrell ML, Rhodes A, Dantanarayana A, Tumpach C, Tennakoon S, Crane M, Price DJ, Braat S, Mason H, Roche M, Kashuba ADM, Revill PA, Audsley J, Lewin SR. HIV DNA persists in hepatocytes in people with HIV-hepatitis B co-infection on antiretroviral therapy. EBioMedicine 2023;87:104391. [PMID: 36502576 DOI: 10.1016/j.ebiom.2022.104391] [Reference Citation Analysis]
30 Petrella F, Manganaro L, Rizzo S. Editorial: State of the art body composition profiling: Advances in imaging modalities and patient outcomes. Front Oncol 2022;12:1096671. [PMID: 36544701 DOI: 10.3389/fonc.2022.1096671] [Reference Citation Analysis]
31 Elorz M, Benito-Boilos A, Marin BA, Pérez Díaz Del Campo N, Herrero JI, Monreal JI, Tur JA, Martínez JA, Zulet MA, Abete I. Neck Circumference for NAFLD Assessment during a 2-Year Nutritional Intervention: The FLiO Study. Nutrients 2022;14. [PMID: 36501189 DOI: 10.3390/nu14235160] [Reference Citation Analysis]
32 Pirasteh A, Periyasamy S, Meudt JJ, Liu Y, Lee LM, Schachtschneider KM, Schook LB, Gaba RC, Mao L, Said A, McMillan AB, Laeseke PF, Shanmuganayagam D. Staging Liver Fibrosis by Fibroblast Activation Protein Inhibitor PET in a Human-Sized Swine Model. J Nucl Med 2022;63:1956-61. [PMID: 35450958 DOI: 10.2967/jnumed.121.263736] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
33 Ueno T, Takase K, Deguchi K, Masahata K, Nomura M, Watanabe M, Kamiyama M, Tazuke Y, Bessho K, Okuyama H. Early detection of liver fibrosis with serum Mac-2 binding protein glycosylation-modified isomer (M2BPGi) during follow-up intestinal failure patients without intestinal failure-associated liver disease (IFALD). Pediatr Surg Int 2022;38:1807-13. [PMID: 36125546 DOI: 10.1007/s00383-022-05240-w] [Reference Citation Analysis]
34 Graf C, Friedrich-rust M. Elastografie: Stellenwert im Gastrointestinaltrakt. Gastroenterologie up2date 2022;18:349-366. [DOI: 10.1055/a-1810-5534] [Reference Citation Analysis]
35 Wear KA, Han A, Rubin JM, Gao J, Lavarello R, Cloutier G, Bamber J, Tuthill T. US Backscatter for Liver Fat Quantification: An AIUM-RSNA QIBA Pulse-Echo Quantitative Ultrasound Initiative. Radiology 2022;305:526-37. [PMID: 36255312 DOI: 10.1148/radiol.220606] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
36 Shukla TS, Gutlapalli SD, Farhat H, Irfan H, Muthiah K, Pallipamu N, Taheri S, Thiagaraj SS, Hamid P. The Usefulness of Combining Noninvasive Methods for Early Identification and Potential Prevention of Cystic Fibrosis-Associated Liver Disease. Cureus 2022;14:e32340. [PMID: 36628032 DOI: 10.7759/cureus.32340] [Reference Citation Analysis]
37 Abayli B, Abayli C, Gencdal G. Retrospective evaluation of liver transaminase abnormalities in asymptomatic and symptomatic patients according to liver biopsy results. J Contemp Med 2022;12:891-894. [DOI: 10.16899/jcm.1066589] [Reference Citation Analysis]
38 Aly RA, Foda RF, Al-warraky MS, Korayem EM. Liver elasticity assessment after biliary drainage in patients with extrahepatic cholestasis by shear wave sono-elastography (SWE). Egypt J Radiol Nucl Med 2022;53:246. [DOI: 10.1186/s43055-022-00924-8] [Reference Citation Analysis]
39 Sato S, Kawai H, Sato S, Iwasaki H, Omori M, Kita Y, Ikeda Y, Awatsu T, Murata A, Taniguchi G, Shimada Y, Genda T. Hypertension and diabetes mellitus are associated with high FIB-4 index in a health checkup examination cohort without known liver disease. BMC Gastroenterol 2022;22:478. [PMID: 36411436 DOI: 10.1186/s12876-022-02575-5] [Reference Citation Analysis]
40 Huang Y, Zeng Y, Bin G, Ding Q, Wu S, Tai DI, Tsui PH, Zhou Z. Evaluation of Hepatic Fibrosis Using Ultrasound Backscattered Radiofrequency Signals and One-Dimensional Convolutional Neural Networks. Diagnostics (Basel) 2022;12. [PMID: 36428892 DOI: 10.3390/diagnostics12112833] [Reference Citation Analysis]
41 Kiyoaki I, Sumida Y, Nakade Y, Okumura A, Nishimura S, Ibusuki M, Kitano R, Sakamoto K, Kimoto S, Inoue T, Kobayashi Y, Fukuzawa Y, Yoneda M. Mac-2 binding protein glycosylation isomer, the FIB-4 index, and a combination of the two as predictors of non-alcoholic steatohepatitis. PLoS ONE 2022;17:e0277380. [DOI: 10.1371/journal.pone.0277380] [Reference Citation Analysis]
42 Liu CH, Liu CJ, Su TH, Huang SC, Tseng TC, Wu JH, Chen PJ, Kao JH. Serum Mac-2 Binding Protein Glycosylation Isomer to Predict the Severity of Hepatic Fibrosis in Patients with Hepatitis C Virus Infection. Diagnostics (Basel) 2022;12. [PMID: 36359492 DOI: 10.3390/diagnostics12112650] [Reference Citation Analysis]
43 Hong SB, Lee NK, Kim S, Um K, Kim K, Kim IJ. Hepatic Fat Quantification with the Multi-Material Decomposition Algorithm by Using Low-Dose Non-Contrast Material-Enhanced Dual-Energy Computed Tomography in a Prospectively Enrolled Cohort. Medicina (Kaunas) 2022;58. [PMID: 36295617 DOI: 10.3390/medicina58101459] [Reference Citation Analysis]
44 Park HJ, Seo KI, Lee SU, Han BH, Yun BC, Park ET, Lee J, Hwang H, Yoon M. Clinical usefulness of Mac-2 binding protein glycosylation isomer for diagnosing liver cirrhosis and significant fibrosis in patients with chronic liver disease: A retrospective single-center study. Medicine (Baltimore) 2022;101:e30489. [PMID: 36221351 DOI: 10.1097/MD.0000000000030489] [Reference Citation Analysis]
45 Rathod K, Deshmukh H, Sundaram S, Radhakrishnan H, Thakkar D, Ramani N, Bhatia S. Plugged percutaneous liver biopsy using Tru-cut needle and coils: A retrospective study. Indian J Gastroenterol 2022;41:424-9. [PMID: 36422847 DOI: 10.1007/s12664-022-01271-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Cunha-silva M, Torres LD, Fernandes MF, Secundo TDML, Moreira MC, Yamanaka A, Monici LT, Costa LBED, Mazo DF, Sevá-pereira T. Changes in indications for outpatient percutaneous liver biopsy over 5 years: from hepatitis C to fatty liver disease. Gastroenterología y Hepatología (English Edition) 2022;45:579-584. [DOI: 10.1016/j.gastre.2021.12.005] [Reference Citation Analysis]
47 Ho Lee D, Young Lee J, Ihn Choi B. Evaluation of Liver Fibrosis Using Shear Wave Elastography: An Overview. Elastography - Applications in Clinical Medicine 2022. [DOI: 10.5772/intechopen.102853] [Reference Citation Analysis]
48 Şendur HN, Özdemir Kalkan D, Cerit MN, Kalkan G, Şendur AB, Özhan Oktar S. Hepatic Fat Quantification With Novel Ultrasound Based Techniques: A Diagnostic Performance Study Using Magnetic Resonance Imaging Proton Density Fat Fraction as Reference Standard. Can Assoc Radiol J. [DOI: 10.1177/08465371221123696] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 Ueno T, Takase K, Deguchi K, Masahata K, Nomura M, Watanabe M, Kamiyama M, Tazuke Y, Bessho K, Okuyama H. Early detection of liver fibrosis with serum Mac-2 binding protein glycosylation-modified isomer (M2BPGi) during follow-up intestinal failure patients without intestinal failure–associated liver disease (IFALD).. [DOI: 10.21203/rs.3.rs-2047447/v1] [Reference Citation Analysis]
50 Leone A, Bertoli S, Bedogni G, Vignati L, Pellizzari M, Battezzati A. Association between Mediterranean Diet and Fatty Liver in Women with Overweight and Obesity. Nutrients 2022;14. [PMID: 36145146 DOI: 10.3390/nu14183771] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
51 Liang J, Qiu B, Yin S, Chen Y, Zhang S. Predictive Value of Liver Stiffness Measurement by Magnetic Resonance Elastography for Complications after Liver Resection: A Systematic Review and Meta-Analysis. Digestion 2022;103:357-66. [PMID: 35780768 DOI: 10.1159/000525081] [Reference Citation Analysis]
52 Blukacz Ł, Nowak A, Wójtowicz M, Krawczyk A, Franik G, Madej P, Pluta D, Kowalczyk K, Żorniak M. Clinical Usefulness of Non-Invasive Metabolic-Associated Fatty Liver Disease Risk Assessment Methods in Patients with Full-Blown Polycystic Ovary Syndrome in Relation to the MRI Examination with the Ideal IQ Sequence. Biomedicines 2022;10:2193. [DOI: 10.3390/biomedicines10092193] [Reference Citation Analysis]
53 Chandramohan A. ARFI Elastography in Chronic Hepatitis B Virus Infection-The Sources of Variations. Indian J Radiol Imaging 2022;32:285-6. [PMID: 36177291 DOI: 10.1055/s-0042-1757423] [Reference Citation Analysis]
54 Ozturk A, Olson MC, Samir AE, Venkatesh SK. Liver fibrosis assessment: MR and US elastography. Abdom Radiol (NY) 2022;47:3037-50. [PMID: 34687329 DOI: 10.1007/s00261-021-03269-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
55 Daniş N. Karaciğer biyopsisi endikasyonlarında ve histopatolojik tanılarda yıllar içindeki değişim: 7 yıllık tek merkez deneyimi. Akademik Gastroenteroloji Dergisi 2022. [DOI: 10.17941/agd.1164387] [Reference Citation Analysis]
56 Strotzer QD, Winther H, Utpatel K, Scheiter A, Fellner C, Doppler MC, Ringe KI, Raab F, Haimerl M, Uller W, Stroszczynski C, Luerken L, Verloh N. Application of A U-Net for Map-like Segmentation and Classification of Discontinuous Fibrosis Distribution in Gd-EOB-DTPA-Enhanced Liver MRI. Diagnostics 2022;12:1938. [DOI: 10.3390/diagnostics12081938] [Reference Citation Analysis]
57 Fujimoto K, Shiinoki T, Yuasa Y, Kawazoe Y, Yamane M, Sera T, Tanaka H. Assessing liver fibrosis distribution through liver elasticity estimates obtained using a biomechanical model of respiratory motion with magnetic resonance elastography. Phys Med Biol 2022;67:155005. [DOI: 10.1088/1361-6560/ac7d35] [Reference Citation Analysis]
58 Wada N, Fujita N, Ishimatsu K, Takao S, Yoshizumi T, Miyazaki Y, Oda Y, Nishie A, Ishigami K, Ushijima Y. A novel fast kilovoltage switching dual-energy computed tomography technique with deep learning: Utility for non-invasive assessments of liver fibrosis. European Journal of Radiology 2022. [DOI: 10.1016/j.ejrad.2022.110461] [Reference Citation Analysis]
59 Jinato T, Chayanupatkul M, Dissayabutra T, Chutaputti A, Tangkijvanich P, Chuaypen N. Litchi-Derived Polyphenol Alleviates Liver Steatosis and Gut Dysbiosis in Patients with Non-Alcoholic Fatty Liver Disease: A Randomized Double-Blinded, Placebo-Controlled Study. Nutrients 2022;14:2921. [PMID: 35889878 DOI: 10.3390/nu14142921] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
60 Cairoli V, De Matteo E, Casciato P, Ameigeiras B, Preciado MV, Valva P. The performance of soluble CD163 as a non-invasive biomarker of liver damage in chronically HCV and HCV/HIV infected subjects. PLoS ONE 2022;17:e0270911. [DOI: 10.1371/journal.pone.0270911] [Reference Citation Analysis]
61 Kamada Y, Nakahara T, Munekage K, Fujii H, Sawai Y, Doi Y, Ono M, Hyogo H, Sumida Y, Morishita K, Asuka T, Ouchida T, Imai Y, Miyoshi E; Japan Study Group of NAFLD. Serum Mac-2 binding protein level predicts the development of liver-related events and colorectal cancer in patients with NAFLD. Hepatol Commun 2022;6:1527-36. [PMID: 35478356 DOI: 10.1002/hep4.1934] [Reference Citation Analysis]
62 Welle CL, Olson MC, Reeder SB, Venkatesh SK. Magnetic Resonance Imaging of Liver Fibrosis, Fat, and Iron. Radiologic Clinics of North America 2022. [DOI: 10.1016/j.rcl.2022.04.003] [Reference Citation Analysis]
63 Horst LJ, Weidemann S, Lohse AW, Sebode M. [Hepatic granuloma-A diagnostic challenge]. Z Rheumatol 2022. [PMID: 35763059 DOI: 10.1007/s00393-022-01235-z] [Reference Citation Analysis]
64 Feng M, Lei L, Xu J, Shi Y, Yang W. Platelet-to-Portal Vein Width Ratio and Platelet-to-Spleen Thickness Ratio Can Be Used to Predict Progressive Liver Fibrosis Among Patients With HBV Infection With HBeAg-Negativity and a Normal ALT Level. Front Med 2022;9:837898. [DOI: 10.3389/fmed.2022.837898] [Reference Citation Analysis]
65 Chuaypen N, Siripongsakun S, Hiranrat P, Tanpowpong N, Avihingsanon A, Tangkijvanich P. Improvement of liver fibrosis, but not steatosis, after HCV eradication as assessment by MR-based imaging: Role of metabolic derangement and host genetic variants. PLoS ONE 2022;17:e0269641. [DOI: 10.1371/journal.pone.0269641] [Reference Citation Analysis]
66 Li T, Wang P, Gong X, Chong W, Hai Y, You C, Kang J, Fang F, Zhang Y. Prevalence and Prognostic Significance of Liver Fibrosis in Patients With Aneurysmal Subarachnoid Hemorrhage. Front Neurol 2022;13:850405. [DOI: 10.3389/fneur.2022.850405] [Reference Citation Analysis]
67 Yazaki T, Tobita H, Sato S, Miyake T, Kataoka M, Ishihara S. Combinational elastography for assessment of liver fibrosis in patients with liver injury. J Int Med Res 2022;50:3000605221100126. [PMID: 35735003 DOI: 10.1177/03000605221100126] [Reference Citation Analysis]
68 Lai C, Zhao Y, Zou X, Liang Y, Lin W. Quantification of lipid droplets polarity for evaluating non-alcoholic fatty liver disease via fluorescence lifetime imaging. Sensors and Actuators B: Chemical 2022;369:132267. [DOI: 10.1016/j.snb.2022.132267] [Reference Citation Analysis]
69 Kongkam P, Nalinthassanai N, Prueksapanich P, Sanpavat A, Cañones AR, Luangsukrerk T, Angsuwatcharakon P, Ridtitid W, Kullavanijaya P, Treeprasertsuk S, Rerknimitr R. A comparison of the antegrade core trap and reverse bevel needles for EUS-guided fine-needle biopsy sampling of liver mass: a prospective randomized cross over study. HPB (Oxford) 2022;24:797-805. [PMID: 34794898 DOI: 10.1016/j.hpb.2021.10.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
70 Chen Z, Yang R, Xu Y, Liang L, Ao S, Wang Z, Bai P, Gu D, Duan X, Liu Y, Zhong W, Xu P, Deng T, Zeng G, Wang C. PET Imaging of Bromodomain and Extra-Terminal Domain Inhibitors for the Noninvasive Assessment of Metabolic Changes in the Liver and Brain of Early-Stage Alcoholic Liver Disease. Mol Pharm 2022. [PMID: 35604773 DOI: 10.1021/acs.molpharmaceut.2c00143] [Reference Citation Analysis]
71 Zhelezniakova N, Babak O, Aleksandrova T. MODERN METHODS OF DIAGNOSIS AND SCREENING OF NON-ALCOHOLIC FATTY LIVER DISEASE AND ITS STAGES: review. IC 2022;8:226-231. [DOI: 10.35339/ic.8.4.226-231] [Reference Citation Analysis]
72 Cioni D, Gabelloni M, Sanguinetti A, De Rosa L, Aringhieri G, Tintori R, Candita G, Febi M, Faita F, Lencioni R, Neri E. A New SteatoScore in the Evaluation of Non-Alcoholic Liver Disease in Oncologic Patients. Front Oncol 2022;12:873524. [PMID: 35574336 DOI: 10.3389/fonc.2022.873524] [Reference Citation Analysis]
73 Vali Y, Eijk R, Hicks T, Jones WS, Suklan J, Holleboom AG, Ratziu V, Langendam MW, Anstee QM, Bossuyt PMM; LITMUS Investigators. Clinicians' Perspectives on Barriers and Facilitators for the Adoption of Non-Invasive Liver Tests for NAFLD: A Mixed-Method Study. J Clin Med 2022;11:2707. [PMID: 35628838 DOI: 10.3390/jcm11102707] [Reference Citation Analysis]
74 Cetinic I, de Lange C, Simrén Y, Ekvall N, Östling M, Stén L, Boström H, Lagerstrand K, Hebelka H. Ultrasound Shear Wave Elastography, Shear Wave Dispersion and Attenuation Imaging of Pediatric Liver Disease with Histological Correlation. Children (Basel) 2022;9. [PMID: 35626865 DOI: 10.3390/children9050692] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
75 Sim KC, Kim MJ, Cho Y, Kim HJ, Park BJ, Sung DJ, Han YE, Han NY, Kim TH, Lee YJ. Diagnostic Feasibility of Magnetic Resonance Elastography Radiomics Analysis for the Assessment of Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. J Comput Assist Tomogr 2022. [PMID: 35483092 DOI: 10.1097/RCT.0000000000001308] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
76 Balachandran YL, Wang W, Yang H, Tong H, Wang L, Liu F, Chen H, Zhong K, Liu Y, Jiang X. Heterogeneous Iron Oxide/Dysprosium Oxide Nanoparticles Target Liver for Precise Magnetic Resonance Imaging of Liver Fibrosis. ACS Nano 2022;16:5647-59. [PMID: 35312295 DOI: 10.1021/acsnano.1c10618] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
77 Bae J, Kim JE, Perumalsamy H, Park S, Kim Y, Jun DW, Yoon TH. Mass Cytometry Study on Hepatic Fibrosis and Its Drug-Induced Recovery Using Mouse Peripheral Blood Mononuclear Cells. Front Immunol 2022;13:814030. [PMID: 35222390 DOI: 10.3389/fimmu.2022.814030] [Reference Citation Analysis]
78 Renninger CH, Jaeblon T, Slobogean GP, O'Toole RV, O'Hara NN. Patients With Cirrhosis Who Have a Model for End-stage Liver Disease Sodium Score of 8 or Greater Are at Increased Risk of Poor Outcomes in Operatively Treated Tibia Fractures. Orthopedics 2022;45:79-85. [PMID: 35021031 DOI: 10.3928/01477447-20220105-01] [Reference Citation Analysis]
79 Choo D, Shin KS, Min JH, You SK, Kim KH, Lee JE. Noninvasive Assessment of Liver Fibrosis with ElastPQ in Patients with Chronic Viral Hepatitis: Comparison Using Histopathological Findings. Diagnostics (Basel) 2022;12. [PMID: 35328259 DOI: 10.3390/diagnostics12030706] [Reference Citation Analysis]
80 Venkatesh SK, Torbenson MS. Liver fibrosis quantification. Abdom Radiol (NY) 2022;47:1032-52. [PMID: 35022806 DOI: 10.1007/s00261-021-03396-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
81 Singh A, Case JB. Laparoscopic Liver Biopsy, Resection, Ablation and Cholecystocentesis. Small Animal Laparoscopy and Thoracoscopy 2022. [DOI: 10.1002/9781119666912.ch15] [Reference Citation Analysis]
82 Wang XD, Pan CW, Zhou GY, Gao F, Wang FL, Fu RQ, Xiao EH, Li P, Zhang H, Zheng MH. Effect of liver steatosis on liver stiffness measurement in chronic hepatitis B patients with normal serum alanine aminotransferase levels: A multicentre cohort study. J Viral Hepat 2022;29:196-204. [PMID: 34902216 DOI: 10.1111/jvh.13640] [Reference Citation Analysis]
83 Huang K, Li Q, Zeng W, Chen X, Liu L, Wan X, Feng C, Li Z, Liu Z, Dong C. Ultrasound score combined with liver stiffness measurement by sound touch elastography for staging liver fibrosis in patients with chronic hepatitis B: a clinical prospective study. Ann Transl Med 2022;10:271. [PMID: 35434021 DOI: 10.21037/atm-22-505] [Reference Citation Analysis]
84 Han SK, Kim MY, Kang SH, Baik SK. Application of ultrasound for the diagnosis of cirrhosis/portal hypertension. J Med Ultrason (2001) 2022. [PMID: 35179669 DOI: 10.1007/s10396-022-01191-w] [Reference Citation Analysis]
85 De Rosa L, Salvati A, Bonino F, Brunetto MR, Faita F. Effects of Different Scan Projections on the Quantitative Ultrasound-Based Evaluation of Hepatic Steatosis. Healthcare 2022;10:374. [DOI: 10.3390/healthcare10020374] [Reference Citation Analysis]
86 Marri UK, Madhusudhan KS. Dual-Energy Computed Tomography in Diffuse Liver Diseases. Journal of Gastrointestinal and Abdominal Radiology. [DOI: 10.1055/s-0042-1742432] [Reference Citation Analysis]
87 Donners R, Zaugg C, Gehweiler JE, Boldanova T, Heim MH, Terracciano LM, Boll DT. Computed tomography (CT) and magnetic resonance imaging (MRI) of diffuse liver disease: a multiparametric predictive modelling algorithm can aid categorization of liver parenchyma. Quant Imaging Med Surg 2022;12:1186-97. [PMID: 35111615 DOI: 10.21037/qims-21-384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 Dawod E, Nieto J, Saab S. Endoscopic Ultrasound-Guided Liver Biopsy: Where Do We Stand? Am J Gastroenterol 2022;117:205-8. [PMID: 34797223 DOI: 10.14309/ajg.0000000000001551] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Higuchi M, Tamaki N, Kurosaki M, Inada K, Kirino S, Yamashita K, Hayakawa Y, Osawa L, Takaura K, Maeyashiki C, Kaneko S, Yasui Y, Takahashi Y, Tsuchiya K, Nakanishi H, Itakura J, Loomba R, Enomoto N, Izumi N. Longitudinal association of magnetic resonance elastography-associated liver stiffness with complications and mortality. Aliment Pharmacol Ther 2022;55:292-301. [PMID: 34927277 DOI: 10.1111/apt.16745] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 14.0] [Reference Citation Analysis]
90 Jiang K, Zhang L, Li J, Hu H, Huang Q, Qiu T, Mo X, Ren J, Guo W, Tao Y, Cui H, Zuo Y, Chen X, Xie Y, Li Y, Liang H, Liu Z, Xie L, Mao R, Jiang Q, Huang K. Diagnostic efficacy of FibroScan for liver inflammation in patients with chronic hepatitis B: a single-center study with 1185 liver biopsies as controls. BMC Gastroenterol 2022;22. [DOI: 10.1186/s12876-022-02108-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
91 Mukund A, Rana S, Mohan C, Kalra N, Baijal SS. Indian College of Radiology and Imaging Evidence-Based Guidelines for Interventions in Portal Hypertension and Its Complications. Indian J Radiol Imaging. [DOI: 10.1055/s-0041-1740235] [Reference Citation Analysis]
92 Diehl DL. How to do Endoscopic Ultrasound‐guided Liver Biopsy. Atlas of Endoscopic Ultrasonography 2022. [DOI: 10.1002/9781119522997.ch41] [Reference Citation Analysis]
93 Toyoda H, Atsukawa M, Uojima H, Nozaki A, Takaguchi K, Hiraoka A, Itobayashi E, Watanabe T, Matsuura K, Shimada N, Abe H, Tsuji K, Itokawa N, Mikami S, Ishikawa T, Oikawa T, Yasuda S, Chuma M, Tsutsui A, Ikeda H, Arai T, Tsubota A, Kumada T, Tanaka Y, Tanaka J. The Impact of Cirrhosis and History of Hepatocellular Carcinoma on All-Cause Mortality After Eradication of Hepatitis C Virus in Patients With Chronic Hepatitis C. Gastro Hep Advances 2022;1:508-515. [DOI: 10.1016/j.gastha.2022.02.018] [Reference Citation Analysis]
94 Pineda M, Cárdenas LL, Navarro J, Sánchez-Palencia DM, López-Panqueva RDP, Pérez JM, Briceño JC. Prevention of bleeding after percutaneous biopsy with a small intestinal submucosa hemostatic plug. Acta Biomater 2022;137:103-11. [PMID: 34687955 DOI: 10.1016/j.actbio.2021.10.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
95 Ekin N, Ucmak F, Ebik B, Tugba Tuncel E, Kacmaz H, Arpa M, Engin Atay A. GPR, King's Score and S-Index are superior to other non-invasive fibrosis markers in predicting the liver fibrosis in chronic Hepatitis B patients. Acta Gastroenterol Belg 2022;85:62-8. [PMID: 35304995 DOI: 10.51821/85.1.9156] [Reference Citation Analysis]
96 Ishikawa T, Ohashi K, Kodama E, Kobayashi T, Azumi M, Nozawa Y, Iwanaga A, Sano T, Honma T. Histologic Analysis of Transjugular Liver Biopsy Specimens for Early Prediction of Prognosis in Acute Liver Failure. Gastro Hep Advances 2022;1:431-436. [DOI: 10.1016/j.gastha.2022.02.017] [Reference Citation Analysis]
97 Fitzpatrick E. Nonalcoholic Fatty Liver Disease. In Clinical Practice 2022. [DOI: 10.1007/978-3-030-98808-1_10] [Reference Citation Analysis]
98 Yoneda M, Honda Y, Nogami A, Imajo K, Nakajima A. Advances in ultrasound elastography for nonalcoholic fatty liver disease. Jpn J Med Ultrasonics 2022;49:397-410. [DOI: 10.3179/jjmu.jjmu.r.202] [Reference Citation Analysis]
99 Sarkar A, Dellatore P, Bhurwal A, Tyberg A, Shahid H, Minacapelli CD, Kahaleh M, Rustgi VK, Nieto J. Endoscopic Ultrasound-Guided Liver Biopsy in Clinical Practice. Gastro Hep Advances 2022;1:936-941. [DOI: 10.1016/j.gastha.2022.07.007] [Reference Citation Analysis]
100 De A, Keisham A, Mishra S, Mehta M, Verma N, Premkumar M, Taneja S, Das A, Singh V, Duseja A. FibroScan-AST (FAST) Score for Nonalcoholic Steatohepatitis - Validation in an Indian Cohort. J Clin Exp Hepatol 2022;12:440-7. [PMID: 35535068 DOI: 10.1016/j.jceh.2021.06.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
101 Bergasa NV. Complications of Liver Disease. Clinical Cases in Hepatology 2022. [DOI: 10.1007/978-1-4471-4715-2_15] [Reference Citation Analysis]
102 Henning Niehoff J, Michael Woeltjen M, Saeed S, Elias Michael A, Boriesosdick J, Borggrefe J, Robert Kroeger J. Assessment of Hepatic Steatosis Based on Virtual Non-Contrast Computed Tomography: Initial Experiences with a Photon Counting Scanner Approved for Clinical Use. European Journal of Radiology 2022. [DOI: 10.1016/j.ejrad.2022.110185] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
103 鲁 景. Research Progress of Non-Invasive Diagnostic Methods for Hepatic Steatosis in Patients with Chronic Hepatitis B. ACM 2022;12:7400-7404. [DOI: 10.12677/acm.2022.1281068] [Reference Citation Analysis]
104 Fitzpatrick E. Nonalcoholic Fatty Liver Disease. Textbook of Pediatric Gastroenterology, Hepatology and Nutrition 2022. [DOI: 10.1007/978-3-030-80068-0_69] [Reference Citation Analysis]
105 Hart GR, Yan V, Nartowt BJ, Roffman DA, Stark G, Muhammad W, Deng J. Statistical biopsy: An emerging screening approach for early detection of cancers. Front Artif Intell 2022;5:1059093. [PMID: 36744110 DOI: 10.3389/frai.2022.1059093] [Reference Citation Analysis]
106 Ishikawa T, Kodama E, Kobayashi T, Azumi M, Nozawa Y, Iwanaga A, Sano T, Honma T. Clinical Usefulness of Transjugular Liver Biopsy in Patients With Hematological Diseases With Liver Dysfunction. Cureus 2021;13:e19555. [PMID: 34917436 DOI: 10.7759/cureus.19555] [Reference Citation Analysis]
107 Rungta S, Kumari S, Verma K, Akhtar G, Deep A Sr, Swaroop S. A Comparative Analysis of the APRI, FIB4, and FibroScan Score in Evaluating the Severity of Chronic Liver Disease in Chronic Hepatitis B Patients in India. Cureus 2021;13:e19342. [PMID: 34909303 DOI: 10.7759/cureus.19342] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
108 Kaufman CS, Cretcher MR. Transjugular Liver Biopsy. Tech Vasc Interv Radiol 2021;24:100795. [PMID: 34895709 DOI: 10.1016/j.tvir.2021.100795] [Reference Citation Analysis]
109 Wang Z, Yang X, Gui S, Yang F, Cao Z, Cheng R, Xia X, Li C. The Roles and Mechanisms of lncRNAs in Liver Fibrosis. Front Pharmacol 2021;12:779606. [PMID: 34899344 DOI: 10.3389/fphar.2021.779606] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
110 Nastasa R, Stanciu C, Zenovia S, Singeap AM, Cojocariu C, Sfarti C, Girleanu I, Chiriac S, Cuciureanu T, Huiban L, Muzica CM, Trifan A. The Prevalence of Liver Steatosis and Fibrosis Assessed by Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter in Apparently Healthy Romanian Medical Students. Diagnostics (Basel) 2021;11. [PMID: 34943578 DOI: 10.3390/diagnostics11122341] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
111 Pollack BL, Batmanghelich K, Cai SS, Gordon E, Wallace S, Catania R, Morillo-Hernandez C, Furlan A, Borhani AA. Deep Learning Prediction of Voxel-Level Liver Stiffness in Patients with Nonalcoholic Fatty Liver Disease. Radiol Artif Intell 2021;3:e200274. [PMID: 34870213 DOI: 10.1148/ryai.2021200274] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
112 McBennett K, MacAskill CJ, Keshock E, Mahani MG, Mata J, Towbin AJ, Sankararaman S, Drumm ML, Yu X, Ren CL, Nasr SZ, Kutney K, Flask CA. Magnetic resonance imaging of cystic fibrosis: Multi-organ imaging in the age of CFTR modulator therapies. J Cyst Fibros 2021:S1569-1993(21)02143-3. [PMID: 34879996 DOI: 10.1016/j.jcf.2021.11.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
113 Amernia B, Moosavy SH, Banookh F, Zoghi G. FIB-4, APRI, and AST/ALT ratio compared to FibroScan for the assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease in Bandar Abbas, Iran. BMC Gastroenterol 2021;21:453. [PMID: 34861841 DOI: 10.1186/s12876-021-02038-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
114 Price A, Schwertner A, Tran D, Kohi M, Pallav Kolli K, Taylor A, Fidelman N. Outcomes of transjugular liver biopsies for liver transplant recipients with bicaval and piggyback hepatic vein anastomoses. Acta Radiol 2021;62:1537-47. [PMID: 33167667 DOI: 10.1177/0284185120969953] [Reference Citation Analysis]
115 Alsowey AM, Shehata SM. Non-invasive staging of liver fibrosis by two-dimensional shear wave elastography (2D-SWE) in patients with chronic hepatitis C and B. Egypt J Radiol Nucl Med 2021;52:122. [DOI: 10.1186/s43055-021-00502-4] [Reference Citation Analysis]
116 Sarafiloski G, Marinova MR, Tonchev PT. Intrahepatic Hematoma and Haemobilia after Percutaneous Liver Biopsy: A Clinical Case Report. Journal of Biomedical and Clinical Research 2021;14:182-185. [DOI: 10.2478/jbcr-2021-0014] [Reference Citation Analysis]
117 Bang JY, Ward TJ, Guirguis S, Krall K, Contreras F, Jhala N, Navaneethan U, Hawes RH, Varadarajulu S. Radiology-guided percutaneous approach is superior to EUS for performing liver biopsies. Gut 2021;70:2224-6. [PMID: 33766911 DOI: 10.1136/gutjnl-2021-324495] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
118 Rudolph B, Selig T, Li Y, Ovchinsky N, Kogan-Liberman D, Liszewski MC, Levin T, Ewart M, Liu Q, Viswanathan S, Lin J, Xue X, Burk RD, Strickler HD. Relationship of Vitamin D Deficiency and Fatty Liver in Children as Defined by Multiple Imaging and Histologic Endpoints. JPGN Rep 2021;2:e077. [PMID: 34723254 DOI: 10.1097/PG9.0000000000000077] [Reference Citation Analysis]
119 Numao H, Shimaya K, Kakuta A, Shibutani K, Igarashi S, Hasui K, Hanabata N, Kanazawa K, Munakata M. The utility of two-dimensional real-time shear wave elastography for assessing liver fibrosis in patients with chronic hepatitis C virus infection. Eur J Gastroenterol Hepatol 2021;33:1400-7. [PMID: 32804841 DOI: 10.1097/MEG.0000000000001887] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
120 Kanki A, Maeba K, Sotozono H, Yasokawa K, Higaki A, Yamamoto A, Tamada T. Evaluation of liver fibrosis using hepatic extracellular volume fraction by contrast-enhanced computed tomography before and after direct-acting antiviral therapy in patients with chronic hepatitis C infection: comparison with serological liver fibrosis markers. Br J Radiol 2021;94:20210045. [PMID: 34586878 DOI: 10.1259/bjr.20210045] [Reference Citation Analysis]
121 Stefano JT, Guedes LV, de Souza AAA, Vanni DS, Alves VAF, Carrilho FJ, Largura A, Arrese M, Oliveira CP. Usefulness of collagen type IV in the detection of significant liver fibrosis in nonalcoholic fatty liver disease. Ann Hepatol 2021;20:100253. [PMID: 32949785 DOI: 10.1016/j.aohep.2020.08.070] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
122 Chang CC, Huang ZY, Shih SF, Luo Y, Ko A, Cui Q, Sumner J, Cavallero S, Das S, Gao W, Sinsheimer J, Bui A, Jacobs JP, Pajukanta P, Wu H, Tai YC, Li Z, Hsiai TK. Electrical impedance tomography for non-invasive identification of fatty liver infiltrate in overweight individuals. Sci Rep 2021;11:19859. [PMID: 34615918 DOI: 10.1038/s41598-021-99132-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
123 Sahin S, Karadeniz A. Pancretic Fat Accummulation is Associated with Subclinical Atherosclerosis. Angiology 2021;:33197211038334. [PMID: 34607492 DOI: 10.1177/00033197211038334] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
124 Higashiura A, Nishimura T, Yoshida M, Nishimura J, Hashimoto M, Shibata Y, Fujiwara A, Yuri Y, Takashima T, Aizawa N, Ikeda N, Enomoto H, Imamura M, Miyoshi Y, Hirota S, Iijima H. Breast cancer diffuse liver metastasis with high liver stiffness using ultrasound elastography. Acta hepatologica Japonica 2021;62:647-655. [DOI: 10.2957/kanzo.62.647] [Reference Citation Analysis]
125 Yoo JJ, Kim SG, Kim YS. The Diagnostic Accuracy of LOGIQ S8 and E9 Shear Wave Elastography for Staging Hepatic Fibrosis, in Comparison with Transient Elastography. Diagnostics (Basel) 2021;11:1817. [PMID: 34679515 DOI: 10.3390/diagnostics11101817] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
126 Ruan D, Shi Y, Jin L, Yang Q, Yu W, Ren H, Zheng W, Chen Y, Zheng N, Zheng M. An ultrasound image-based deep multi-scale texture network for liver fibrosis grading in patients with chronic HBV infection. Liver Int 2021;41:2440-54. [PMID: 34219353 DOI: 10.1111/liv.14999] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
127 Yoo SH, Lim TS, Lee HW, Kim JK, Lee JS, Lee HW, Kim BK, Park JY, Kim DY, Ahn SH, Lee JI, Lee KS, Kim SU. Risk assessment of hepatocellular carcinoma and liver-related events using ultrasonography and transient elastography in patients with chronic hepatitis B. J Viral Hepat 2021;28:1362-72. [PMID: 34185929 DOI: 10.1111/jvh.13560] [Reference Citation Analysis]
128 Anteby R, Klang E, Horesh N, Nachmany I, Shimon O, Barash Y, Kopylov U, Soffer S. Deep learning for noninvasive liver fibrosis classification: A systematic review. Liver Int 2021;41:2269-78. [PMID: 34008300 DOI: 10.1111/liv.14966] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
129 Saoi M, Britz-McKibbin P. New Advances in Tissue Metabolomics: A Review. Metabolites 2021;11:672. [PMID: 34677387 DOI: 10.3390/metabo11100672] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
130 Cui Q, He F, Hu J, Li S, Guo D, Bie X, Liu W, Zhao Y. Evaluation of Rabbits Liver Fibrosis Using Gd-DTPA-BMA of Dynamic Contrast-Enhanced Magnetic Resonance Imaging. Evid Based Complement Alternat Med 2021;2021:2791142. [PMID: 34567208 DOI: 10.1155/2021/2791142] [Reference Citation Analysis]
131 Jing H, Yi Z, He E, Xu R, Shi X, Li L, Sun L, Liu Y, Zhang L, Qian L. Evaluation of Risk Factors for Bleeding After Ultrasound-Guided Liver Biopsy. Int J Gen Med 2021;14:5563-71. [PMID: 34539186 DOI: 10.2147/IJGM.S328205] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
132 Wu YL, Kumar R, Wang MF, Singh M, Huang JF, Zhu YY, Lin S. Validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease. World J Gastroenterol 2021; 27(34): 5753-5763 [PMID: 34629799 DOI: 10.3748/wjg.v27.i34.5753] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
133 Prasad VK, Bala B, Basumazumder B, Narayan Ray A. ASSESSMENT OF LIVER FIBROSIS IN ALCOHOLIC PATIENTS BY USING FIBROSCAN IN A TERTIARY CARE HOSPITAL. IJAR. [DOI: 10.36106/ijar/2004149] [Reference Citation Analysis]
134 Cho HJ, Choi J, Kim B, Ko J, Choi JI, Huh J, Lee JH, Kim JK. Combining hepatic surface nodularity and serum tests better predicts hepatic fibrosis stages in chronic liver disease. Abdom Radiol (NY) 2021;46:4189-99. [PMID: 33977353 DOI: 10.1007/s00261-021-03113-9] [Reference Citation Analysis]
135 Lee DH. Quantitative assessment of fatty liver using ultrasound attenuation imaging. J Med Ultrason (2001) 2021;48:465-70. [PMID: 34453237 DOI: 10.1007/s10396-021-01132-z] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
136 Grieser C. Editorial comment: advances in the evaluation of liver imaging and function with gadoxetic acid-enhanced MRI. Eur Radiol 2021;31:8374-5. [PMID: 34424395 DOI: 10.1007/s00330-021-08182-4] [Reference Citation Analysis]
137 Vetter M, Kremer AE, Agaimy A, Pfeifer L, Neurath MF, Siebler J, Zopf S. How Much Liver Tissue Is Required for Sufficient Histological Staging in Patients with Primary Biliary Cholangitis? Digestion 2021;102:428-36. [PMID: 32492681 DOI: 10.1159/000507392] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
138 Audière S, Labourdette A, Miette V, Fournier C, Ternifi R, Boussida S, Pouletaut P, Charleux F, Bensamoun SF, Harrison SA, Sandrin L. Improved Ultrasound Attenuation Measurement Method for the Non-invasive Evaluation of Hepatic Steatosis Using FibroScan. Ultrasound Med Biol 2021;47:3181-95. [PMID: 34373137 DOI: 10.1016/j.ultrasmedbio.2021.07.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
139 Cui E, Long W, Wu J, Li Q, Ma C, Lei Y, Lin F. Predicting the stages of liver fibrosis with multiphase CT radiomics based on volumetric features. Abdom Radiol (NY) 2021;46:3866-76. [PMID: 33751193 DOI: 10.1007/s00261-021-03051-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
140 Fujita K, Masaki T. Serum Biomarkers of Liver Fibrosis Staging in the Era of the Concept "Compensated Advanced Chronic Liver Disease". J Clin Med 2021;10:3340. [PMID: 34362121 DOI: 10.3390/jcm10153340] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
141 Kesimal U, Öztürk Durmaz Ş. Kronik Hepatit B Hastalarında Non-invaziv Fibrozis Skorlama Yöntemlerinin Karaciğer Biyopsisi ile Karşılaştırılması. Akdeniz Medical Journal 2021;7:283-288. [DOI: 10.53394/akd.959578] [Reference Citation Analysis]
142 Khalifa A, Lewin DN, Sasso R, Rockey DC. The Utility of Liver Biopsy in the Evaluation of Liver Disease and Abnormal Liver Function Tests. Am J Clin Pathol 2021;156:259-67. [PMID: 33693456 DOI: 10.1093/ajcp/aqaa225] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
143 Bilgin E, Yaltirik Bilgin E, Özhan Oktar S. The role of sonoelastography in the evaluation of hepatic fibrosis in pediatric patients. Journal of Surgery and Medicine 2021;5:700-704. [DOI: 10.28982/josam.817897] [Reference Citation Analysis]
144 Roh YH, Kang BK, Jun DW, Lee CM, Kim M. Role of FIB-4 for reassessment of hepatic fibrosis burden in referral center. Sci Rep 2021;11:13616. [PMID: 34193951 DOI: 10.1038/s41598-021-93038-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
145 Meneses A, Santabárbara JM, Romero JA, Aliaga R, Maceira AM, Moratal D. Determination of Non-Invasive Biomarkers for the Assessment of Fibrosis, Steatosis and Hepatic Iron Overload by MR Image Analysis. A Pilot Study. Diagnostics (Basel) 2021;11:1178. [PMID: 34209547 DOI: 10.3390/diagnostics11071178] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
146 Prieto Ortiz JE, Garzón-orjuela N, Sánchez Pardo S, Prieto Ortíz RG, Ochoa Díaz AF, Eslava-schmalbach JH. Calidad de la biopsia hepática en diez instituciones hospitalarias de Bogotá. Rev colomb Gastroenterol 2021;36:191-199. [DOI: 10.22516/25007440.613] [Reference Citation Analysis]
147 Connoley D, Patel PJ, Hogan B, Tanwar S, Rhodes F, Parkes J, Burt A, Watkins J, Sievert W, Rosenberg W. The Enhanced Liver Fibrosis test maintains its diagnostic and prognostic performance in alcohol-related liver disease: a cohort study. BMC Gastroenterol 2021;21:268. [PMID: 34182924 DOI: 10.1186/s12876-021-01795-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
148 Tamaki N, Kurosaki M, Yasui Y, Tsuchiya K, Izumi N. Attenuation coefficient (ATT) measurement for liver fat quantification in chronic liver disease. J Med Ultrason (2001) 2021. [PMID: 34165645 DOI: 10.1007/s10396-021-01103-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
149 Ding Z, Lin K, Fu J, Huang Q, Fang G, Tang Y, You W, Lin Z, Lin Z, Pan X, Zeng Y. An MR-based radiomics model for differentiation between hepatocellular carcinoma and focal nodular hyperplasia in non-cirrhotic liver. World J Surg Oncol 2021;19:181. [PMID: 34154624 DOI: 10.1186/s12957-021-02266-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
150 Fujii H, Enomoto M, Fukumoto S, Kimura T, Nadatani Y, Takashima S, Hagihara A, Uchida-Kobayashi S, Tamori A, Nishimoto N, Kawada N. Validation of a two-step approach combining serum biomarkers and liver stiffness measurement to predict advanced fibrosis. JGH Open 2021;5:801-8. [PMID: 34263075 DOI: 10.1002/jgh3.12590] [Reference Citation Analysis]
151 Lee SH, Shin HP, Lee JI. Real-world single-center experience with direct-acting antivirals for improvement of the liver fibrosis after chronic hepatitis C treatment. Antivir Chem Chemother 2020;28:2040206620974835. [PMID: 33215505 DOI: 10.1177/2040206620974835] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
152 Vali Y, Lee J, Boursier J, Spijker R, Verheij J, Brosnan MJ, Anstee QM, Bossuyt PM, Zafarmand MH, On Behalf Of The Litmus Systematic Review Team. FibroTest for Evaluating Fibrosis in Non-Alcoholic Fatty Liver Disease Patients: A Systematic Review and Meta-Analysis. J Clin Med 2021;10:2415. [PMID: 34072480 DOI: 10.3390/jcm10112415] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
153 Toyoda H, Kikuchi K, Tsuruta Y, Hiraoka A, Tsuji K, Tanaka J. Utility of serological tumor biomarkers for surveillance of hepatocellular carcinoma in patients undergoing dialysis. Nephrol Dial Transplant 2021;36:1097-103. [PMID: 33009910 DOI: 10.1093/ndt/gfaa165] [Reference Citation Analysis]
154 Miyoshi T, Hamaguchi M, Kitagawa N, Hashimoto Y, Fukui M. Correlation between Liver Stiffness by Two-Dimensional Shear Wave Elastography and Waist Circumference in Japanese Local Citizens with Abdominal Obesity. J Clin Med 2021;10:1971. [PMID: 34064337 DOI: 10.3390/jcm10091971] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
155 Chuaypen N, Chittmittrapap S, Avihingsanon A, Siripongsakun S, Wongpiyabovorn J, Tanpowpong N, Tanaka Y, Tangkijvanich P. Liver fibrosis improvement assessed by magnetic resonance elastography and Mac-2-binding protein glycosylation isomer in patients with hepatitis C virus infection receiving direct-acting antivirals. Hepatol Res 2021;51:528-37. [PMID: 33615687 DOI: 10.1111/hepr.13630] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
156 Hashimoto R, Lee DP, Samarasena JB, Chandan VS, Guo W, Lee JG, Chang KJ. Comparison of Two Specialized Histology Needles for Endoscopic Ultrasound (EUS)-Guided Liver Biopsy: A Pilot Study. Dig Dis Sci 2021;66:1700-6. [PMID: 32556821 DOI: 10.1007/s10620-020-06391-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
157 Schembre D. The point of EUS-guided liver biopsy. Gastrointest Endosc 2021;93:1139-41. [PMID: 33691978 DOI: 10.1016/j.gie.2020.12.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
158 Liu JY, Lv WJ, Jian JB, Xin XH, Zhao XY, Hu CH. High-resolution three-dimensional visualization of hepatic sinusoids in cirrhotic rats via serial histological sections. Histol Histopathol 2021;36:577-86. [PMID: 33851410 DOI: 10.14670/HH-18-339] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
159 Yang L, Ling W, He D, Lu C, Ma L, Tang L, Luo Y, Chen S. Shear wave-based sound touch elastography in liver fibrosis assessment for patients with autoimmune liver diseases. Quant Imaging Med Surg 2021;11:1532-42. [PMID: 33816189 DOI: 10.21037/qims-20-521] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
160 Suenaga R, Suka M, Hirao T, Hidaka I, Sakaida I, Ishida H. Cost-effectiveness of a "treat-all" strategy using Direct-Acting Antivirals (DAAs) for Japanese patients with chronic hepatitis C genotype 1 at different fibrosis stages. PLoS One 2021;16:e0248748. [PMID: 33793594 DOI: 10.1371/journal.pone.0248748] [Reference Citation Analysis]
161 Nakano C, Nishimura T, Tada T, Yoshida M, Takashima T, Aizawa N, Ikeda N, Nishikawa H, Enomoto H, Hatano E, Yano H, Hirota S, Hachiya H, Iijima H. Severity of liver fibrosis using shear wave elastography is influenced by hepatic necroinflammation in chronic hepatitis patients, but not in cirrhotic patients. Hepatol Res 2021;51:436-44. [PMID: 33462941 DOI: 10.1111/hepr.13617] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
162 Chalasani N, Toden S, Sninsky JJ, Rava RP, Braun JV, Gawrieh S, Zhuang J, Nerenberg M, Quake SR, Maddala T. Noninvasive stratification of nonalcoholic fatty liver disease by whole transcriptome cell-free mRNA characterization. Am J Physiol Gastrointest Liver Physiol 2021;320:G439-49. [PMID: 33501884 DOI: 10.1152/ajpgi.00397.2020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
163 Nakashima M, Sakuragi S, Miyoshi T, Takayama S, Kawaguchi T, Kodera N, Akai H, Koide Y, Otsuka H, Wada T, Kawamoto K, Tanakaya M, Katayama Y, Ito H. Fibrosis-4 index reflects right ventricular function and prognosis in heart failure with preserved ejection fraction. ESC Heart Fail 2021;8:2240-7. [PMID: 33760403 DOI: 10.1002/ehf2.13317] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
164 Yang X, Chang X, Wu S, Sun X, Zhu X, Wang L, Xu Y, Yao X, Rao S, Hu X, Xia M, Bian H, Yan H, Gao X. Performance of liver stiffness measurements obtained with FibroScan is affected by glucose metabolism in patients with nonalcoholic fatty liver disease. Lipids Health Dis 2021;20:27. [PMID: 33757528 DOI: 10.1186/s12944-021-01453-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
165 Lee EW, Saab S, Kaldas FM. Algorithm to Evaluate Abnormal Liver Function Tests in Liver Transplant Patients-Reply. JAMA 2021;325:1110. [PMID: 33724321 DOI: 10.1001/jama.2021.0165] [Reference Citation Analysis]
166 Cashmore MT, McCann AJ, Wastling SJ, McGrath C, Thornton J, Hall MG. Clinical quantitative MRI and the need for metrology. Br J Radiol 2021;94:20201215. [PMID: 33710907 DOI: 10.1259/bjr.20201215] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
167 Koyuncu Sokmen B, Sahin T, Oral A, Kocak E, Inan N. The comparison of pancreatic and hepatic steatosis in healthy liver donor candidates. Sci Rep 2021;11:4507. [PMID: 33627704 DOI: 10.1038/s41598-021-83871-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
168 Liang J, Abbuhl MF, Wang H, Prasad V, Coogan A. Improvement of Pediatric Liver Core Biopsy Adequacy by Reducing Laboratory-Related Tissue Fragmentation and Increasing Portal Tract Yield. Am J Clin Pathol 2021;155:461-9. [PMID: 32915192 DOI: 10.1093/ajcp/aqaa145] [Reference Citation Analysis]
169 Martin K, Hatab A, Athwal VS, Jokl E, Piper Hanley K. Genetic Contribution to Non-alcoholic Fatty Liver Disease and Prognostic Implications. Curr Diab Rep 2021;21:8. [PMID: 33544287 DOI: 10.1007/s11892-021-01377-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
170 Kimura Y, Taura K, Hai Nam N, Uemoto Y, Yoshino K, Ikeno Y, Okuda Y, Nishio T, Yamamoto G, Tanabe K, Koyama Y, Anazawa T, Fukumitsu K, Ito T, Yagi S, Kamo N, Seo S, Iwaisako K, Hata K, Imai T, Uemoto S. Utility of Mac-2 Binding Protein Glycosylation Isomer to Evaluate Graft Status After Liver Transplantation. Liver Transpl 2021;27:403-15. [PMID: 32780942 DOI: 10.1002/lt.25870] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
171 Mo YH, Chen HL, Hsu WM, Chang CH, Peng SS. A noninvasive index to predict liver cirrhosis in biliary atresia. Pediatr Radiol 2021;51:257-64. [PMID: 32964265 DOI: 10.1007/s00247-020-04823-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
172 Huang J, Shen J, Yang Q, Cheng Z, Chen X, Yu T, Zhong J, Su Y, Guo H, Liang B. Quantification of pancreatic iron overload and fat infiltration and their correlation with glucose disturbance in pediatric thalassemia major patients. Quant Imaging Med Surg 2021;11:665-75. [PMID: 33532266 DOI: 10.21037/qims-20-292] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
173 Suyama Y, Tomita K, Soga S, Kuwamura H, Murakami W, Hokari R, Shinmoto H. T1ρ magnetic resonance imaging value as a potential marker to assess the severity of liver fibrosis: A pilot study. Eur J Radiol Open 2021;8:100321. [PMID: 33490312 DOI: 10.1016/j.ejro.2021.100321] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
174 Towbin AJ, Roth CJ, Petersilge CA, Garriott K, Buckwalter KA, Clunie DA. The Importance of Body Part Labeling to Enable Enterprise Imaging: A HIMSS-SIIM Enterprise Imaging Community Collaborative White Paper. J Digit Imaging 2021;34:1-15. [PMID: 33481143 DOI: 10.1007/s10278-020-00415-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
175 Iijima M, Arisaka T, Yamamiya A, Tominaga K, Nagashima K, Kanamori A, Masuyama S, Majima Y, Goda K, Ishida K, Irisawa A. Feasibility and Safety of Transjugular Liver Biopsy for Japanese Patients with Chronic Liver Diseases. Diagnostics (Basel) 2021;11:131. [PMID: 33467069 DOI: 10.3390/diagnostics11010131] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
176 Chang JW, Lee HW, Kim BK, Park JY, Kim DY, Ahn SH, Han KH, Kim SU. Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy. Gut Liver 2021;15:117-27. [PMID: 32066210 DOI: 10.5009/gnl19301] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
177 Çakir Ö. Ultrason Eşliğinde Perkütan Yolla Yapılan Karaciğer Biyopsi Uygulaması: Kocaeli Üniversitesi Girişimsel Radyoloji Deneyimi. Kocaeli Üniversitesi Sağlık Bilimleri Dergisi 2021. [DOI: 10.30934/kusbed.749910] [Reference Citation Analysis]
178 Patel HK, Saxena R, Rush N, Patel SK, Dasari CS, Mneimneh W, Quickery A, Rahal MA, Temnykh L, DeWitt J, Al-Haddad M. A Comparative Study of 22G versus 19G Needles for EUS-Guided Biopsies for Parenchymal Liver Disease: Are Thinner Needles Better? Dig Dis Sci 2021;66:238-46. [PMID: 32128647 DOI: 10.1007/s10620-020-06165-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
179 Onishi Y, Arai Y, Sone M, Sugawara S, Itou C, Kimura S. Percutaneous Transhepatic Biopsy for Extrahepatic Lesions. The Arab Journal of Interventional Radiology 2021;5:041-044. [DOI: 10.1055/s-0041-1731127] [Reference Citation Analysis]
180 Chan HJ, Zhou Z, Fang J, Tai DI, Tseng JH, Lai MW, Hsieh BY, Yamaguchi T, Tsui PH. Ultrasound Sample Entropy Imaging: A New Approach for Evaluating Hepatic Steatosis and Fibrosis. IEEE J Transl Eng Health Med 2021;9:1800612. [PMID: 34786215 DOI: 10.1109/JTEHM.2021.3124937] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
181 Colantonio S, Salvati A, Caudai C, Bonino F, Rosa LD, Pascali MA, Germanese D, Brunetto MR, Faita F. A Deep Learning Approach for Hepatic Steatosis Estimation from Ultrasound Imaging. Advances in Computational Collective Intelligence 2021. [DOI: 10.1007/978-3-030-88113-9_57] [Reference Citation Analysis]
182 Castera L. Assessment of Liver Disease Severity. Hepatitis C: Care and Treatment 2021. [DOI: 10.1007/978-3-030-67762-6_1] [Reference Citation Analysis]
183 Lefkowitch JH. The Liver in Systemic Disease and Pregnancy. Scheuer's Liver Biopsy Interpretation 2021. [DOI: 10.1016/b978-0-7020-7584-1.00015-2] [Reference Citation Analysis]
184 Rosso C, Caviglia GP, Armandi A, Abate ML, Olivero A, Ribaldone DG, Pellicano R, Saracco GM, Bugianesi E. Performance of cytokeratin-18 apoptotic fragment for the identification of hepatic fibrosis and inflammation in patients with chronic viral hepatitis: a meta-analysis. Minerva Biotecnol 2020;32. [DOI: 10.23736/s1120-4826.20.02681-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
185 Silva MBDBE, Tustumi F, Dantas ACB, Miranda BCJ, Pajecki D, De-cleva R, Santo MA, Nahas SC. OBESIDADE E ESTEATOSE GRAVE: A IMPORTÂNCIA DA AVALIAÇÃO BIOQUÍMICA E ESCORES. ABCD, arq bras cir dig 2021;34:e1626. [DOI: 10.1590/0102-672020210002e1626] [Reference Citation Analysis]
186 Fraquelli M, Fanetti I, Costantino A. Elastography After Treatment and During Follow-Up. Elastography of the Liver and Beyond 2021. [DOI: 10.1007/978-3-030-74132-7_9] [Reference Citation Analysis]
187 França M, Louro JM. Liver Steatosis and NAFLD. Imaging of the Liver and Intra-hepatic Biliary Tract 2021. [DOI: 10.1007/978-3-030-38983-3_13] [Reference Citation Analysis]
188 Bhardwaj K, Mohan C, Mukund A. Percutaneous FNA/Biopsy and Drainage Procedures. Basics of Hepatobiliary Interventions 2021. [DOI: 10.1007/978-981-15-6856-5_1] [Reference Citation Analysis]
189 Bernardinello V, Ceccato S, Giangregorio A, Magnaguagno S, Crimí F, Quaia E. Liver Biopsy. Imaging of the Liver and Intra-hepatic Biliary Tract 2021. [DOI: 10.1007/978-3-030-38983-3_7] [Reference Citation Analysis]
190 Heyens LJM, Busschots D, Koek GH, Robaeys G, Francque S. Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment. Front Med (Lausanne) 2021;8:615978. [PMID: 33937277 DOI: 10.3389/fmed.2021.615978] [Cited by in Crossref: 49] [Cited by in F6Publishing: 33] [Article Influence: 24.5] [Reference Citation Analysis]
191 Janowski K, Shumbayawonda E, Dennis A, Kelly M, Bachtiar V, DeBrota D, Langford C, Thomaides-Brears H, Pronicki M, Grajkowska W, Wozniak M, Pawliszak P, Chełstowska S, Jurkiewicz E, Banerjee R, Socha P. Multiparametric MRI as a Noninvasive Monitoring Tool for Children With Autoimmune Hepatitis. J Pediatr Gastroenterol Nutr 2021;72:108-14. [PMID: 32925554 DOI: 10.1097/MPG.0000000000002930] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
192 Iijima H, Tada T, Hachiya H, Nishimura T, Nishimura J, Yoshida M, Aizawa N, Hirata S, Kumada T. Diagnosis of liver fibrosis based on quantification of factors associated with shear wave speed. Jpn J Med Ultrasonics 2021;48:193-199. [DOI: 10.3179/jjmu.jjmu.a.191] [Reference Citation Analysis]
193 Ding R, Zheng J, Huang D, Wang Y, Li X, Zhou X, Yan L, Lu W, Yang Z, Zhang Z. INR-to-platelet ratio (INPR) as a novel noninvasive index for predicting liver fibrosis in chronic hepatitis B. Int J Med Sci 2021;18:1159-66. [PMID: 33526976 DOI: 10.7150/ijms.51799] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
194 Bakir A, Güney M, Erdal H, Yavuz Ö, Günal A, Gülşen M, Yavuz MT. Assessment of The Performances of Hepatitis C Virus Viral Markers, Age-Platelet Index and Aspartate aminotransferase to Alanine Aminotransferase Ratio Scores, in Predicting Liver Histopathology. Turkish Journal of Internal Medicine 2020. [DOI: 10.46310/tjim.825814] [Reference Citation Analysis]
195 Chang C, Huang Z, Shih S, Luo Y, Ko A, Cui Q, Cavallero S, Das S, Thames G, Bui A, Jacobs JP, Pajukanta P, Wu H, Tai Y, Li Z, Hsiai TK. Liver Electrical Impedance Tomography for Early Identification of Fatty Infiltrate in Obesity.. [DOI: 10.1101/2020.12.21.423854] [Reference Citation Analysis]
196 Aquino-Matus J, Uribe M, Chavez-Tapia N. Liver and spleen elastography as predictor of portal hypertension and esophageal varices. Minerva Gastroenterol (Torino) 2021;67:122-8. [PMID: 33337116 DOI: 10.23736/S2724-5985.20.02779-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
197 Burhans MS, Balu N, Schmidt KA, Cromer G, Utzschneider KM, Schur EA, Holte SE, Randolph TW, Kratz M. Impact of the Analytical Approach on the Reliability of MRI-Based Assessment of Hepatic Fat Content. Curr Dev Nutr 2020;4:nzaa171. [PMID: 33381677 DOI: 10.1093/cdn/nzaa171] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
198 Michel M, Schattenberg JM. [Liver-specific diagnostic for non-alcoholic fatty liver disease (NAFLD) - time to replace liver biopsy?]. Z Gastroenterol 2020;58:1233-40. [PMID: 33291177 DOI: 10.1055/a-1291-8483] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
199 Cai Q, Yin H, Liu D, Liu P. Using Learnt Nakagami parametric mapping to classify fatty liver in rabbits. The Fourth International Symposium on Image Computing and Digital Medicine 2020. [DOI: 10.1145/3451421.3451460] [Reference Citation Analysis]
200 Lai LY, Huang MP, Su S, Shu J. Liver Fibrosis Staging with Gadolinium Ethoxybenzyl Diethylenetriamine Penta-Acetic Acid-enhanced: A Systematic Review and Meta-analysis. Curr Med Imaging 2021;17:854-63. [PMID: 33256584 DOI: 10.2174/1573405616666201130101229] [Reference Citation Analysis]
201 Stift J, Semmler G, Wöran K, Simbrunner B, Scheiner B, Schwabl P, Paternostro R, Pinter M, Stättermayer AF, Meischl T, Beer A, Trauner M, Mandorfer M, Reiberger T. Comparison of the diagnostic quality of aspiration and core-biopsy needles for transjugular liver biopsy. Dig Liver Dis 2020;52:1473-9. [PMID: 32928675 DOI: 10.1016/j.dld.2020.08.028] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
202 Rigamonti C, Sangiovanni A, Donato MF. Transjugular liver biopsy: The Tru-cut needle might be better for stiffer livers. Dig Liver Dis 2020;52:1381-2. [PMID: 33144056 DOI: 10.1016/j.dld.2020.10.013] [Reference Citation Analysis]
203 Bhogal N, Lamb B, Arbeiter B, Malik S, Sayles H, Lazenby AJ, Chandan S, Dhaliwal A, Singh S, Bhat I. Safety and adequacy of endoscopic ultrasound-guided random liver biopsy in comparison with transjugular and percutaneous approaches. Endosc Int Open 2020;8:E1850-4. [PMID: 33269320 DOI: 10.1055/a-1274-9763] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
204 Martinez-Urbistondo D, Suarez Del Villar R, Argemí J, Daimiel L, Ramos-López O, San-Cristobal R, Villares P, Martinez JA. Antioxidant Lifestyle, Co-Morbidities and Quality of Life Empowerment Concerning Liver Fibrosis. Antioxidants (Basel) 2020;9:E1125. [PMID: 33202851 DOI: 10.3390/antiox9111125] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
205 Del Chicca F, Richter H, Steger GL, Salesov E, Reusch CE, Kircher PR. Sample strategies for quantification of hepatic fat fraction mean MRI in healthy cats during body weight gain. PLoS One 2020;15:e0241905. [PMID: 33180808 DOI: 10.1371/journal.pone.0241905] [Reference Citation Analysis]
206 Patel M, Tann M, Liangpunsakul S. CT-scan Based Liver and Spleen Volume Measurement as a Prognostic Indicator for Patients with Cirrhosis. Am J Med Sci 2020:S0002-9629(20)30485-7. [PMID: 33947583 DOI: 10.1016/j.amjms.2020.10.031] [Reference Citation Analysis]
207 Zhou IY, Tanabe KK, Fuchs BC, Caravan P. Collagen-targeted molecular imaging in diffuse liver diseases. Abdom Radiol (NY) 2020;45:3545-56. [PMID: 32737546 DOI: 10.1007/s00261-020-02677-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
208 Zhou IY, Catalano OA, Caravan P. Advances in functional and molecular MRI technologies in chronic liver diseases. J Hepatol 2020;73:1241-54. [PMID: 32585160 DOI: 10.1016/j.jhep.2020.06.020] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
209 Reece J, Pavlick M, Penninck DG, Webster CRL. Hemorrhage and complications associated with percutaneous ultrasound guided liver biopsy in dogs. J Vet Intern Med 2020;34:2398-404. [PMID: 33125175 DOI: 10.1111/jvim.15942] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
210 Campos-Murguía A, Ruiz-Margáin A, González-Regueiro JA, Macías-Rodríguez RU. Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease. World J Gastroenterol 2020; 26(39): 5919-5943 [PMID: 33132645 DOI: 10.3748/wjg.v26.i39.5919] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
211 Seko Y, Yano K, Takahashi A, Okishio S, Kataoka S, Okuda K, Umemura A, Yamaguchi K, Moriguchi M, Tanaka S, Itoh Y. The Appropriate Opportunity for Evaluating Liver Fibrosis by Using the FIB-4 Index in Patients with Nonalcoholic Fatty Liver Disease in Japan. Diagnostics (Basel) 2020;10:E842. [PMID: 33086582 DOI: 10.3390/diagnostics10100842] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
212 Alomari MH, Kerr CL, Chewning R, Chaudry G, Shaikh R, Padua H, Landrigan-Ossar M, Alomari AI. Two-hour Observation After Liver Biopsy in Children: Clinical and Economic Outcome of a Quality Improvement Intervention. J Pediatr Gastroenterol Nutr 2020;71:e105-8. [PMID: 32960537 DOI: 10.1097/MPG.0000000000002821] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
213 Mojtahed A, Gee MS, Yokoo T. Pearls and Pitfalls of Metabolic Liver Magnetic Resonance Imaging in the Pediatric Population. Seminars in Ultrasound, CT and MRI 2020;41:451-461. [DOI: 10.1053/j.sult.2020.05.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
214 McCarty TR, Bazarbashi AN, Njei B, Ryou M, Aslanian HR, Muniraj T. Endoscopic Ultrasound-Guided, Percutaneous, and Transjugular Liver Biopsy: A Comparative Systematic Review and Meta-Analysis. Clin Endosc 2020;53:583-93. [PMID: 33027584 DOI: 10.5946/ce.2019.211] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
215 Amorim VB, Parente DB, Paiva FF, Oliveira Neto JA, Miranda AA, Moreira CC, Fernandes FF, Campos CFF, Leite NC, Perez RM, Rodrigues RS. Can gadoxetic acid-enhanced magnetic resonance imaging be used to avoid liver biopsy in patients with nonalcoholic fatty liver disease? World J Hepatol 2020;12:661-71. [PMID: 33033571 DOI: 10.4254/wjh.v12.i9.661] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
216 Ueda N, Kawaoka T, Imamura M, Aikata H, Nakahara T, Murakami E, Tsuge M, Hiramatsu A, Hayes CN, Yokozaki M, Chayama K. Liver fibrosis assessments using FibroScan, virtual-touch tissue quantification, the FIB-4 index, and mac-2 binding protein glycosylation isomer levels compared with pathological findings of liver resection specimens in patients with hepatitis C infection. BMC Gastroenterol 2020;20:314. [PMID: 32977741 DOI: 10.1186/s12876-020-01459-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
217 Parmar KL, O'Reilly D, Valle JW, Braun M, Naish JH, Williams SR, Lloyd WK, Malcomson L, Cresswell K, Bamford C, Renehan AG. Prospective study of change in liver function and fat in patients with colorectal liver metastases undergoing preoperative chemotherapy: protocol for the CLiFF Study. BMJ Open 2020;10:e027630. [PMID: 32967864 DOI: 10.1136/bmjopen-2018-027630] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
218 Tao H, Guo J, Ma Y, Zhao Y, Jin T, Gu L, Dou Y, Liu J, Hu H, Xiong X, Zhang J. Luminescence Imaging of Acute Liver Injury by Biodegradable and Biocompatible Nanoprobes. ACS Nano 2020;14:11083-99. [PMID: 32790342 DOI: 10.1021/acsnano.0c00539] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
219 Mada PK, Malus ME, Saldaña Koppel DA, Adley S, Moore M, Alam MJ, Feldman M. Predicting Liver Fibrosis in the Hepatitis C Population: Concordance Analysis Between Noninvasive Scoring Systems and Percutaneous Liver Biopsy. Cureus 2020. [DOI: 10.7759/cureus.10376] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
220 Mada PK, Malus ME, Saldaña Koppel DA, Adley S, Moore M, Alam MJ, Feldman M. Predicting Liver Fibrosis in the Hepatitis C Population: Concordance Analysis Between Noninvasive Scoring Systems and Percutaneous Liver Biopsy. Cureus 2020;12:e10376. [PMID: 33062499 DOI: 10.7759/cureus.10376] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
221 Yao TT, Pan J, Qian JD, Cheng H, Wang Y, Wang GQ. Shear wave elastography may be sensitive and more precise than transient elastography in predicting significant fibrosis. World J Clin Cases 2020; 8(17): 3730-3742 [PMID: 32953849 DOI: 10.12998/wjcc.v8.i17.3730] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
222 Talwar S, Gudala V, Joshi R, Shalimar DM, Madhusudhan KS, Kalaivani M, Choudhary SK. Noninvasive Assessment of Liver Stiffness in Patients Undergoing the Fontan Procedure. World J Pediatr Congenit Heart Surg 2020;11:572-7. [PMID: 32853080 DOI: 10.1177/2150135120935418] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
223 Fang F, Fang J, Li Q, Tai DI, Wan YL, Tamura K, Yamaguchi T, Tsui PH. Ultrasound Assessment of Hepatic Steatosis by Using the Double Nakagami Distribution: A Feasibility Study. Diagnostics (Basel) 2020;10. [PMID: 32759867 DOI: 10.3390/diagnostics10080557] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
224 Gulbay M, Ciliz DS, Celikbas AK, Ocalan DT, Sayin B, Ozbay BO, Alp E. Intravoxel incoherent motion parameters in the evaluation of chronic hepatitis B virus-induced hepatic injury: fibrosis and capillarity changes. Abdom Radiol (NY) 2020;45:2345-57. [PMID: 32162021 DOI: 10.1007/s00261-020-02430-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
225 Toyoda H, Atsukawa M, Watanabe T, Nakamuta M, Uojima H, Nozaki A, Takaguchi K, Fujioka S, Iio E, Shima T, Akahane T, Fukunishi S, Asano T, Michitaka K, Tsuji K, Abe H, Mikami S, Okubo H, Okubo T, Shimada N, Ishikawa T, Moriya A, Tani J, Morishita A, Ogawa C, Tachi Y, Ikeda H, Yamashita N, Yasuda S, Chuma M, Tsutsui A, Hiraoka A, Ikegami T, Genda T, Tsubota A, Masaki T, Iwakiri K, Kumada T, Tanaka Y, Okanoue T. Marked heterogeneity in the diagnosis of compensated cirrhosis of patients with chronic hepatitis C virus infection in a real-world setting: A large, multicenter study from Japan. J Gastroenterol Hepatol 2020;35:1420-5. [PMID: 31950525 DOI: 10.1111/jgh.14982] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
226 Lee DH, Lee ES, Lee JY, Bae JS, Kim H, Lee KB, Yu SJ, Cho EJ, Lee JH, Cho YY, Han JK, Choi BI. Two-Dimensional-Shear Wave Elastography with a Propagation Map: Prospective Evaluation of Liver Fibrosis Using Histopathology as the Reference Standard. Korean J Radiol 2020;21:1317-25. [PMID: 32729274 DOI: 10.3348/kjr.2019.0978] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
227 Lardi LL, Lul RM, Port GZ, Coral GP, Peres A, Dornelles GP, Branco F, Fernandes S, Leães CG, Mattos AA, Buss C, Tovo CV. Fibromax and inflamatory markers cannot replace liver biopsy in the evaluation of non-alcoholic fatty liver disease. Minerva Gastroenterol (Torino) 2022;68:85-90. [PMID: 32700499 DOI: 10.23736/S2724-5985.20.02746-4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
228 Lim Z, Whitaker T, DeColle K, Barrett K, Harlton C, Paskar L, Low G. Interobserver and Intraobserver Reliability of Hepatic Shear Wave Elastography and the Influence of Fasted Versus Nonfasted States in Healthy Volunteers. J Ultrasound Med 2021;40:259-67. [PMID: 32686849 DOI: 10.1002/jum.15395] [Reference Citation Analysis]
229 de Lange D, van den Dobbelsteen JJ, Moelker A, van de Berg NJ. Ultrasound-Guided Percutaneous Liver Biopsy: A Review on Obtaining Adequate Specimens. Journal of Medical Devices 2020;14:034503. [DOI: 10.1115/1.4047543] [Reference Citation Analysis]
230 Choi B, Choi IY, Cha SH, Yeom SK, Chung HH, Lee SH, Cha J, Lee JH. Feasibility of computed tomography texture analysis of hepatic fibrosis using dual-energy spectral detector computed tomography. Jpn J Radiol 2020;38:1179-89. [PMID: 32666182 DOI: 10.1007/s11604-020-01020-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
231 Bae JS, Lee JY, Lee DH, Kim H, Lee Y, Han JK. Quantitative Evaluation of Hepatic Steatosis Using Normalized Local Variance in a Rat Model: Comparison with Histopathology as the Reference Standard. Korean J Radiol 2019;20:1399-407. [PMID: 31464118 DOI: 10.3348/kjr.2019.0068] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
232 Joshita S, Yamashita Y, Sugiura A, Uehara T, Usami Y, Yamazaki T, Fujimori N, Matsumoto A, Tanaka E, Umemura T. Clinical utility of FibroScan as a non-invasive diagnostic test for primary biliary cholangitis. J Gastroenterol Hepatol 2020;35:1208-14. [PMID: 31724755 DOI: 10.1111/jgh.14929] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
233 Nieto J, Dawod E, Deshmukh A, Penn E, Adler D, Saab S. EUS-guided fine-needle core liver biopsy with a modified one-pass, one-actuation wet suction technique comparing two types of EUS core needles. Endosc Int Open 2020;8:E938-43. [PMID: 32617398 DOI: 10.1055/a-1165-1767] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
234 Lee DH. Noninvasive Evaluation of Nonalcoholic Fatty Liver Disease. Endocrinol Metab (Seoul) 2020;35:243-59. [PMID: 32615709 DOI: 10.3803/EnM.2020.35.2.243] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
235 Laursen TL, Sandahl TD, Kazankov K, George J, Grønbæk H. Liver-related effects of chronic hepatitis C antiviral treatment. World J Gastroenterol 2020; 26(22): 2931-2947 [PMID: 32587440 DOI: 10.3748/wjg.v26.i22.2931] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
236 Kamada Y, Morishita K, Koseki M, Nishida M, Asuka T, Naito Y, Yamada M, Takamatsu S, Sakata Y, Takehara T, Miyoshi E. Serum Mac-2 Binding Protein Levels Associate with Metabolic Parameters and Predict Liver Fibrosis Progression in Subjects with Fatty Liver Disease: A 7-Year Longitudinal Study. Nutrients 2020;12:E1770. [PMID: 32545650 DOI: 10.3390/nu12061770] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
237 Li K, Qin L, Jiang S, Li A, Zhang C, Liu G, Sun J, Sun H, Zhao Y, Li N, Zhang Y. The signature of HBV-related liver disease in peripheral blood mononuclear cell DNA methylation. Clin Epigenetics 2020;12:81. [PMID: 32513305 DOI: 10.1186/s13148-020-00847-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
238 Chen J, Duan S, Ma J, Wang R, Chen J, Liu X, Xue L, Xie S, Yao S. MRI-determined liver fat correlates with risk of metabolic syndrome in patients with nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol 2020;32:754-61. [PMID: 32091437 DOI: 10.1097/MEG.0000000000001688] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
239 Chang Y, Kim JI, Lee B, Kim SG, Jung MJ, Kim YS, Jeong SW, Jang JY, Yoo JJ. Clinical application of ultrasonography-guided percutaneous liver biopsy and its safety over 18 years. Clin Mol Hepatol 2020;26:318-27. [PMID: 32447878 DOI: 10.3350/cmh.2019.0019n] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
240 Villani R, Cavallone F, Romano AD, Bellanti F, Serviddio G. Two-Dimensional Shear Wave Elastography versus Transient Elastography: A Non-Invasive Comparison for the Assessment of Liver Fibrosis in Patients with Chronic Hepatitis C. Diagnostics (Basel) 2020;10. [PMID: 32429410 DOI: 10.3390/diagnostics10050313] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
241 Lee BW, Lee YH, Park CY, Rhee EJ, Lee WY, Kim NH, Choi KM, Park KG, Choi YK, Cha BS, Lee DH; Korean Diabetes Association (KDA) Fatty Liver Research Group. Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Position Statement of the Fatty Liver Research Group of the Korean Diabetes Association. Diabetes Metab J 2020;44:382-401. [PMID: 32431115 DOI: 10.4093/dmj.2020.0010] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 9.0] [Reference Citation Analysis]
242 Myazin RG, Emel’yanov DN. Features of therapy of alcoholic liver disease in persons of young age. jour 2020;174:80-85. [DOI: 10.31146/1682-8658-ecg-174-2-80-85] [Reference Citation Analysis]
243 Khalifa A, Rockey DC. The utility of liver biopsy in 2020. Curr Opin Gastroenterol 2020;36:184-91. [PMID: 32097176 DOI: 10.1097/MOG.0000000000000621] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 14.7] [Reference Citation Analysis]
244 Caussy C, Johansson L. Magnetic resonance-based biomarkers in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.Endocrinol Diabetes Metab. 2020;3:e00134. [PMID: 33102797 DOI: 10.1002/edm2.134] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
245 Li J, Dong XQ, Wu Z, Ma AL, Xie SB, Zhang XQ, Zhang ZQ, Zhang DZ, Zhao WF, Zhang G, Cheng J, Xie Q, Li J, Zou ZQ, Liu YX, Wang GQ, Zhao H; China Hepatitis B Related Fibrosis Assessment Research Group. Unsatisfying antiviral therapeutic effect in patients with mother-to-child transmissed chronic hepatitis B virus infection: a prospective multi-center clinical study. Chin Med J (Engl) 2019;132:2647-56. [PMID: 31725459 DOI: 10.1097/CM9.0000000000000522] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
246 Srivastava A, Prasad D, Panda I, Yadav R, Jain M, Sarma MS, Prasad R, Poddar U, Yachha SK. Transjugular Versus Percutaneous Liver Biopsy in Children: Indication, Success, Yield, and Complications. J Pediatr Gastroenterol Nutr 2020;70:417-22. [PMID: 31821233 DOI: 10.1097/MPG.0000000000002587] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
247 Wegner M, Iskender E, Azzarok A, Sagir A. Comparison of acoustic radiation force impulse imaging with the convex probe 6C1 and linear probe 9L4. Medicine (Baltimore) 2020;99:e19701. [PMID: 32311951 DOI: 10.1097/MD.0000000000019701] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
248 Iacob DG, Rosca A, Ruta SM. Circulating microRNAs as non-invasive biomarkers for hepatitis B virus liver fibrosis. World J Gastroenterol 2020; 26(11): 1113-1127 [PMID: 32231417 DOI: 10.3748/wjg.v26.i11.1113] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
249 Murata A, Amano N, Sato S, Tsuzura H, Tomishima K, Sato S, Matsumoto K, Shimada Y, Iijima K, Genda T. On-treatment Serum Mac-2 Binding Protein Glycosylation Isomer (M2BPGi) Level and Risk of Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B during Nucleot(s)ide Analogue Therapy. Int J Mol Sci 2020;21:E2051. [PMID: 32192084 DOI: 10.3390/ijms21062051] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
250 Johnson KD, Laoveeravat P, Yee EU, Perisetti A, Thandassery RB, Tharian B. Endoscopic ultrasound guided liver biopsy: Recent evidence. World J Gastrointest Endosc 2020; 12(3): 83-97 [PMID: 32218888 DOI: 10.4253/wjge.v12.i3.83] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
251 Osman AM, El Shimy A, Abd El Aziz MM. 2D shear wave elastography (SWE) performance versus vibration-controlled transient elastography (VCTE/fibroscan) in the assessment of liver stiffness in chronic hepatitis. Insights Imaging 2020;11:38. [PMID: 32152802 DOI: 10.1186/s13244-020-0839-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
252 Keller LM, Eighmy S, Li C, Winter L, Kerecman J, Goodman Z, Mittal N, Blanco CL. Association of novel markers of liver disease with neonatal liver disease in premature baboons, Papio sp. PLoS One 2020;15:e0228985. [PMID: 32150543 DOI: 10.1371/journal.pone.0228985] [Reference Citation Analysis]
253 Ali AH, Panchal S, Rao DS, Gan Y, Al-Juboori A, Samiullah S, Ibdah JA, Hammoud GM. The efficacy and safety of endoscopic ultrasound-guided liver biopsy versus percutaneous liver biopsy in patients with chronic liver disease: a retrospective single-center study. J Ultrasound 2020;23:157-67. [PMID: 32141043 DOI: 10.1007/s40477-020-00436-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
254 Pirmoazen AM, Khurana A, El Kaffas A, Kamaya A. Quantitative ultrasound approaches for diagnosis and monitoring hepatic steatosis in nonalcoholic fatty liver disease. Theranostics 2020;10:4277-89. [PMID: 32226553 DOI: 10.7150/thno.40249] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 12.0] [Reference Citation Analysis]
255 Maev IV, Samsonov AA, Palgova LK, Pavlov CS, Vovk EI, Shirokova EN, Starostin KM. Effectiveness of phosphatidylcholine in alleviating steatosis in patients with non-alcoholic fatty liver disease and cardiometabolic comorbidities (MANPOWER study). BMJ Open Gastroenterol 2020;7:e000341. [PMID: 32095253 DOI: 10.1136/bmjgast-2019-000341] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
256 Kim JW, Lee YS, Park YS, Kim BH, Lee SY, Yeon JE, Lee CH. Multiparametric MR Index for the Diagnosis of Non-Alcoholic Steatohepatitis in Patients with Non-Alcoholic Fatty Liver Disease. Sci Rep 2020;10:2671. [PMID: 32060386 DOI: 10.1038/s41598-020-59601-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
257 Schaible J, Utpatel K, Verloh N, Einspieler I, Pregler B, Zeman F, Wiggermann P, Schreyer AG, Stroszczynski C, Beyer LP. Full-Core Biopsy Systems Take Larger Liver Tissue Samples with Lower Fragmentation Rates Than Conventional Side-Notch Systems: A Randomized Trial. Cancer Manag Res 2020;12:1121-8. [PMID: 32104092 DOI: 10.2147/CMAR.S209824] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
258 Fu J, Wu B, Wu H, Lin F, Deng W. Accuracy of real-time shear wave elastography in staging hepatic fibrosis: a meta-analysis. BMC Med Imaging 2020;20:16. [PMID: 32046659 DOI: 10.1186/s12880-020-0414-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
259 Wang L, Yao M, Liu S, Yang D, Wen X, Ning J, Wang L, Zhou G, Xu Q, Chen X, Zhao J, Lu F. Serum Golgi Protein 73 as a Potential Biomarker for Hepatic Necroinflammation in Population with Nonalcoholic Steatohepatitis. Dis Markers 2020;2020:6036904. [PMID: 32089754 DOI: 10.1155/2020/6036904] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
260 Majumdar A, Campos S, Gurusamy K, Pinzani M, Tsochatzis EA. Defining the Minimum Acceptable Diagnostic Accuracy of Noninvasive Fibrosis Testing in Cirrhosis: A Decision Analytic Modeling Study. Hepatology 2020;71:627-42. [PMID: 31297832 DOI: 10.1002/hep.30846] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
261 Zheng S, Tong M, Dong L, Du C, Zheng X, Wang L, Huang P, Liu W, Lin M, Liu C. Lipid accumulation product independently correlate with hepatic steatosis quantified by controlled attenuation parameter in women with polycystic ovary syndrome. Endocr Connect 2020;9:154-62. [PMID: 31910158 DOI: 10.1530/EC-19-0559] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
262 Baudi I, Inoue T, Tanaka Y. Novel Biomarkers of Hepatitis B and Hepatocellular Carcinoma: Clinical Significance of HBcrAg and M2BPGi. Int J Mol Sci. 2020;21. [PMID: 32023902 DOI: 10.3390/ijms21030949] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
263 Baudi I, Inoue T, Tanaka Y. Novel Biomarkers of Hepatitis B and Hepatocellular Carcinoma: Clinical Significance of HBcrAg and M2BPGi. IJMS 2020;21:949. [DOI: 10.3390/ijms21030949] [Cited by in Crossref: 18] [Article Influence: 6.0] [Reference Citation Analysis]
264 Suciu A, Abenavoli L, Pellicano R, Luzza F, Dumitrascu DL. Transaminases: oldies but goldies. A narrative review. Minerva Gastroenterol Dietol 2020;66:246-51. [PMID: 31994373 DOI: 10.23736/S1121-421X.20.02660-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
265 Patel K, Sebastiani G. Limitations of non-invasive tests for assessment of liver fibrosis. JHEP Rep. 2020;2:100067. [PMID: 32118201 DOI: 10.1016/j.jhepr.2020.100067] [Cited by in Crossref: 68] [Cited by in F6Publishing: 73] [Article Influence: 22.7] [Reference Citation Analysis]
266 Xie S, Qi H, Li Q, Zhang K, Zhang L, Cheng Y, Shen W. Liver injury monitoring, fibrosis staging and inflammation grading using T1rho magnetic resonance imaging: an experimental study in rats with carbon tetrachloride intoxication. BMC Gastroenterol 2020;20:14. [PMID: 31941457 DOI: 10.1186/s12876-020-1161-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
267 Korean Association for the Study of the Liver (KASL). KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications. Clin Mol Hepatol 2020;26:83-127. [PMID: 31918536 DOI: 10.3350/cmh.2019.0010n] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 11.3] [Reference Citation Analysis]
268 Sasso M, Sandrin L. Steatosis Assessment by Controlled Attenuation Parameter (CAP™). Liver Elastography 2020. [DOI: 10.1007/978-3-030-40542-7_37] [Reference Citation Analysis]
269 Hamesch K, Strnad P. Non-Invasive Assessment and Management of Liver Involvement in Adults With Alpha-1 Antitrypsin Deficiency. Chronic Obstr Pulm Dis 2020;7:260-71. [PMID: 32697896 DOI: 10.15326/jcopdf.7.3.2019.0161] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
270 Shiha G, Mousa N. Noninvasive Biomarkers for Liver Fibrosis. Liver Diseases 2020. [DOI: 10.1007/978-3-030-24432-3_36] [Reference Citation Analysis]
271 Fuchikami H, Takeda N, Suno Y, Iijima H, Takagi M, Sato K. Clinical Significance and Problems of Percutaneous Biopsy of Liver Metastasis in Patients with Breast Cancer. Nihon Rinsho Geka Gakkai Zasshi (J Jpn Surg Assoc) 2020;81:14-9. [DOI: 10.3919/jjsa.81.14] [Reference Citation Analysis]
272 Fu F, Li X, Chen C, Bai Y, Liu Q, Shi D, Sang J, Wang K, Wang M. Non-invasive assessment of hepatic fibrosis: comparison of MR elastography to transient elastography and intravoxel incoherent motion diffusion-weighted MRI. Abdom Radiol (NY) 2020;45:73-82. [PMID: 31372777 DOI: 10.1007/s00261-019-02140-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
273 Hyun Kim K, Kyung Kim B, Yong Park J, Young Kim D, Hoon Ahn S, Han KH, Kim SU. Sarcopenia assessed using bioimpedance analysis is associated independently with significant liver fibrosis in patients with chronic liver diseases. Eur J Gastroenterol Hepatol 2020;32:58-65. [PMID: 31283527 DOI: 10.1097/MEG.0000000000001475] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
274 Da BL, Koh C, Heller T. Reply. Hepatology 2020;71:397-8. [PMID: 31531987 DOI: 10.1002/hep.30955] [Reference Citation Analysis]
275 Kinkel H, Călinescu FB. Liver Biopsy for Histopathology. Liver Diseases 2020. [DOI: 10.1007/978-3-030-24432-3_39] [Reference Citation Analysis]
276 Danta M, Kim AY. Hepatobiliary Diseases. Hunter's Tropical Medicine and Emerging Infectious Diseases 2020. [DOI: 10.1016/b978-0-323-55512-8.00004-1] [Reference Citation Analysis]
277 Makhija N, Vikram NK, Kaur G, Sharma R, Srivastava DN, Madhusudhan KS. Role of Magnetic Resonance Imaging in the Monitoring of Patients with Nonalcoholic Fatty Liver Disease: Comparison with Ultrasonography, Lipid Profile, and Body Mass Index. J Clin Exp Hepatol 2020;10:139-49. [PMID: 32189929 DOI: 10.1016/j.jceh.2019.09.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
278 Özdemir A, Şahan MH. ULTRASONOGRAFİ REHBERLİĞİNDE PERKÜTAN KESİCİ KARACİĞER BİYOPSİSİ (PARANKİM VE LEZYON): KLİNİK DENEYİMİMİZ. Kırıkkale Üniversitesi Tıp Fakültesi Dergisi 2019. [DOI: 10.24938/kutfd.555778] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
279 Zhang GL, Xu SC, Zeng J, Chen Z, Li YP, Zhang T, Gao ZL. Optimizing the Use of the Gamma-Glutamyl Transpeptidase-to-Platelet Ratio and Transient Elastography to Identify Liver Cirrhosis in Patients with Chronic Hepatitis B Concurrent with Nonalcoholic Fatty Liver Disease. Dis Markers 2019;2019:2585409. [PMID: 31885733 DOI: 10.1155/2019/2585409] [Reference Citation Analysis]
280 Wang Z, Ai X, Zhang Z, Wang Y, Wu X, Haindl R, Yeow EKL, Drexler W, Gao M, Xing B. NIR nanoprobe-facilitated cross-referencing manifestation of local disease biology for dynamic therapeutic response assessment. Chem Sci 2019;11:803-11. [PMID: 34123056 DOI: 10.1039/c9sc04909f] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
281 Feier D, Muntean D, Bastati N, Ba-ssalamah A. Current Noninvasive MR-Based Imaging Methods in Assessing NAFLD Patients. Nonalcoholic Fatty Liver Disease - An Update 2019. [DOI: 10.5772/intechopen.82096] [Reference Citation Analysis]
282 Gagnadoux F, Boursier J, Calès P, Trzepizur W. Obstructive sleep apnoea and non-alcoholic fatty liver disease: Which patients should be referred to hepatologists? Clin Res Hepatol Gastroenterol 2019;43:e90-2. [PMID: 30935907 DOI: 10.1016/j.clinre.2019.02.013] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
283 Chalouni M, Sogni P, Miailhes P, Lacombe K, Poizot-Martin I, Chas J, Vittecoq D, Neau D, Aumaitre H, Alric L, Piroth L, Bouchaud O, Katlama C, Morlat P, Lascoux-Combe C, Gervais A, Naqvi A, Rosenthal E, Garipuy D, Barange K, Esterle L, Salmon D, Wittkop L; ANRS CO13 HEPAVIH study group. Liver stiffness and fibrosis-4 alone better predict liver events compared with aspartate aminotransferase to platelet ratio index in a cohort of human immunodeficiency virus and hepatitis C virus co-infected patients from ANRS CO13 HEPAVIH cohort. Eur J Gastroenterol Hepatol 2019;31:1387-96. [PMID: 31033848 DOI: 10.1097/MEG.0000000000001408] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
284 Khatun M, Ray RB. Mechanisms Underlying Hepatitis C Virus-Associated Hepatic Fibrosis. Cells 2019;8:E1249. [PMID: 31615075 DOI: 10.3390/cells8101249] [Cited by in Crossref: 74] [Cited by in F6Publishing: 77] [Article Influence: 18.5] [Reference Citation Analysis]
285 Yamada K, Mizukoshi E, Seike T, Horii R, Terashima T, Iida N, Kitahara M, Sunagozaka H, Arai K, Yamashita T, Honda M, Takamura T, Harada K, Kaneko S. Serum C16:1n7/C16:0 ratio as a diagnostic marker for non-alcoholic steatohepatitis. J Gastroenterol Hepatol 2019;34:1829-35. [PMID: 30864239 DOI: 10.1111/jgh.14654] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
286 Ueno T, Kodama T, Noguchi Y, Nomura M, Saka R, Takama Y, Tazuke Y, Bessho K, Okuyama H. Serum Mac-2-binding protein (M2BPGi) as a marker of chronological liver fibrosis in biliary atresia patients with cirrhosis. Pediatr Surg Int 2019;35:1065-70. [PMID: 31392502 DOI: 10.1007/s00383-019-04535-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
287 Chung M, Baird GL, Weiss KE, Beland MD. 2D shear wave elastography: measurement acquisition and reliability criteria in noninvasive assessment of liver fibrosis. Abdom Radiol (NY) 2019;44:3285-94. [PMID: 31435762 DOI: 10.1007/s00261-019-02183-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
288 Qu Y, Li M, Hamilton G, Zhang YN, Song B. Diagnostic accuracy of hepatic proton density fat fraction measured by magnetic resonance imaging for the evaluation of liver steatosis with histology as reference standard: a meta-analysis. Eur Radiol 2019;29:5180-9. [PMID: 30877459 DOI: 10.1007/s00330-019-06071-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
289 Chen CC, Hsu HT, Chen YL, Chen RC, Wu WP, Chou CT. Diagnostic Accuracy of Acoustic Radiation Force Impulse (ARFI) and Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein (WFA⁺-M2BP) in Patients with Chronic Liver Disease. Med Sci Monit 2019;25:7169-74. [PMID: 31548540 DOI: 10.12659/MSM.916533] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
290 Wu Z, Gong Y, Peng J, Zhang X, Tang L. Correlation Between Serum Entecavir Concentration and Virological Response in Patients with Chronic Type B Hepatitis. Med Sci Monit 2019;25:6998-7004. [PMID: 31530794 DOI: 10.12659/MSM.916553] [Reference Citation Analysis]
291 Lee JI, Lee HW, Lee KS. Value of controlled attenuation parameter in fibrosis prediction in nonalcoholic steatohepatitis. World J Gastroenterol 2019; 25(33): 4959-4969 [PMID: 31543686 DOI: 10.3748/wjg.v25.i33.4959] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
292 Perazzo H, Cardoso SW, Yanavich C, Nunes EP, Morata M, Gorni N, da Silva PS, Cardoso C, Almeida C, Luz P, Veloso VG, Grinsztejn B. Predictive factors associated with liver fibrosis and steatosis by transient elastography in patients with HIV mono-infection under long-term combined antiretroviral therapy. J Int AIDS Soc. 2018;21:e25201. [PMID: 30394678 DOI: 10.1002/jia2.25201] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 8.3] [Reference Citation Analysis]
293 Xu Y, Liu Y, Cao Z, Wang L, Li Z, Sheng Z, Cai W, Wang H, Bao S, Xie Q. Comparison of FibroTouch and FibroScan for staging fibrosis in chronic liver disease: Single-center prospective study. Dig Liver Dis 2019;51:1323-9. [PMID: 30928419 DOI: 10.1016/j.dld.2019.02.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
294 Calle-Toro JS, Barrera CA, Khrichenko D, Otero HJ, Serai SD. R2 relaxometry based MR imaging for estimation of liver iron content: A comparison between two methods. Abdom Radiol (NY) 2019;44:3058-68. [PMID: 31161282 DOI: 10.1007/s00261-019-02074-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
295 Sönmez S, Boşat M, Yurtseven N, Yurtseven E. The role of elastography in the assessment of chronic liver disease in children. Afr Health Sci 2019;19:2806-11. [PMID: 32127854 DOI: 10.4314/ahs.v19i3.57] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
296 Wm T, L S, C K, K E, T H, H B, T K, K N, M H, S K. Quantification of Hemodynamic Changes in Chronic Liver Disease: Correlation of Perfusion-CT Data with Histopathologic Staging of Fibrosis. Acad Radiol 2019;26:1174-80. [PMID: 30528750 DOI: 10.1016/j.acra.2018.11.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
297 Olson MC, Reeder SB, Venkatesh SK. Quantitative MRI Biomarkers of Diffuse Liver Disease. Advances in Clinical Radiology 2019;1:55-69. [DOI: 10.1016/j.yacr.2019.04.009] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
298 Tamura M, Ohta H, Shimbo G, Osuga T, Sasaki N, Morishita K, Kagawa Y, Takiguchi M. Usefulness of noninvasive shear wave elastography for the assessment of hepatic fibrosis in dogs with hepatic disease. J Vet Intern Med 2019;33:2067-74. [PMID: 31461576 DOI: 10.1111/jvim.15598] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
299 Sawh MC, Newton KP, Goyal NP, Angeles JE, Harlow K, Bross C, Schlein AN, Hooker JC, Sy EZ, Glaser KJ, Yin M, Ehman RL, Sirlin CB, Schwimmer JB. Normal range for MR elastography measured liver stiffness in children without liver disease. J Magn Reson Imaging 2020;51:919-27. [PMID: 31452280 DOI: 10.1002/jmri.26905] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
300 Yeh ML, Huang CF, Huang CI, Dai CY, Lin IH, Liang PC, Hsieh MH, Lin ZY, Chen SC, Huang JF, Chen JJ, Yu ML, Chuang WL. Wisteria floribunda agglutinin-positive Mac-2-binding protein in the prediction of disease severity in chronic hepatitis B patients. PLoS One 2019;14:e0220663. [PMID: 31393964 DOI: 10.1371/journal.pone.0220663] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
301 Xu XY, Wang WS, Zhang QM, Li JL, Sun JB, Qin TT, Liu HB. Performance of common imaging techniques vs serum biomarkers in assessing fibrosis in patients with chronic hepatitis B: A systematic review and meta-analysis. World J Clin Cases 2019; 7(15): 2022-2037 [PMID: 31423434 DOI: 10.12998/wjcc.v7.i15.2022] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 23] [Article Influence: 5.3] [Reference Citation Analysis]
302 Tomeno W, Imajo K, Kuwada Y, Ogawa Y, Kikuchi M, Honda Y, Kato T, Kessoku T, Kirikoshi H, Yoneda M, Kitahora T, Saito S, Ozawa Y, Nakajima A. Distribution of liver stiffness in non-alcoholic fatty liver disease with higher fibrosis-4 index than low cut-off index. J Gastroenterol Hepatol 2019;34:1411-6. [PMID: 30506860 DOI: 10.1111/jgh.14559] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
303 Koļesova O, Eglīte J, Koļesovs A, Krūmiņa A, Ekšteina I, Madelāne M, Vīksna L. Association of Non-Invasive Markers of Liver Fibrosis with HCV Coinfection and Antiretroviral Therapy in Patients with HIV. Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences. 2019;73:400-402. [DOI: 10.2478/prolas-2019-0062] [Reference Citation Analysis]
304 Darweesh SK, Omar H, Medhat E, Abd-Al Aziz RA, Ayman H, Saad Y, Yosry A. The clinical usefulness of elastography in the evaluation of nonalcoholic fatty liver disease patients: A biopsy-controlled study. Eur J Gastroenterol Hepatol 2019;31:1010-6. [PMID: 30807444 DOI: 10.1097/MEG.0000000000001365] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
305 Stift J, Semmler G, Walzel C, Mandorfer M, Schwarzer R, Schwabl P, Paternostro R, Scheiner B, Wöran K, Pinter M, Stättermayer AF, Trauner M, Peck-Radosavljevic M, Ferlitsch A, Reiberger T. Transjugular aspiration liver biopsy performed by hepatologists trained in HVPG measurements is safe and provides important diagnostic information. Dig Liver Dis 2019;51:1144-51. [PMID: 30862438 DOI: 10.1016/j.dld.2019.01.020] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
306 Eskandari A, Koo P, Bang H, Gui D, Urayama S. Comparison of Endoscopic Ultrasound Biopsy Needles for Endoscopic Ultrasound-Guided Liver Biopsy. Clin Endosc 2019;52:347-52. [PMID: 31288504 DOI: 10.5946/ce.2019.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
307 Park HS, Choe WH, Han HS, Yu MH, Kim YJ, Jung SI, Kim JH, Kwon SY. Assessing significant fibrosis using imaging-based elastography in chronic hepatitis B patients: Pilot study. World J Gastroenterol 2019; 25(25): 3256-3267 [PMID: 31333316 DOI: 10.3748/wjg.v25.i25.3256] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
308 Fujita K, Oura K, Yoneyama H, Shi T, Takuma K, Nakahara M, Tadokoro T, Nomura T, Morishita A, Tsutsui K, Himoto T, Masaki T. Albumin-bilirubin score indicates liver fibrosis staging and prognosis in patients with chronic hepatitis C. Hepatol Res 2019;49:731-42. [PMID: 30892804 DOI: 10.1111/hepr.13333] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 6.5] [Reference Citation Analysis]
309 Özer Sarı S, Köseoğlu H, Akar M, Solakoğlu T, Ersoy O. Nötrofil / lenfosit oranı kronik hepatit B hastalarında karaciğer fibrozisini saptamada kullanılabilir mi? Ege Tıp Dergisi 2019;58:136-139. [DOI: 10.19161/etd.504466] [Reference Citation Analysis]
310 Lee DH, Lee JY, Park MS, Han JK. Non-invasive monitoring of hepatic steatosis via acoustic structure quantification of ultrasonography with MR spectroscopy as the reference standard. Ultrasonography 2020;39:70-8. [PMID: 31639886 DOI: 10.14366/usg.19002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
311 Glińska-Suchocka K, Jankowski M, Kubiak K, Spużak J, Borusewicz P, Kubiak-Nowak D. A liver core needle biopsy technique in guinea pigs (Cavia porcellus). Acta Vet Scand 2019;61:27. [PMID: 31196125 DOI: 10.1186/s13028-019-0462-4] [Reference Citation Analysis]
312 Wang B, Sun Y, Zhou J, Wu X, Chen S, Shi Y, Wu S, Liu H, Ren Y, Ou X, Jia J, You H. SHG/TPEF-based image technology improves liver fibrosis assessment of minimally sized needle biopsies. Hepatol Int 2019;13:501-9. [PMID: 31187402 DOI: 10.1007/s12072-019-09955-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
313 Kolhe KM, Amarapurkar A, Parikh P, Chaubal A, Chauhan S, Khairnar H, Walke S, Ingle M, Pandey V, Shukla A. Aspartate transaminase to platelet ratio index (APRI) but not FIB-5 or FIB-4 is accurate in ruling out significant fibrosis in patients with non-alcoholic fatty liver disease (NAFLD) in an urban slum-dwelling population. BMJ Open Gastroenterol. 2019;6:e000288. [PMID: 31275584 DOI: 10.1136/bmjgast-2019-000288] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
314 Bae JS, Lee DH, Lee JY, Kim H, Yu SJ, Lee JH, Cho EJ, Lee YB, Han JK, Choi BI. Assessment of hepatic steatosis by using attenuation imaging: a quantitative, easy-to-perform ultrasound technique. Eur Radiol. 2019;. [PMID: 31175413 DOI: 10.1007/s00330-019-06272-y] [Cited by in Crossref: 62] [Cited by in F6Publishing: 50] [Article Influence: 15.5] [Reference Citation Analysis]
315 Alharbi SM, Zaidan AD, Aljuffri AA, Sukkar GA, Almaghrabi HQ. Predictors of adequate percutaneous liver biopsy specimens: a single-center experience. Egypt J Intern Med 2019;31:222-225. [DOI: 10.4103/ejim.ejim_67_18] [Reference Citation Analysis]
316 Obrzut M, Atamaniuk V, Obrzut B, Ehman R, Cholewa M, Rzucidło M, Pozaruk A, Gutkowski K. Normative values for magnetic resonance elastography-based liver stiffness in a healthy population. Pol Arch Intern Med 2019;129:321-6. [PMID: 30793705 DOI: 10.20452/pamw.4456] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
317 Fintelmann FJ, Troschel FM, Kuklinski MW, McDermott S, Petranovic M, Digumarthy SR, Sharma A, Troschel AS, Price MC, Hariri LP, Gilman MD, Shepard JO, Sequist LV, Piotrowska Z. Safety and Success of Repeat Lung Needle Biopsies in Patients with Epidermal Growth Factor Receptor-Mutant Lung Cancer. Oncologist 2019;24:1570-6. [PMID: 31152082 DOI: 10.1634/theoncologist.2019-0158] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
318 Surana P, Kapuria D, Broadwell C, Wright EC, Takyar V, Kleiner DE, Ghany MG, Ben-Yakov G, Heller T, Liang TJ, Koh C. Longitudinal effects of Nucleos(t)ide analogue therapy in chronic hepatitis B patients and the utility of non-invasive fibrosis markers during treatment: A single-center experience for up to 17 years. Antiviral Res 2019;168:61-7. [PMID: 31125632 DOI: 10.1016/j.antiviral.2019.05.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
319 Verloh N, Probst U, Utpatel K, Zeman F, Brennfleck F, Werner JM, Fellner C, Stroszczynski C, Evert M, Wiggermann P, Haimerl M. Influence of hepatic fibrosis and inflammation: Correlation between histopathological changes and Gd-EOB-DTPA-enhanced MR imaging. PLoS One 2019;14:e0215752. [PMID: 31083680 DOI: 10.1371/journal.pone.0215752] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
320 Chrostek L, Przekop D, Gruszewska E, Gudowska-Sawczuk M, Cylwik B. Noninvasive Indirect Markers of Liver Fibrosis in Alcoholics. Biomed Res Int 2019;2019:3646975. [PMID: 31192254 DOI: 10.1155/2019/3646975] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
321 Chalasani N, Abdelmalek MF, Loomba R, Kowdley KV, McCullough AJ, Dasarathy S, Neuschwander-Tetri BA, Terrault N, Ferguson B, Shringarpure R, Shapiro D, Sanyal AJ. Relationship between three commonly used non-invasive fibrosis biomarkers and improvement in fibrosis stage in patients with non-alcoholic steatohepatitis. Liver Int 2019;39:924-32. [PMID: 30253043 DOI: 10.1111/liv.13974] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 9.8] [Reference Citation Analysis]
322 Zhan C, Kannengiesser S, Chandarana H, Fenchel M, Ream J, Shanbhogue KP. MR elastography of liver at 3 Tesla: comparison of gradient-recalled echo (GRE) and spin-echo (SE) echo-planar imaging (EPI) sequences and agreement across stiffness measurements. Abdom Radiol (NY) 2019;44:1825-33. [PMID: 30796479 DOI: 10.1007/s00261-019-01932-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
323 Shah AR, Al-Hanayneh M, Chowdhry M, Bilal M, Singh S. Endoscopic ultrasound guided liver biopsy for parenchymal liver disease. World J Hepatol 2019;11:335-43. [PMID: 31114638 DOI: 10.4254/wjh.v11.i4.335] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
324 Liu Y, Jiang M, Xue J, Yan H, Liang X. Serum HBV RNA quantification: useful for monitoring natural history of chronic hepatitis B infection. BMC Gastroenterol 2019;19:53. [PMID: 30991954 DOI: 10.1186/s12876-019-0966-4] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 8.5] [Reference Citation Analysis]
325 Pu K, Wang Y, Bai S, Wei H, Zhou Y, Fan J, Qiao L. Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta-analysis. BMC Gastroenterol 2019;19:51. [PMID: 30961539 DOI: 10.1186/s12876-019-0961-9] [Cited by in Crossref: 76] [Cited by in F6Publishing: 82] [Article Influence: 19.0] [Reference Citation Analysis]
326 Gorka-Dynysiewicz J, Pazgan-Simon M, Zuwala-Jagiello J. Pentraxin 3 Detects Clinically Significant Fibrosis in Patients with Chronic Viral Hepatitis C. Biomed Res Int 2019;2019:2639248. [PMID: 31061822 DOI: 10.1155/2019/2639248] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
327 Watt GP, Lee M, Pan JJ, Fallon MB, Loomba R, Beretta L, McCormick JB, Fisher-Hoch SP. High Prevalence of Hepatic Fibrosis, Measured by Elastography, in a Population-Based Study of Mexican Americans. Clin Gastroenterol Hepatol 2019;17:968-975.e5. [PMID: 29902644 DOI: 10.1016/j.cgh.2018.05.046] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
328 Dong XQ, Wu Z, Li J, Wang GQ, Zhao H; China HepB-Related Fibrosis Assessment Research Group. Declining in liver stiffness cannot indicate fibrosis regression in patients with chronic hepatitis B: A 78-week prospective study. J Gastroenterol Hepatol 2019;34:755-63. [PMID: 30290019 DOI: 10.1111/jgh.14498] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
329 Yoshino K, Taura K, Okuda Y, Ikeno Y, Uemoto Y, Nishio T, Yamamoto G, Tanabe K, Koyama Y, Seo S, Kaido T, Okajima H, Imai T, Tanaka S, Uemoto S. Efficiency of acoustic radiation force impulse imaging for the staging of graft fibrosis after liver transplantation. Hepatol Res 2019;49:394-403. [PMID: 30471140 DOI: 10.1111/hepr.13289] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
330 Wang K, Lu X, Zhou H, Gao Y, Zheng J, Tong M, Wu C, Liu C, Huang L, Jiang T, Meng F, Lu Y, Ai H, Xie XY, Yin LP, Liang P, Tian J, Zheng R. Deep learning Radiomics of shear wave elastography significantly improved diagnostic performance for assessing liver fibrosis in chronic hepatitis B: a prospective multicentre study. Gut 2019;68:729-41. [PMID: 29730602 DOI: 10.1136/gutjnl-2018-316204] [Cited by in Crossref: 226] [Cited by in F6Publishing: 234] [Article Influence: 56.5] [Reference Citation Analysis]
331 Zhang YN, Fowler KJ, Ozturk A, Potu CK, Louie AL, Montes V, Henderson WC, Wang K, Andre MP, Samir AE, Sirlin CB. Liver fibrosis imaging: A clinical review of ultrasound and magnetic resonance elastography. J Magn Reson Imaging 2020;51:25-42. [PMID: 30859677 DOI: 10.1002/jmri.26716] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 7.0] [Reference Citation Analysis]
332 Behera MK, Shukla SK, Dixit VK, Nath P, Abhilash VB, Asati PK, Jain AK. Effect of vitamin D supplementation on sustained virological response in genotype 1/4 chronic hepatitis C treatment-naïve patients from India. Indian J Med Res 2018;148:200-6. [PMID: 30381543 DOI: 10.4103/ijmr.IJMR_1295_15] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
333 Webster CRL, Center SA, Cullen JM, Penninck DG, Richter KP, Twedt DC, Watson PJ. ACVIM consensus statement on the diagnosis and treatment of chronic hepatitis in dogs. J Vet Intern Med 2019;33:1173-200. [PMID: 30844094 DOI: 10.1111/jvim.15467] [Cited by in Crossref: 40] [Cited by in F6Publishing: 47] [Article Influence: 10.0] [Reference Citation Analysis]
334 Hsu C, Caussy C, Imajo K, Chen J, Singh S, Kaulback K, Le MD, Hooker J, Tu X, Bettencourt R, Yin M, Sirlin CB, Ehman RL, Nakajima A, Loomba R. Magnetic Resonance vs Transient Elastography Analysis of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Pooled Analysis of Individual Participants. Clin Gastroenterol Hepatol 2019;17:630-637.e8. [PMID: 29908362 DOI: 10.1016/j.cgh.2018.05.059] [Cited by in Crossref: 177] [Cited by in F6Publishing: 182] [Article Influence: 44.3] [Reference Citation Analysis]
335 Calle-Toro JS, Serai SD, Hartung EA, Goldberg DJ, Bolster BD Jr, Darge K, Anupindi SA. Magnetic resonance elastography SE-EPI vs GRE sequences at 3T in a pediatric population with liver disease. Abdom Radiol (NY) 2019;44:894-902. [PMID: 30600386 DOI: 10.1007/s00261-018-1884-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
336 Yuemin Nan, Xuemin Niu, Rongqi Wang, Suxian Zhao, Na Fu, Jinghua Du, Yang Wang, Baoyu Wang, Yuguo Zhang. microRNA-1273g-3p is a useful non-invasive test for the prediction of liver fibrosis in patients with chronic hepatitis C. Exp Ther Med 2019;17. [PMID: 30783454 DOI: 10.3892/etm.2018.7114] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
337 Mullish BH, Kumar N, Goldin RD, Manousou P. Liver Biopsy. Evidence-based Gastroenterology and Hepatology 4e 2019. [DOI: 10.1002/9781119211419.ch27] [Reference Citation Analysis]
338 Lee JG, Sohn JH, Jeong JY, Kim TY, Kim SM, Cho YS, Kim Y. Combined effect of hepatic venous pressure gradient and liver stiffness on long-term mortality in patients with cirrhosis. Korean J Intern Med 2020;35:88-98. [PMID: 30791681 DOI: 10.3904/kjim.2018.151] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
339 Ciccarelli N, Fabbiani M, Brita AC, De Marco R, Grima P, Gagliardini R, Borghetti A, Cauda R, Di Giambenedetto S. Liver fibrosis is associated with cognitive impairment in people living with HIV. Infection 2019;47:589-93. [PMID: 30784024 DOI: 10.1007/s15010-019-01284-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
340 Köksal İ, Yılmaz G, Parlak M, Demirdal T, Kınıklı S, Candan M, Kaya A, Akhan S, Aydoğdu Ö, Turgut H, Gürbüz Y, Dağlı Ö, Gökal AA, Güner R, Kuruüzüm Z, Tarakçı H, Beslen N, Erdoğan S, Özdener F, Study Group TCHC. Diagnostic value of combined serum biomarkers for the evaluation of liver fibrosis in chronic hepatitis C infection: A multicenter, noninterventional, observational study. Turk J Gastroenterol 2018;29:464-72. [PMID: 30249562 DOI: 10.5152/tjg.2018.16597] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
341 Roth NC, Qin J. Histopathology of Alcohol-Related Liver Diseases. Clin Liver Dis 2019;23:11-23. [PMID: 30454825 DOI: 10.1016/j.cld.2018.09.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
342 Trivedi HD, Patwardhan VR, Malik R. Chronic hepatitis C infection - Noninvasive assessment of liver fibrosis in the era of direct acting antivirals. Dig Liver Dis 2019;51:183-9. [PMID: 30553749 DOI: 10.1016/j.dld.2018.11.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
343 Costa RS, Cardoso AF, Ferreira A, Costa J, Costa D, Fernandes D, Caetano AC. What recovery position should patients adopt after percutaneous liver biopsy? Eur J Gastroenterol Hepatol 2019;31:253-9. [PMID: 30358572 DOI: 10.1097/MEG.0000000000001290] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
344 Mohan BP, Shakhatreh M, Garg R, Ponnada S, Adler DG. Efficacy and safety of EUS-guided liver biopsy: a systematic review and meta-analysis. Gastrointest Endosc 2019;89:238-246.e3. [PMID: 30389469 DOI: 10.1016/j.gie.2018.10.018] [Cited by in Crossref: 73] [Cited by in F6Publishing: 71] [Article Influence: 18.3] [Reference Citation Analysis]
345 Mok SRS, Diehl DL. The Role of EUS in Liver Biopsy. Curr Gastroenterol Rep 2019;21:6. [PMID: 30706151 DOI: 10.1007/s11894-019-0675-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
346 Endo Y, Ohta M, Tada K, Nakanuma H, Saga K, Masuda T, Hirashita T, Iwashita Y, Ozeki Y, Masaki T, Inomata M. Improvement of non-alcoholic fatty liver disease after laparoscopic sleeve gastrectomy in Japanese obese patients. Ann Gastroenterol Surg 2019;3:285-90. [PMID: 31131357 DOI: 10.1002/ags3.12234] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
347 Zhang GL, Zhao QY, Lin CS, Hu ZX, Zhang T, Gao ZL. Transient Elastography and Ultrasonography: Optimal Evaluation of Liver Fibrosis and Cirrhosis in Patients with Chronic Hepatitis B Concurrent with Nonalcoholic Fatty Liver Disease. Biomed Res Int 2019;2019:3951574. [PMID: 30809540 DOI: 10.1155/2019/3951574] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
348 Marra G, Ploussard G, Futterer J, Valerio M; EAU-YAU Prostate Cancer Working Party. Controversies in MR targeted biopsy: alone or combined, cognitive versus software-based fusion, transrectal versus transperineal approach? World J Urol 2019;37:277-87. [PMID: 30610359 DOI: 10.1007/s00345-018-02622-5] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 9.5] [Reference Citation Analysis]
349 Wakui N, Nagai H, Matsukiyo Y, Ogino Y, Matsui D, Mukozu T, Kogame M, Matsui T, Daido Y, Momiyama K, Maruyama K, Kudo T, Shinohara M, Ikehara T, Sumino Y, Igarashi Y. Effect of Hepatic Inflammation in Chronic Hepatitis C Infection on Fibrosis Assessment by Arrival Time Parametric Imaging. Ultrasound Q 2018;34:128-32. [PMID: 29634669 DOI: 10.1097/RUQ.0000000000000355] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
350 van Welzen BJ, Mudrikova T, El Idrissi A, Hoepelman AIM, Arends JE. A review of Non-Alcoholic Fatty Liver Disease in HIV-infected patients: The next big thing? Infect Dis Ther. 2019;8:33-50. [PMID: 30607807 DOI: 10.1007/s40121-018-0229-7] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]
351 Diehl DL. Endoscopic Ultrasound-Guided Liver Biopsy. Interventional Endoscopic Ultrasound 2019. [DOI: 10.1007/978-3-319-97376-0_9] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
352 Mok SRS, Diehl DL, Johal AS, Khara HS, Confer BD, Mudireddy PR, Kovach AH, Diehl MM, Kirchner HL, Chen ZE. Endoscopic ultrasound-guided biopsy in chronic liver disease: a randomized comparison of 19-G FNA and 22-G FNB needles. Endosc Int Open 2019;7:E62-71. [PMID: 30648141 DOI: 10.1055/a-0655-7462] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
353 Shah ND, Baron TH. Taking a poke at the liver: which way is best? Endosc Int Open 2019;7:E72-3. [PMID: 30648701 DOI: 10.1055/a-0747-5713] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
354 Ranete M, Grasu MC, Dumitru R, Rusu G, Toma M, Lupescu IG. Overview of intrahepatic cholangiocarcinoma – from imaging aspects to interventional approach. Oncolog-Hematolog ro 2019;4:16. [DOI: 10.26416/onhe.49.4.2019.2738] [Reference Citation Analysis]
355 Lee J, Cho J, Kim J, Uh Y, Youn KJ. Evaluation of Noninvasive Liver Fibrosis Blood Markers in Patients with Chronic Hepatitis B and Hepatitis C. Lab Med Online 2019;9:153. [DOI: 10.3343/lmo.2019.9.3.153] [Reference Citation Analysis]
356 Allen AM, Shah VH, Therneau TM, Venkatesh SK, Mounajjed T, Larson JJ, Mara KC, Schulte PJ, Kellogg TA, Kendrick ML, McKenzie TJ, Greiner SM, Li J, Glaser KJ, Wells ML, Chen J, Ehman RL, Yin M. The Role of Three-Dimensional Magnetic Resonance Elastography in the Diagnosis of Nonalcoholic Steatohepatitis in Obese Patients Undergoing Bariatric Surgery. Hepatology 2020;71:510-21. [PMID: 30582669 DOI: 10.1002/hep.30483] [Cited by in Crossref: 40] [Cited by in F6Publishing: 48] [Article Influence: 8.0] [Reference Citation Analysis]
357 Nar H, Kırhan İ, Taşkıran H, Uyanıkoğlu A, Yenice N. Kronik hepatitli ve karaciğer sirozlu hastaların biyoelektrik impedans yöntemi ile değerlendirilmesi. Akademik Gastroenteroloji Dergisi 2018. [DOI: 10.17941/agd.498555] [Reference Citation Analysis]
358 Schekotova AP, Bulatova IA, Paducheva SV. Clinicodiagnostic problems of hepatic fibrosis/cirrhosis. Perm Med J 2018;35:98-107. [DOI: 10.17816/pmj35598-107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
359 Danin PE, Anty R, Patouraux S, Raucoules-Aimé M, Gugenheim J, Tran A, Gual P, Iannelli A. Non-invasive Evaluation of NAFLD with Indocyanine Green Clearance Test: a Preliminary Study in Morbidly Obese Patients Undergoing Bariatric Surgery. Obes Surg 2018;28:735-42. [PMID: 28875438 DOI: 10.1007/s11695-017-2914-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
360 Emara DM, Reda MM, Elwazzan DA. Utility of diffusion weighted imaging (DWI) in assessment of liver fibrosis. Alexandria Journal of Medicine 2018;54:347-352. [DOI: 10.1016/j.ajme.2017.06.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
361 Jung IJ, Kim SU. Clinical Implications of Shear Wave Elastography in Patients with Chronic Hepatitis B. Clin Ultrasound 2018;3:45-49. [DOI: 10.18525/cu.2018.3.2.45] [Reference Citation Analysis]
362 Lin YH, Liao YY, Yeh CK, Yang KC, Tsui PH. Ultrasound Entropy Imaging of Nonalcoholic Fatty Liver Disease: Association with Metabolic Syndrome. Entropy (Basel) 2018;20:E893. [PMID: 33266617 DOI: 10.3390/e20120893] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
363 Bellamkonda S, Paruthikunnan SM, Kadavigere R, Sripathi S. Role of Shear Wave Elastography in the Assessment of Fibrosis in Chronic Liver Disease. Journal of Diagnostic Medical Sonography 2018;34:460-465. [DOI: 10.1177/8756479318799340] [Reference Citation Analysis]
364 Wildman-Tobriner B, Middleton MM, Moylan CA, Rossi S, Flores O, Chang ZA, Abdelmalek MF, Sirlin CB, Bashir MR. Association Between Magnetic Resonance Imaging-Proton Density Fat Fraction and Liver Histology Features in Patients With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis. Gastroenterology 2018;155:1428-1435.e2. [PMID: 30031769 DOI: 10.1053/j.gastro.2018.07.018] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 7.6] [Reference Citation Analysis]
365 Zhao H. Harmonic Shear Wave Elastography. Ultrasound Elastography for Biomedical Applications and Medicine 2018. [DOI: 10.1002/9781119021520.ch16] [Reference Citation Analysis]
366 Lee YB, Ha Y, Chon YE, Kim MN, Lee JH, Park H, Kim KI, Kim SH, Rim KS, Hwang SG. Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B. Clin Mol Hepatol. 2019;25:52-64. [PMID: 30360031 DOI: 10.3350/cmh.2018.0040] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 8.8] [Reference Citation Analysis]
367 Chen Y, Li Y, Li N, Fan X, Li C, Zhang P, Han Q, Liu Z. A Noninvasive Score to Predict Liver Fibrosis in HBeAg-Positive Hepatitis B Patients with Normal or Minimally Elevated Alanine Aminotransferase Levels. Dis Markers 2018;2018:3924732. [PMID: 30405859 DOI: 10.1155/2018/3924732] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
368 Ueno T, Kodama T, Noguchi Y, Saka R, Takama Y, Tazuke Y, Bessho K, Okuyama H. Clinical implications of serum Mac-2-binding protein (M2BPGi) during regular follow-up of patients with biliary atresia. Pediatr Surg Int 2018;34:1065-71. [PMID: 30128700 DOI: 10.1007/s00383-018-4317-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
369 Gül Utku Ö, Bektaş A. Analysis of liver biopsies performed as outpatient and ınpatient, due to diffuse liver diseases. Ortadogu Tıp Derg 2018;10:331-342. [DOI: 10.21601/ortadogutipdergisi.397750] [Reference Citation Analysis]
370 Heo JY, Kim BK, Park JY, Kim DY, Ahn SH, Kim HS, Park YN, Han KH, Song K, Kim SU. Combination of Transient Elastography and an Enhanced Liver Fibrosis Test to Assess the Degree of Liver Fibrosis in Patients with Chronic Hepatitis B. Gut Liver 2018;12:190-200. [PMID: 29069887 DOI: 10.5009/gnl17092] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
371 Jeong JY, Cho YS, Sohn JH. Role of two-dimensional shear wave elastography in chronic liver diseases: A narrative review. World J Gastroenterol 2018; 24(34): 3849-3860 [PMID: 30228779 DOI: 10.3748/wjg.v24.i34.3849] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
372 Moon HW, Park M, Hur M, Kim H, Choe WH, Yun YM. Usefulness of Enhanced Liver Fibrosis, Glycosylation Isomer of Mac-2 Binding Protein, Galectin-3, and Soluble Suppression of Tumorigenicity 2 for Assessing Liver Fibrosis in Chronic Liver Diseases. Ann Lab Med 2018;38:331-7. [PMID: 29611383 DOI: 10.3343/alm.2018.38.4.331] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
373 Aumann EK, Server S, Koyuncu Sokmen B, Oz A, Namal E, Gurcan NI, Balci NC, Tokat Y. Diagnostic performances of intravoxel incoherent motion and conventional diffusion-weighted imaging in the differential diagnosis of benign and malignant portal vein thrombus. Abdom Radiol (NY) 2018;43:2270-6. [PMID: 29411058 DOI: 10.1007/s00261-018-1467-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
374 Shiha GE, El-Etreby S, Bahgat M, Hamed M, El Sherbini M, Ghoneem EA, Zalata K, Soliman RE, El Basiouny MA, Mikhail NN. Chronic Hepatitis C Patients with Obesity: Do we Need two Operators for Accurate Evaluation of Liver Stiffness? Ann Hepatol 2018;17:795-801. [PMID: 30145567 DOI: 10.5604/01.3001.0012.3138] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
375 Yao M, Wang L, Leung PSC, Li Y, Liu S, Wang L, Guo X, Zhou G, Yan Y, Guan G, Chen X, Bowlus CL, Liu T, Jia J, Gershwin ME, Ma X, Zhao J, Lu F. The Clinical Significance of GP73 in Immunologically Mediated Chronic Liver Diseases: Experimental Data and Literature Review. Clin Rev Allergy Immunol. 2018;54:282-294. [PMID: 29256057 DOI: 10.1007/s12016-017-8655-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
376 Tulin-Silver S, Obi C, Kothary N, Lungren MP. Comparison of Transjugular Liver Biopsy and Percutaneous Liver Biopsy With Tract Embolization in Pediatric Patients. J Pediatr Gastroenterol Nutr 2018;67:180-4. [PMID: 29509634 DOI: 10.1097/MPG.0000000000001951] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 3.4] [Reference Citation Analysis]
377 Caussy C, Reeder SB, Sirlin CB, Loomba R. Noninvasive, Quantitative Assessment of Liver Fat by MRI-PDFF as an Endpoint in NASH Trials. Hepatology 2018;68:763-72. [PMID: 29356032 DOI: 10.1002/hep.29797] [Cited by in Crossref: 209] [Cited by in F6Publishing: 215] [Article Influence: 41.8] [Reference Citation Analysis]
378 Zhang Y, Wang C, Duanmu Y, Zhang C, Zhao W, Wang L, Cheng X, Veronese N, Guglielmi G. Comparison of CT and magnetic resonance mDIXON-Quant sequence in the diagnosis of mild hepatic steatosis. Br J Radiol 2018;91:20170587. [PMID: 30028193 DOI: 10.1259/bjr.20170587] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
379 Cristina SJL, Marta CM, Mercedes GS, Almudena PM, Álvaro HM, Luis VSJ, Tesifón PC. Characterization and evaluation of liver fibrosis grade in patients with chronic hepatitis B virus infection and normal transaminases. Clin Mol Hepatol 2018;24:384-91. [PMID: 29969885 DOI: 10.3350/cmh.2018.0004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
380 Venkatesh SK, Wells ML, Miller FH, Jhaveri KS, Silva AC, Taouli B, Ehman RL. Magnetic resonance elastography: beyond liver fibrosis-a case-based pictorial review. Abdom Radiol (NY) 2018;43:1590-611. [PMID: 29143076 DOI: 10.1007/s00261-017-1383-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
381 Lee CK, Mitchell PD, Raza R, Harney S, Wiggins SM, Jonas MM. Validation of Transient Elastography Cut Points to Assess Advanced Liver Fibrosis in Children and Young Adults: The Boston Children's Hospital Experience. J Pediatr 2018;198:84-89.e2. [PMID: 29685617 DOI: 10.1016/j.jpeds.2018.02.062] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 5.4] [Reference Citation Analysis]
382 Kosmalski M, Mokros Ł, Kuna P, Witusik A, Pietras T. Changes in the immune system - the key to diagnostics and therapy of patients with non-alcoholic fatty liver disease. Cent Eur J Immunol 2018;43:231-9. [PMID: 30135638 DOI: 10.5114/ceji.2018.77395] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
383 Jiang H, Zheng T, Duan T, Chen J, Song B. Non-invasive in vivo Imaging Grading of Liver Fibrosis. J Clin Transl Hepatol 2018;6:198-207. [PMID: 29951365 DOI: 10.14218/JCTH.2017.00038] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
384 Jeong JY, Sohn JH, Sohn W, Park CH, Kim TY, Jun DW, Kim Y, Jeong WK. Role of Shear Wave Elastography in Evaluating the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B. Gut Liver. 2017;11:852-859. [PMID: 28651307 DOI: 10.5009/gnl16521] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
385 Patch D, Luong TV. Biopsy of the Liver. Sherlock's Diseases of the Liver and Biliary System 2018. [DOI: 10.1002/9781119237662.ch3] [Reference Citation Analysis]
386 Majumdar A, Pinzani M. Non-invasive Assessment of Fibrosis and Cirrhosis. Sherlock's Diseases of the Liver and Biliary System 2018. [DOI: 10.1002/9781119237662.ch7] [Reference Citation Analysis]
387 Hayashi T, Fukuzawa K, Kondo H, Onodera H, Tojo R, Yano S, Miyati T, Kotoku J, Okamoto T, Toyoda K, Oba H. Influence of Gd-EOB-DTPA on T1 dependence of the proton density fat fraction using magnetic resonance spectroscopy. Radiol Phys Technol 2018;11:338-44. [PMID: 29858768 DOI: 10.1007/s12194-018-0466-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
388 Valva P, Rios D, Casciato P, Gadano A, Galdame O, Mullen E, Bertot G, de Matteo E, Preciado MV. Nonalcoholic fatty liver disease: biomarkers as diagnostic tools for liver damage assessment in adult patients from Argentina. Eur J Gastroenterol Hepatol 2018;30:637-44. [PMID: 29384795 DOI: 10.1097/MEG.0000000000001079] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
389 Joshita S, Umemura T, Usami Y, Yamashita Y, Norman GL, Sugiura A, Yamazaki T, Fujimori N, Kimura T, Matsumoto A, Igarashi K, Yoshizawa K, Ota M, Tanaka E. Serum Autotaxin Is a Useful Disease Progression Marker in Patients with Primary Biliary Cholangitis. Sci Rep 2018;8:8159. [PMID: 29802350 DOI: 10.1038/s41598-018-26531-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
390 Felicani C, De Molo C, Stefanescu H, Conti F, Mazzotta E, Gabusi V, Nardi E, Morselli-Labate AM, Andreone P, Serra C. Point quantification elastography in the evaluation of liver elasticity in healthy volunteers: a reliability study based on operator expertise. J Ultrasound 2018;21:89-98. [PMID: 29790083 DOI: 10.1007/s40477-018-0300-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
391 Pan S, Wang XQ, Guo QY. Quantitative assessment of hepatic fibrosis in chronic hepatitis B and C: T1 mapping on Gd-EOB-DTPA-enhanced liver magnetic resonance imaging. World J Gastroenterol 2018; 24(18): 2024-2035 [PMID: 29760545 DOI: 10.3748/wjg.v24.i18.2024] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
392 Almeida P, Schreiber RA, Liang J, Mujawar Q, Guttman OR. Clinical Characteristics and Complications of Pediatric Liver Biopsy: A Single Centre Experience. Ann Hepatol 2017;16:797-801. [PMID: 28809725 DOI: 10.5604/01.3001.0010.2809] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
393 Bartoș A, Cioltean C, Breazu C, Bartoș D. Evaluation and Surgical Management of Hepatocellular Carcinoma. Liver Research and Clinical Management 2018. [DOI: 10.5772/intechopen.75164] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
394 Kennedy P, Wagner M, Castéra L, Hong CW, Johnson CL, Sirlin CB, Taouli B. Quantitative Elastography Methods in Liver Disease: Current Evidence and Future Directions. Radiology 2018;286:738-63. [PMID: 29461949 DOI: 10.1148/radiol.2018170601] [Cited by in Crossref: 164] [Cited by in F6Publishing: 173] [Article Influence: 32.8] [Reference Citation Analysis]
395 Verloh N, Utpatel K, Haimerl M, Zeman F, Beyer L, Fellner C, Brennfleck F, Dahlke MH, Stroszczynski C, Evert M, Wiggermann P. Detecting liver fibrosis with Gd-EOB-DTPA-enhanced MRI: A confirmatory study. Sci Rep 2018;8:6207. [PMID: 29670136 DOI: 10.1038/s41598-018-24316-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
396 Verloh N, Utpatel K, Haimerl M, Zeman F, Fellner C, Dahlke M, Renner P, Seyfried T, Müller M, Stroszczynski C, Evert M, Wiggermann P. DWI - histology: a possible means of determining degree of liver fibrosis? Oncotarget 2018;9:20112-8. [PMID: 29732007 DOI: 10.18632/oncotarget.24981] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
397 Song JE, Lee DW, Kim EY. Endoscopic Ultrasound Real-Time Elastography in Liver Disease. Clin Endosc 2018;51:118-9. [PMID: 29618176 DOI: 10.5946/ce.2018.049] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
398 Wang D, Wang L, Wang Z, Chen S, Ni Y, Jiang D. Higher non-HDL-cholesterol to HDL-cholesterol ratio linked with increased nonalcoholic steatohepatitis. Lipids Health Dis 2018;17:67. [PMID: 29615042 DOI: 10.1186/s12944-018-0720-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
399 Larrey D, Meunier L, Ursic-Bedoya J. Liver Biopsy in Chronic Liver Diseases: Is There a Favorable Benefit: Risk Balance? Ann Hepatol 2017;16:487-9. [PMID: 28612749 DOI: 10.5604/01.3001.0010.0272] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
400 Tada T, Kumada T, Toyoda H, Kobayashi N, Akita T, Tanaka J. Hepatitis B virus core-related antigen levels predict progression to liver cirrhosis in hepatitis B carriers. J Gastroenterol Hepatol 2018;33:918-25. [PMID: 28914957 DOI: 10.1111/jgh.13989] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
401 Satkunasingham J, Nik HH, Fischer S, Menezes R, Selzner N, Cattral M, Grant D, Jhaveri K. Can negligible hepatic steatosis determined by magnetic resonance imaging-proton density fat fraction obviate the need for liver biopsy in potential liver donors? Liver Transpl 2018;24:470-7. [PMID: 29080242 DOI: 10.1002/lt.24965] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
402 Caussy C, Alquiraish MH, Nguyen P, Hernandez C, Cepin S, Fortney LE, Ajmera V, Bettencourt R, Collier S, Hooker J, Sy E, Rizo E, Richards L, Sirlin CB, Loomba R. Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis. Hepatology 2018;67:1348-59. [PMID: 29108123 DOI: 10.1002/hep.29639] [Cited by in Crossref: 186] [Cited by in F6Publishing: 187] [Article Influence: 37.2] [Reference Citation Analysis]
403 Wadhva RK, Haque MM, Luck NH, Tasneem AA, Abbas Z, Mubarak M. Diagnostic Accuracy of Aspartate Aminotransferase to Platelet Ratio Index and Fibrosis 4 Scores in Predicting Advanced Liver Fibrosis in Patients with End-stage Renal Disease and Chronic Viral Hepatitis: Experience from Pakistan. J Transl Int Med 2018;6:38-42. [PMID: 29607303 DOI: 10.2478/jtim-2018-0008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
404 Zhang X, Zhou X, Hara T, Fujita H. Non-Invasive Assessment of Hepatic Fibrosis by Elastic Measurement of Liver Using Magnetic Resonance Tagging Images. Applied Sciences 2018;8:437. [DOI: 10.3390/app8030437] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
405 Joshita S, Ichikawa Y, Umemura T, Usami Y, Sugiura A, Shibata S, Yamazaki T, Fujimori N, Komatsu M, Matsumoto A, Igarashi K, Ota M, Tanaka E. Serum autotaxin is a useful liver fibrosis marker in patients with chronic hepatitis B virus infection. Hepatol Res 2018;48:275-85. [PMID: 29114991 DOI: 10.1111/hepr.12997] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 5.6] [Reference Citation Analysis]
406 Fraum TJ, Ludwig DR, Kilian S, Curtis WA, Pilgram TK, Sirlin CB, Fowler KJ. Epidemiology of Hepatic Steatosis at a Tertiary Care Center: An MRI-based Analysis. Acad Radiol 2018;25:317-27. [PMID: 29199057 DOI: 10.1016/j.acra.2017.10.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
407 Liang X, Xie Q, Tan D, Ning Q, Niu J, Bai X, Chen S, Cheng J, Yu Y, Wang H, Xu M, Shi G, Wan M, Chen X, Tang H, Sheng J, Dou X, Shi J, Ren H, Wang M, Zhang H, Gao Z, Chen C, Ma H, Chen Y, Fan R, Sun J, Jia J, Hou J. Interpretation of liver stiffness measurement-based approach for the monitoring of hepatitis B patients with antiviral therapy: A 2-year prospective study. J Viral Hepat 2018;25:296-305. [PMID: 29080299 DOI: 10.1111/jvh.12814] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 6.4] [Reference Citation Analysis]
408 Wáng YXJ, Deng M, Lo GG, Liang D, Yuan J, Chen W. Breath-hold black-blood T1rho mapping improves liver T1rho quantification in healthy volunteers. Acta Radiol 2018;59:257-65. [PMID: 28679324 DOI: 10.1177/0284185117717764] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
409 Imanzadeh F, Dara N, Rohani P, Emadi B, Sanii S, Mousavi - Khorshidi M, Hosseini AH. Validation of Aspartate Aminotransferase to Platelet Ratio for Diagnosis of Hepatic Fibrosis and Prognostic Prediction of Infants with Biliary Atresia after Portoenterostomy. J Compr Ped 2018;9. [DOI: 10.5812/compreped.13304] [Reference Citation Analysis]
410 Urasaki Y, Zhang C, Cheng JX, Le TT. Quantitative Assessment of Liver Steatosis and Affected Pathways with Molecular Imaging and Proteomic Profiling. Sci Rep 2018;8:3606. [PMID: 29483581 DOI: 10.1038/s41598-018-22082-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
411 Wang J, Li J, Zhou Q, Zhang D, Bi Q, Wu Y, Huang W. Liver stiffness measurement predicted liver-related events and all-cause mortality: A systematic review and nonlinear dose-response meta-analysis. Hepatol Commun 2018;2:467-76. [PMID: 29619424 DOI: 10.1002/hep4.1154] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
412 Fang J, Chang NF, Tsui PH. Performance Evaluations on Using Entropy of Ultrasound Log-Compressed Envelope Images for Hepatic Steatosis Assessment: An In Vivo Animal Study. Entropy (Basel) 2018;20:E120. [PMID: 33265211 DOI: 10.3390/e20020120] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
413 Lin Z, Liang J, Zhu J, Hu C, Gu Y, Lai J, Zheng Y, Gao Z. Diverse correlations between fibrosis-related factors and liver stiffness measurement by transient elastography in chronic hepatitis B. Eur J Gastroenterol Hepatol 2018;30:217-25. [PMID: 29194232 DOI: 10.1097/MEG.0000000000001023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
414 Tag-Adeen M, Omar MZ, Abd-Elsalam FM, Hasaneen A, Mohamed MA, Elfeky HM, Said EM, Abdul-Aziz B, Osman AH, Ahmed ES, Osman GS, Abdul-Samie T. Assessment of liver fibrosis in Egyptian chronic hepatitis B patients: A comparative study including 5 noninvasive indexes. Medicine (Baltimore) 2018;97:e9781. [PMID: 29419671 DOI: 10.1097/MD.0000000000009781] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
415 Yokoo T, Serai SD, Pirasteh A, Bashir MR, Hamilton G, Hernando D, Hu HH, Hetterich H, Kühn JP, Kukuk GM, Loomba R, Middleton MS, Obuchowski NA, Song JS, Tang A, Wu X, Reeder SB, Sirlin CB; RSNA-QIBA PDFF Biomarker Committee. Linearity, Bias, and Precision of Hepatic Proton Density Fat Fraction Measurements by Using MR Imaging: A Meta-Analysis. Radiology 2018;286:486-98. [PMID: 28892458 DOI: 10.1148/radiol.2017170550] [Cited by in Crossref: 161] [Cited by in F6Publishing: 163] [Article Influence: 32.2] [Reference Citation Analysis]
416 Tsai E, Lee TP. Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient Elastography. Clin Liver Dis 2018;22:73-92. [PMID: 29128062 DOI: 10.1016/j.cld.2017.08.004] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 9.8] [Reference Citation Analysis]
417 Nieto J, Khaleel H, Challita Y, Jimenez M, Baron TH, Walters L, Hathaway K, Patel K, Lankarani A, Herman M, Holloman D, Saab S. EUS-guided fine-needle core liver biopsy sampling using a novel 19-gauge needle with modified 1-pass, 1 actuation wet suction technique. Gastrointest Endosc 2018;87:469-75. [PMID: 28551024 DOI: 10.1016/j.gie.2017.05.013] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 7.8] [Reference Citation Analysis]
418 Kim BS, Seo YS, Kim YS, Lee CH, Lee HA, Um SH, Yoo JJ, Kim SG, Suh SJ, Jung YK, Ahn SH, Han KH, Yim HJ, Kim SU; Korean Transient Elastography Study Group. Reduced risk of hepatocellular carcinoma by achieving a subcirrhotic liver stiffness through antiviral agents in hepatitis B virus-related advanced fibrosis or cirrhosis. J Gastroenterol Hepatol 2018;33:503-10. [PMID: 28666070 DOI: 10.1111/jgh.13854] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
419 Ferhan AR, Jackman JA, Park JH, Cho NJ, Kim DH. Nanoplasmonic sensors for detecting circulating cancer biomarkers. Adv Drug Deliv Rev 2018;125:48-77. [PMID: 29247763 DOI: 10.1016/j.addr.2017.12.004] [Cited by in Crossref: 66] [Cited by in F6Publishing: 69] [Article Influence: 13.2] [Reference Citation Analysis]
420 Łucejko M, Flisiak R. Effect of HCV Core Antigen and RNA Clearance during Therapy with Direct Acting Antivirals on Hepatic Stiffness Measured with Shear Wave Elastography in Patients with Chronic Viral Hepatitis C. Applied Sciences 2018;8:198. [DOI: 10.3390/app8020198] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
421 Cai S, Ou Z, Liu D, Liu L, Liu Y, Wu X, Yu T, Peng J. Risk factors associated with liver steatosis and fibrosis in chronic hepatitis B patient with component of metabolic syndrome. United European Gastroenterol J. 2018;6:558-566. [PMID: 29881611 DOI: 10.1177/2050640617751252] [Cited by in Crossref: 31] [Cited by in F6Publishing: 37] [Article Influence: 6.2] [Reference Citation Analysis]
422 Chen YP, Hu XM, Liang XE, Huang LW, Zhu YF, Hou JL. Stepwise application of fibrosis index based on four factors, red cell distribution width-platelet ratio, and aspartate aminotransferase-platelet ratio for compensated hepatitis B fibrosis detection. J Gastroenterol Hepatol 2018;33:256-63. [PMID: 28452125 DOI: 10.1111/jgh.13811] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
423 Tapper EB, Afdhal NH. Noninvasive Assessment of Disease Progression. Zakim and Boyer's Hepatology 2018. [DOI: 10.1016/b978-0-323-37591-7.00008-2] [Reference Citation Analysis]
424 Sherman KE, Sterling RK. HIV and the Liver. Zakim and Boyer's Hepatology 2018. [DOI: 10.1016/b978-0-323-37591-7.00037-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
425 Meijer B, van Everdingen CK, Ramsoekh D, Stedman C, Frampton CMA, Mulder CJJ, Bouma G, de Boer NKH, Gearry RB. Transient elastography to assess liver stiffness in patients with inflammatory bowel disease. Dig Liver Dis 2018;50:48-53. [PMID: 29050997 DOI: 10.1016/j.dld.2017.09.128] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
426 Anstee QM, Day CP. Epidemiology, Natural History, and Evaluation of Nonalcoholic Fatty Liver Disease. Zakim and Boyer's Hepatology 2018. [DOI: 10.1016/b978-0-323-37591-7.00026-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
427 Huang JY. Role of EUS-guided liver biopsy in benign parenchymal disease (with video). Endosc Ultrasound. 2018;7:236-239. [PMID: 30117485 DOI: 10.4103/eus.eus_33_18] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
428 Banini BA, Sanyal AJ. Coagulopathy: Pathophysiology, Evaluation, and Treatment. Liver Anesthesiology and Critical Care Medicine 2018. [DOI: 10.1007/978-3-319-64298-7_15] [Reference Citation Analysis]
429 Leitão J, Carvalhana S, Silva AP, Velasco F, Medeiros I, Alves AC, Bourbon M, Oliveiros B, Carvalho A, Cortez-Pinto H. No Evidence for Lower Levels of Serum Vitamin D in the Presence of Hepatic Steatosis. A Study on the Portuguese General Population. Int J Med Sci 2018;15:1778-86. [PMID: 30588203 DOI: 10.7150/ijms.26586] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
430 Li C, Li R, Zhang W. Progress in non-invasive detection of liver fibrosis. Cancer Biol Med 2018;15:124-36. [PMID: 29951337 DOI: 10.20892/j.issn.2095-3941.2018.0018] [Cited by in Crossref: 44] [Cited by in F6Publishing: 52] [Article Influence: 8.8] [Reference Citation Analysis]
431 Bath RK, Wu GY. Ultrasound-Guided/Ultrasound-Assisted Percutaneous Liver Biopsy. Clinical Gastroenterology 2018. [DOI: 10.1007/978-3-319-62993-3_26] [Reference Citation Analysis]
432 Fishman JA. Biopsy in the Diagnosis of Infection. Diagnostic Pathology of Infectious Disease 2018. [DOI: 10.1016/b978-0-323-44585-6.00003-5] [Reference Citation Analysis]
433 Guido M. Chronic Hepatitis. Practical Hepatic Pathology: a Diagnostic Approach 2018. [DOI: 10.1016/b978-0-323-42873-6.00016-0] [Reference Citation Analysis]
434 Deng H, Qi X, Zhang T, Qi X, Yoshida EM, Guo X. Supersonic shear imaging for the diagnosis of liver fibrosis and portal hypertension in liver diseases: a meta-analysis. Expert Rev Gastroenterol Hepatol 2018;12:91-8. [PMID: 29186994 DOI: 10.1080/17474124.2018.1412257] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
435 Zhang H, Yan XL, Guo XX, Shi MJ, Lu YY, Zhou QM, Chen QL, Hu YY, Xu LM, Huang S, Su SB. MiR-27a as a predictor for the activation of hepatic stellate cells and hepatitis B virus-induced liver cirrhosis. Oncotarget. 2018;9:1075-1090. [PMID: 29416678 DOI: 10.18632/oncotarget.23262] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
436 Ito K, Murotani K, Nakade Y, Inoue T, Nakao H, Sumida Y, Kamada Y, Yoneda M. Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein levels and liver fibrosis: A meta-analysis. J Gastroenterol Hepatol 2017;32:1922-30. [PMID: 28406534 DOI: 10.1111/jgh.13802] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 5.3] [Reference Citation Analysis]
437 Partovi S, Lu Z, Kessner R, Yu A, Ahmed Y, Patel IJ, Nakamoto DA, Azar N. Contrast enhanced ultrasound guided biopsies of liver lesions not visualized on standard B-mode ultrasound-preliminary experience. J Gastrointest Oncol 2017;8:1056-64. [PMID: 29299367 DOI: 10.21037/jgo.2017.08.17] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
438 Mitsuka Y, Midorikawa Y, Abe H, Matsumoto N, Moriyama M, Haradome H, Sugitani M, Tsuji S, Takayama T. A prediction model for the grade of liver fibrosis using magnetic resonance elastography. BMC Gastroenterol 2017;17:133. [PMID: 29179678 DOI: 10.1186/s12876-017-0700-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
439 Ragazzo TG, Paranagua-Vezozzo D, Lima FR, de Campos Mazo DF, Pessoa MG, Oliveira CP, Alves VAF, Carrilho FJ. Accuracy of transient elastography-FibroScan®, acoustic radiation force impulse (ARFI) imaging, the enhanced liver fibrosis (ELF) test, APRI, and the FIB-4 index compared with liver biopsy in patients with chronic hepatitis C. Clinics (Sao Paulo) 2017;72:516-25. [PMID: 29069254 DOI: 10.6061/clinics/2017(09)01] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 5.2] [Reference Citation Analysis]
440 Shao LN, Zhang ST, Zhou SH, Yu WJ, Liu M. Atypical Chemokine Receptor 1 polymorphism cannot be used as an indicator of liver fibrosis progression in Hepatitis C virus positive patients. Pak J Med Sci 2017;33:1134-7. [PMID: 29142552 DOI: 10.12669/pjms.335.12590] [Reference Citation Analysis]
441 Lee C, Wan Y, Hsu T, Huang S, Yu M, Lee W, Tsui P, Chen Y, Lin C, Tai D. Interpretation US Elastography in Chronic Hepatitis B with or without Anti-HBV Therapy. Applied Sciences 2017;7:1164. [DOI: 10.3390/app7111164] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
442 Kang BK, Kim M, Song SY, Jun DW, Jang K. Feasibility of modified Dixon MRI techniques for hepatic fat quantification in hepatic disorders: validation with MRS and histology. Br J Radiol 2018;91:20170378. [PMID: 29022777 DOI: 10.1259/bjr.20170378] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
443 Cai YJ, Dong JJ, Wang XD, Huang SS, Chen RC, Chen Y, Wang YQ, Song M, Chen YP, Li Z, Zhou MT, Shi KQ. A diagnostic algorithm for assessment of liver fibrosis by liver stiffness measurement in patients with chronic hepatitis B. J Viral Hepat 2017;24:1005-15. [PMID: 28419755 DOI: 10.1111/jvh.12715] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
444 Brouwer WP, van der Meer AJP, Boonstra A, Plompen EPC, Pas SD, de Knegt RJ, de Man RA, Ten Kate FJW, Janssen HLA, Hansen BE. Prediction of long-term clinical outcome in a diverse chronic hepatitis B population: Role of the PAGE-B score. J Viral Hepat 2017;24:1023-31. [PMID: 28544398 DOI: 10.1111/jvh.12727] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
445 Cao Z, Li Z, Wang H, Liu Y, Xu Y, Mo R, Ren P, Chen L, Lu J, Li H, Zhuang Y, Liu Y, Wang X, Zhao G, Tang W, Xiang X, Cai W, Liu L, Bao S, Xie Q. Algorithm of Golgi protein 73 and liver stiffness accurately diagnoses significant fibrosis in chronic HBV infection. Liver Int 2017;37:1612-21. [PMID: 28772348 DOI: 10.1111/liv.13536] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
446 Dolmazashvili E, Abutidze A, Chkhartishvili N, Karchava M, Sharvadze L, Tsertsvadze T. Regression of liver fibrosis over a 24-week period after completing direct-acting antiviral therapy in patients with chronic hepatitis C receiving care within the national hepatitis C elimination program in Georgia: results of hepatology clinic HEPA experience. Eur J Gastroenterol Hepatol 2017;29:1223-30. [PMID: 28857900 DOI: 10.1097/MEG.0000000000000964] [Cited by in Crossref: 60] [Cited by in F6Publishing: 58] [Article Influence: 10.0] [Reference Citation Analysis]
447 Koizumi Y, Hirooka M, Abe M, Tokumoto Y, Yoshida O, Watanabe T, Nakamura Y, Imai Y, Yukimoto A, Kumagi T, Takeshita E, Ikeda Y, Hiasa Y. Comparison between real-time tissue elastography and vibration-controlled transient elastography for the assessment of liver fibrosis and disease progression in patients with primary biliary cholangitis. Hepatol Res 2017;47:1252-9. [PMID: 28044427 DOI: 10.1111/hepr.12861] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
448 Hussein HA, Ibrahim A, Ali MF, Abdel-maksoud FM. Development and Complications of Blind and Ultrasound-Guided Percutaneous Liver Biopsy Techniques in Donkeys ( Equus asinus ). Journal of Equine Veterinary Science 2017;58:24-33. [DOI: 10.1016/j.jevs.2017.07.011] [Reference Citation Analysis]
449 Papatheodoridis GV, Idilman R, Dalekos GN, Buti M, Chi H, van Boemmel F, Calleja JL, Sypsa V, Goulis J, Manolakopoulos S, Loglio A, Siakavellas S, Keskın O, Gatselis N, Hansen BE, Lehretz M, de la Revilla J, Savvidou S, Kourikou A, Vlachogiannakos I, Galanis K, Yurdaydin C, Berg T, Colombo M, Esteban R, Janssen HLA, Lampertico P. The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B. Hepatology 2017;66:1444-53. [PMID: 28622419 DOI: 10.1002/hep.29320] [Cited by in Crossref: 196] [Cited by in F6Publishing: 203] [Article Influence: 32.7] [Reference Citation Analysis]
450 Cao Z, Li Z, Wang Y, Liu Y, Mo R, Ren P, Chen L, Lu J, Li H, Zhuang Y, Liu Y, Wang X, Zhao G, Tang W, Xiang X, Wang H, Cai W, Liu L, Zhu C, Bao S, Xie Q. Assessment of serum Golgi protein 73 as a biomarker for the diagnosis of significant fibrosis in patients with chronic HBV infection. J Viral Hepat 2017;24 Suppl 1:57-65. [PMID: 29082644 DOI: 10.1111/jvh.12786] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
451 Qiu T, Wang H, Song J, Ling W, Shi Y, Guo G, Luo Y. Assessment of liver fibrosis by ultrasound elastography and contrast-enhanced ultrasound: a randomized prospective animal study. Exp Anim 2018;67:117-26. [PMID: 29081454 DOI: 10.1538/expanim.17-0098] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
452 Mancini M, Salomone Megna A, Ragucci M, De Luca M, Marino Marsilia G, Nardone G, Coccoli P, Prinster A, Mannelli L, Vergara E, Monti S, Liuzzi R, Incoronato M. Reproducibility of shear wave elastography (SWE) in patients with chronic liver disease. PLoS One. 2017;12:e0185391. [PMID: 29023554 DOI: 10.1371/journal.pone.0185391] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
453 Lee DH. Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification. Clin Mol Hepatol 2017;23:290-301. [PMID: 28994271 DOI: 10.3350/cmh.2017.0042] [Cited by in Crossref: 63] [Cited by in F6Publishing: 68] [Article Influence: 10.5] [Reference Citation Analysis]
454 Wang D, Zhang P, Zhang M. Predictors for advanced liver fibrosis in chronic hepatitis B virus infection with persistently normal or mildly elevated alanine aminotransferase. Exp Ther Med 2017;14:5363-70. [PMID: 29285064 DOI: 10.3892/etm.2017.5219] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
455 Noguchi R, Kaji K, Namisaki T, Moriya K, Kitade M, Takeda K, Kawaratani H, Okura Y, Aihara Y, Furukawa M, Mitoro A, Yoshiji H. Serum angiotensin-converting enzyme level for evaluating significant fibrosis in chronic hepatitis B. World J Gastroenterol 2017; 23(36): 6705-6714 [PMID: 29085215 DOI: 10.3748/wjg.v23.i36.6705] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
456 Lee WJ, Uradomo LT, Zhang Y, Twaddell W, Darwin P. Comparison of the Diagnostic Yield of EUS Needles for Liver Biopsy: Ex Vivo Study. Diagn Ther Endosc 2017;2017:1497831. [PMID: 29056843 DOI: 10.1155/2017/1497831] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
457 Torres HA, Shigle TL, Hammoudi N, Link JT, Samaniego F, Kaseb A, Mallet V. The oncologic burden of hepatitis C virus infection: A clinical perspective. CA Cancer J Clin 2017;67:411-31. [PMID: 28683174 DOI: 10.3322/caac.21403] [Cited by in Crossref: 70] [Cited by in F6Publishing: 70] [Article Influence: 11.7] [Reference Citation Analysis]
458 [DOI: 10.1109/ultsym.2017.8091815] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
459 Elsharkawy A, Alem SA, Fouad R, El Raziky M, El Akel W, Abdo M, Tantawi O, AbdAllah M, Bourliere M, Esmat G. Changes in liver stiffness measurements and fibrosis scores following sofosbuvir based treatment regimens without interferon. J Gastroenterol Hepatol 2017;32:1624-30. [PMID: 28177543 DOI: 10.1111/jgh.13758] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 9.0] [Reference Citation Analysis]
460 Dubolazov OV, Vanchuliak O, Grygoryshyn P, Olar OV, Ushenko V, Sakhnovskiy M, Soltys IV. System of Mueller matrix polarization correlometry of biological polycrystalline layers. Biosensing and Nanomedicine X 2017. [DOI: 10.1117/12.2273789] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
461 Sanai FM, Farah T, Albeladi K, Batwa F, Dahlan Y, Babatin MA, Al-Ashgar H, AlMana H, Alsaad KS, AlSwat K, Aljumah A, AlTraif IH, Kailani BE, Bzeizi KI. Diminished accuracy of biomarkers of fibrosis in low replicative chronic hepatitis B. BMC Gastroenterol 2017;17:101. [PMID: 28841822 DOI: 10.1186/s12876-017-0658-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
462 Kamada Y, Ono M, Hyogo H, Fujii H, Sumida Y, Yamada M, Mori K, Tanaka S, Maekawa T, Ebisutani Y, Yamamoto A, Takamatsu S, Yoneda M, Kawada N, Chayama K, Saibara T, Takehara T, Miyoshi E; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG‐NAFLD). Use of Mac-2 binding protein as a biomarker for nonalcoholic fatty liver disease diagnosis. Hepatol Commun 2017;1:780-91. [PMID: 29404494 DOI: 10.1002/hep4.1080] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 5.5] [Reference Citation Analysis]
463 Vaidachovičiūtė B, Šemeklis L, Rimšelytė S. LIETUVOS SVEIKATOS MOKSLŲ UNIVERSITETO LIGONINĖS KAUNO KLINIKŲ GASTROENTEROLOGIJOS KLINIKOJE ATLIKTŲ KEPENŲ BIOPSIJŲ INDIKACIJŲ IR HISTOLOGINIŲ IŠVADŲ TAPATUMAS. Sveikatos mokslai 2017;27:23-26. [DOI: 10.5200/sm-hs.2017.034] [Reference Citation Analysis]
464 Zeng J, Huang ZP, Zheng J, Wu T, Zheng RQ. Non-invasive assessment of liver fibrosis using two-dimensional shear wave elastography in patients with autoimmune liver diseases. World J Gastroenterol 2017; 23(26): 4839-4846 [PMID: 28765706 DOI: 10.3748/wjg.v23.i26.4839] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
465 Kang J, Lee M. Noninvasive Diagnostic and Prognostic Assessment Tools for Liver Fibrosis and Cirrhosis in Patients with Chronic Liver Disease. Liver Cirrhosis - Update and Current Challenges 2017. [DOI: 10.5772/intechopen.68317] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
466 Verdelho Machado M. Controlled Attenuation Parameter as a Noninvasive Method to Detect and Quantify Hepatic Steatosis in Chronic Liver Disease: What Is the Clinical Relevance? GE Port J Gastroenterol 2017;24:157-60. [PMID: 29255744 DOI: 10.1159/000478944] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
467 Kim SJ, Won JH, Kim YB, Wang HJ, Kim BW, Kim H, Kim J. Plugged percutaneous biopsy of the liver in living-donor liver transplantation recipients suspected to have graft rejection. Acta Radiol 2017;58:771-7. [PMID: 27754919 DOI: 10.1177/0284185116673121] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
468 Zhu MY, Zou X, Li Q, Yu DM, Yang ZT, Huang D, Chen J, Gong QM, Zhang DH, Zhang Y, Chen L, Chen PZ, Zhang XX. A novel noninvasive algorithm for the assessment of liver fibrosis in patients with chronic hepatitis B virus infection. J Viral Hepat 2017;24:589-98. [PMID: 28130852 DOI: 10.1111/jvh.12682] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
469 Wang HW, Peng CY, Lai HC, Su WP, Lin CH, Chuang PH, Chen SH, Chen CH, Hsu WF, Huang GT. New noninvasive index for predicting liver fibrosis in Asian patients with chronic viral hepatitis. Sci Rep 2017;7:3259. [PMID: 28607450 DOI: 10.1038/s41598-017-03589-w] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
470 Chon YE, Park JY, Myoung SM, Jung KS, Kim BK, Kim SU, Kim DY, Ahn SH, Han KH. Improvement of Liver Fibrosis after Long-Term Antiviral Therapy Assessed by Fibroscan in Chronic Hepatitis B Patients With Advanced Fibrosis. Am J Gastroenterol 2017;112:882-91. [PMID: 28374814 DOI: 10.1038/ajg.2017.93] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]
471 Tajiri K, Kawai K, Sugiyama T. Strain elastography for assessment of liver fibrosis and prognosis in patients with chronic liver diseases. J Gastroenterol 2017;52:724-33. [PMID: 27787686 DOI: 10.1007/s00535-016-1277-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
472 Omran D, Yosry A, Darweesh SK, Nabeel MM, El-Beshlawey M, Saif S, Fared A, Hassany M, Zayed RA. Enhanced liver fibrosis test using ELISA assay accurately discriminates advanced stage of liver fibrosis as determined by transient elastography fibroscan in treatment naïve chronic HCV patients. Clin Exp Med 2018;18:45-50. [PMID: 28567544 DOI: 10.1007/s10238-017-0463-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
473 Wei B, Feng S, Chen E, Li D, Wang T, Gou Y, Yang T, Zhang D, Tao C, Tang H. M2BPGi as a potential diagnostic tool of cirrhosis in Chinese patients with Hepatitis B virus infection. J Clin Lab Anal 2018;32. [PMID: 28544156 DOI: 10.1002/jcla.22261] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
474 Yang ZX, Liang HY, Hu XX, Huang YQ, Ding Y, Yang S, Zeng MS, Rao SX. Feasibility of histogram analysis of susceptibility-weighted MRI for staging of liver fibrosis. Diagn Interv Radiol 2016;22:301-7. [PMID: 27113421 DOI: 10.5152/dir.2016.15284] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
475 Wáng YXJ, Deng M, Li YT, Huang H, Leung JCS, Chen W, Lu P. A combined use of intravoxel incoherent motion MRI parameters can differentiate early stage hepatitis-b fibrotic livers from healthy livers.. [DOI: 10.1101/138958] [Reference Citation Analysis]
476 Xu H, Kong W, Liu L, Chi X, Wang X, Wu R, Gao X, Wang H, Qu L, Qi Y, Pan Y, Niu J. Accuracy of M2BPGi, compared with Fibro Scan®, in analysis of liver fibrosis in patients with hepatitis C. BMC Gastroenterol 2017;17:62. [PMID: 28486931 DOI: 10.1186/s12876-017-0618-5] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
477 Singh S, Muir AJ, Dieterich DT, Falck-Ytter YT. American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases. Gastroenterology 2017;152:1544-77. [PMID: 28442120 DOI: 10.1053/j.gastro.2017.03.016] [Cited by in Crossref: 171] [Cited by in F6Publishing: 180] [Article Influence: 28.5] [Reference Citation Analysis]
478 Kim MJ, Park HS, Yhim HY. Intravascular large b-cell lymphoma diagnosed via transjugular liver biopsy in a patient with liver dysfunction and thrombocytopenia: A Case Report. Medicine (Baltimore) 2017;96:e6925. [PMID: 28489811 DOI: 10.1097/MD.0000000000006925] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
479 Venuto CS, Markatou M, Woolwine-Cunningham Y, Furlage R, Ocque AJ, DiFrancesco R, Dumas EO, Wallace PK, Morse GD, Talal AH. Paritaprevir and Ritonavir Liver Concentrations in Rats as Assessed by Different Liver Sampling Techniques. Antimicrob Agents Chemother 2017;61:e02283-16. [PMID: 28264852 DOI: 10.1128/AAC.02283-16] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
480 Yamazaki T, Joshita S, Umemura T, Usami Y, Sugiura A, Fujimori N, Shibata S, Ichikawa Y, Komatsu M, Matsumoto A. Association of Serum Autotaxin Levels with Liver Fibrosis in Patients with Chronic Hepatitis C. Sci Rep. 2017;7:46705. [PMID: 28425454 DOI: 10.1038/srep46705] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 6.2] [Reference Citation Analysis]
481 Yen YH, Chen JB, Cheng BC, Chen JF, Chang KC, Tseng PL, Wu CK, Tsai MC, Lin MT, Hu TH. Using controlled attenuation parameter combined with ultrasound to survey non-alcoholic fatty liver disease in hemodialysis patients: A prospective cohort study. PLoS One 2017;12:e0176027. [PMID: 28426815 DOI: 10.1371/journal.pone.0176027] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
482 Taibi L, Guéchot J. Évaluation non invasive de la fibrose hépatique. Revue Francophone des Laboratoires 2017;2017:38-44. [DOI: 10.1016/s1773-035x(17)30117-x] [Reference Citation Analysis]
483 Takyar V, Etzion O, Heller T, Kleiner DE, Rotman Y, Ghany MG, Fryzek N, Williams VH, Rivera E, Auh S, Liang TJ, Hoofnagle JH, Koh C. Complications of percutaneous liver biopsy with Klatskin needles: a 36-year single-centre experience. Aliment Pharmacol Ther 2017;45:744-53. [PMID: 28074540 DOI: 10.1111/apt.13939] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 7.0] [Reference Citation Analysis]
484 Chan AW, Wong GL, Chan HY, Tong JH, Yu YH, Choi PC, Chan HL, To KF, Wong VW. Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B. J Gastroenterol Hepatol 2017;32:667-76. [PMID: 27547913 DOI: 10.1111/jgh.13536] [Cited by in Crossref: 103] [Cited by in F6Publishing: 92] [Article Influence: 17.2] [Reference Citation Analysis]
485 Lambrecht J, Jan Poortmans P, Verhulst S, Reynaert H, Mannaerts I, van Grunsven LA. Circulating ECV-Associated MiRNA s as Potential Clinical Biomarkers in Early Stage HBV and HCV Induced Liver Fibrosis. Front Pharmacol. 2017;8:56. [PMID: 28232800 DOI: 10.3389/fphar.2017.00056] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 5.3] [Reference Citation Analysis]
486 Schulman AR, Thompson CC, Odze R, Chan WW, Ryou M. Optimizing EUS-guided liver biopsy sampling: comprehensive assessment of needle types and tissue acquisition techniques. Gastrointest Endosc 2017;85:419-26. [PMID: 27530070 DOI: 10.1016/j.gie.2016.07.065] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 7.8] [Reference Citation Analysis]
487 Ishii A, Nishikawa H, Enomoto H, Iwata Y, Kishino K, Shimono Y, Hasegawa K, Nakano C, Takata R, Nishimura T, Yoh K, Aizawa N, Sakai Y, Ikeda N, Takashima T, Iijima H, Nishiguchi S. Clinical implications of serum Wisteria floribunda agglutinin-positive Mac-2-binding protein in treatment-naïve chronic hepatitis B. Hepatol Res 2017;47:204-15. [PMID: 26990490 DOI: 10.1111/hepr.12703] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
488 Lutterkort GL, Wranke A, Yurdaydin C, Budde E, Westphal M, Lichtinghagen R, Stift J, Bremer B, Hardtke S, Keskin O, Idilman R, Koch A, Manns MP, Dienes HP, Wedemeyer H, Heidrich B. Non-invasive fibrosis score for hepatitis delta. Liver Int 2017;37:196-204. [PMID: 27428078 DOI: 10.1111/liv.13205] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.7] [Reference Citation Analysis]
489 Jiang H, Chen J, Gao R, Huang Z, Wu M, Song B. Liver fibrosis staging with diffusion-weighted imaging: a systematic review and meta-analysis. Abdom Radiol (NY) 2017;42:490-501. [PMID: 27678393 DOI: 10.1007/s00261-016-0913-6] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 6.3] [Reference Citation Analysis]
490 Conti F, Serra C, Vukotic R, Fiorini E, Felicani C, Mazzotta E, D'Errico A, Verucchi G, Lenzi M, Andreone P. Accuracy of elastography point quantification and steatosis influence on assessing liver fibrosis in patients with chronic hepatitis C. Liver Int 2017;37:187-95. [PMID: 27369740 DOI: 10.1111/liv.13197] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
491 Dichtel LE, Eajazi A, Miller KK, Torriani M, Bredella MA. Short- and Long-Term Reproducibility of Intrahepatic Lipid Quantification by 1H-MR Spectroscopy and CT in Obesity. J Comput Assist Tomogr 2016;40:678-82. [PMID: 27116479 DOI: 10.1097/RCT.0000000000000423] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
492 Gonzalez HC, Duarte-Rojo A. Virologic Cure of Hepatitis C: Impact on Hepatic Fibrosis and Patient Outcomes. Curr Gastroenterol Rep 2016;18:32. [PMID: 27177638 DOI: 10.1007/s11894-016-0508-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
493 Lacasse MC, Tang A, Dubois J, Alvarez F, Spahis S, Chagnon M, Deschênes S, Levy E. Monitoring the efficacy of omega-3 supplementation on liver steatosis and carotid intima-media thickness: a pilot study. Obes Sci Pract 2017;3:201-11. [PMID: 28702213 DOI: 10.1002/osp4.91] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
494 Wang Y, Yu W, Shen C, Wang W, Zhang L, Liu F, Sun H, Zhao Y, Che H, Zhao C. Predictive Value of Serum IFN-γ inducible Protein-10 and IFN-γ/IL-4 Ratio for Liver Fibrosis Progression in CHB Patients. Sci Rep 2017;7:40404. [PMID: 28067328 DOI: 10.1038/srep40404] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
495 Wagner M, Corcuera-Solano I, Lo G, Esses S, Liao J, Besa C, Chen N, Abraham G, Fung M, Babb JS, Ehman RL, Taouli B. Technical Failure of MR Elastography Examinations of the Liver: Experience from a Large Single-Center Study. Radiology 2017;284:401-12. [PMID: 28045604 DOI: 10.1148/radiol.2016160863] [Cited by in Crossref: 101] [Cited by in F6Publishing: 102] [Article Influence: 16.8] [Reference Citation Analysis]
496 Gao S, Li XY, Fan YC, Sun FK, Han LY, Li F, Ji XF, Wang K. A noninvasive model to predict liver histology in HBeAg-positive chronic hepatitis B with alanine aminotransferase ≤ 2upper limit of normal. J Gastroenterol Hepatol 2017;32:215-20. [PMID: 27207016 DOI: 10.1111/jgh.13452] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
497 Takyar V, Surana P, Kleiner DE, Wilkins K, Hoofnagle JH, Liang TJ, Heller T, Koh C. Noninvasive markers for staging fibrosis in chronic delta hepatitis. Aliment Pharmacol Ther 2017;45:127-38. [PMID: 27813124 DOI: 10.1111/apt.13834] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
498 Janowski K, Pronicki M, Grajkowska W, Kaliciński P, Socha P. Analiza wskazań do biopsji wątroby u dzieci w doświadczeniu referencyjnego ośrodka hepatologii dziecięcej. Pediatria Polska 2017;92:11-16. [DOI: 10.1016/j.pepo.2016.11.003] [Reference Citation Analysis]
499 Oshima K. Do I Need a Liver Biopsy? Liver Disorders 2017. [DOI: 10.1007/978-3-319-30103-7_3] [Reference Citation Analysis]
500 Gawrieh S. Nonalcoholic Fatty Liver Disease. Liver Disorders 2017. [DOI: 10.1007/978-3-319-30103-7_14] [Reference Citation Analysis]
501 Derosa G, Maffioli P. Traditional Markers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2017. [DOI: 10.1007/978-94-007-7675-3_13] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
502 Stoopen-rometti M, Encinas-escobar E, Ramirez-carmona C, Wolpert-barraza E, Kimura-hayama E, Sosa-lozano L, Favila R, Kimura-fujikami Y, Saavedra-abril J, Loaeza-del Castillo A. Diagnosis and quantification of fibrosis, steatosis, and hepatic siderosis through multiparametric magnetic resonance imaging. Revista de Gastroenterología de México (English Edition) 2017;82:32-45. [DOI: 10.1016/j.rgmxen.2017.01.003] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
503 Heo N. The Clinical Impact of AST-Platelet Ratio Index for Non-invasive Hepatic Fibrosis in the Patients with Chronic Hepatitis B. Korean J Gastroenterol 2017;69:267. [DOI: 10.4166/kjg.2017.69.5.267] [Reference Citation Analysis]
504 Kayadibi H, Yasar B, Ozkara S, Demirpek U, Uyanik M, Sertoglu E, Ozcelik F, Gonen C, Aksaray S. Re-determining the cut-off points of FIB-4 for patients monoinfected with chronic hepatitis B virus infection. Turkish Journal of Biochemistry 2017;42. [DOI: 10.1515/tjb-2016-0226] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
505 Angelico R, Iaria G, Angelico M. Kidney Transplantation in the Hepatitis C Infected Recipient. Kidney Transplantation, Bioengineering and Regeneration 2017. [DOI: 10.1016/b978-0-12-801734-0.00046-1] [Reference Citation Analysis]
506 Lomas DJ, Godfrey E. Pearls and Pitfalls in Gold Standards and Biological Correlation. Imaging Biomarkers 2017. [DOI: 10.1007/978-3-319-43504-6_12] [Reference Citation Analysis]
507 Choi HJ, Moon JH, Kim HK, Lee YN, Lee TH, Cha SW, Cho YD, Park SH. KRAS mutation analysis by next-generation sequencing in endoscopic ultrasound-guided sampling for solid liver masses. J Gastroenterol Hepatol 2017;32:154-62. [PMID: 27118240 DOI: 10.1111/jgh.13423] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
508 Sira M, El-araby H, Ghoneim E, Konsowa H, El-mwafy E. Serum YKL-40 (Chitinase-3-Like Protein 1) Compared to APRI and FIB-4 in Predicting Liver Fibrosis in Children with Chronic Hepatitis C. Arch Hepat Res 2016;2:015-020. [DOI: 10.17352/ahr.000006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
509 Sato S, Genda T, Ichida T, Amano N, Sato S, Murata A, Tsuzura H, Narita Y, Kanemitsu Y, Hirano K, Shimada Y, Iijima K, Wada R, Nagahara A, Watanabe S. Prediction of Hepatocellular Carcinoma Development after Hepatitis C Virus Eradication Using Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein. Int J Mol Sci. 2016;17. [PMID: 27999409 DOI: 10.3390/ijms17122143] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
510 Park MS, Kim SW, Yoon KT, Kim SU, Park SY, Tak WY, Kweon YO, Cho M, Kim BK, Park JY, Kim DY, Ahn SH, Han KH. Factors Influencing the Diagnostic Accuracy of Acoustic Radiation Force Impulse Elastography in Patients with Chronic Hepatitis B. Gut Liver. 2016;10:275-282. [PMID: 26087790 DOI: 10.5009/gnl14391] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
511 Deng M, Chen SZ, Yuan J, Chan Q, Zhou J, Wáng YX. Chemical Exchange Saturation Transfer (CEST) MR Technique for Liver Imaging at 3.0 Tesla: an Evaluation of Different Offset Number and an After-Meal and Over-Night-Fast Comparison. Mol Imaging Biol 2016;18:274-82. [PMID: 26391991 DOI: 10.1007/s11307-015-0887-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
512 Lungren MP, Lindquester WS, Seidel FG, Kothary N, Monroe EJ, Shivaram G, Gill AE, Hawkins MC. Ultrasound-Guided Liver Biopsy With Gelatin Sponge Pledget Tract Embolization in Infants Weighing Less Than 10 kg. J Pediatr Gastroenterol Nutr 2016;63:e147-51. [PMID: 27749391 DOI: 10.1097/MPG.0000000000001429] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
513 Mortimore G. FibroScan: assessing cirrhosis and advanced fibrosis with vibration-controlled transient elastography. Gastrointestinal Nursing 2016;14:S10-S15. [DOI: 10.12968/gasn.2016.14.sup10.s10] [Reference Citation Analysis]
514 Moon KM, Baik SK. Usefulness of Ultrasonographic Scoring System in Diagnosis of Alcoholic Cirrhosis. Clin Ultrasound 2016;1:92-100. [DOI: 10.18525/cu.2016.1.2.92] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
515 Chen J, Yin M, Talwalkar JA, Oudry J, Glaser KJ, Smyrk TC, Miette V, Sandrin L, Ehman RL. Diagnostic Performance of MR Elastography and Vibration-controlled Transient Elastography in the Detection of Hepatic Fibrosis in Patients with Severe to Morbid Obesity. Radiology. 2017;283:418-428. [PMID: 27861111 DOI: 10.1148/radiol.2016160685] [Cited by in Crossref: 105] [Cited by in F6Publishing: 113] [Article Influence: 15.0] [Reference Citation Analysis]
516 Dulai PS, Sirlin CB, Loomba R. MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice. J Hepatol 2016;65:1006-16. [PMID: 27312947 DOI: 10.1016/j.jhep.2016.06.005] [Cited by in Crossref: 223] [Cited by in F6Publishing: 230] [Article Influence: 31.9] [Reference Citation Analysis]
517 Kim JH, Kim JW, Seo JW, Choe WH, Kwon SY. Noninvasive Tests for Fibrosis Predict 5-Year Mortality and Hepatocellular Carcinoma in Patients With Chronic Hepatitis B. J Clin Gastroenterol 2016;50:882-8. [PMID: 27322532 DOI: 10.1097/MCG.0000000000000574] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
518 Runge JH, Akkerman EM, Troelstra MA, Nederveen AJ, Beuers U, Stoker J. Comparison of clinical MRI liver iron content measurements using signal intensity ratios, R 2 and R 2. Abdom Radiol (NY) 2016;41:2123-31. [PMID: 27431019 DOI: 10.1007/s00261-016-0831-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
519 Fujita N, Nishie A, Asayama Y, Ishigami K, Ushijima Y, Takayama Y, Okamoto D, Shirabe K, Yoshizumi T, Kotoh K, Furusyo N, Hida T, Oda Y, Fujioka T, Honda H. Fibrosis in nonalcoholic fatty liver disease: Noninvasive assessment using computed tomography volumetry. World J Gastroenterol 2016; 22(40): 8949-8955 [PMID: 27833386 DOI: 10.3748/wjg.v22.i40.8949] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
520 Liao YY, Yang KC, Lee MJ, Huang KC, Chen JD, Yeh CK. Multifeature analysis of an ultrasound quantitative diagnostic index for classifying nonalcoholic fatty liver disease. Sci Rep 2016;6:35083. [PMID: 27734972 DOI: 10.1038/srep35083] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
521 Sagir A, Ney D, Oh J, Pandey S, Kircheis G, Mayatepek E, Häussinger D. Evaluation of Acoustic Radiation Force Impulse Imaging (ARFI) for the Determination of Liver Stiffness Using Transient Elastography as a Reference in Children. Ultrasound Int Open 2015;1:E2-7. [PMID: 27689145 DOI: 10.1055/s-0035-1554659] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
522 Xiao G, Zhu F, Wang M, Zhang H, Ye D, Yang J, Jiang L, Liu C, Yan L, Qin R. Diagnostic accuracy of APRI and FIB-4 for predicting hepatitis B virus-related liver fibrosis accompanied with hepatocellular carcinoma. Dig Liver Dis 2016;48:1220-6. [PMID: 27599803 DOI: 10.1016/j.dld.2016.06.001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
523 Srinivasa Babu A, Wells ML, Teytelboym OM, Mackey JE, Miller FH, Yeh BM, Ehman RL, Venkatesh SK. Elastography in Chronic Liver Disease: Modalities, Techniques, Limitations, and Future Directions. Radiographics. 2016;36:1987-2006. [PMID: 27689833 DOI: 10.1148/rg.2016160042] [Cited by in Crossref: 119] [Cited by in F6Publishing: 123] [Article Influence: 17.0] [Reference Citation Analysis]
524 Giunta M, Conte D, Fraquelli M. Role of spleen elastography in patients with chronic liver diseases. World J Gastroenterol 2016; 22(35): 7857-7867 [PMID: 27672283 DOI: 10.3748/wjg.v22.i35.7857] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
525 Patel J, Bettencourt R, Cui J, Salotti J, Hooker J, Bhatt A, Hernandez C, Nguyen P, Aryafar H, Valasek M, Haufe W, Hooker C, Richards L, Sirlin CB, Loomba R. Association of noninvasive quantitative decline in liver fat content on MRI with histologic response in nonalcoholic steatohepatitis. Therap Adv Gastroenterol 2016;9:692-701. [PMID: 27582882 DOI: 10.1177/1756283X16656735] [Cited by in Crossref: 100] [Cited by in F6Publishing: 104] [Article Influence: 14.3] [Reference Citation Analysis]
526 Boursier J, Vergniol J, Guillet A, Hiriart JB, Lannes A, Le Bail B, Michalak S, Chermak F, Bertrais S, Foucher J, Oberti F, Charbonnier M, Fouchard-Hubert I, Rousselet MC, Calès P, de Lédinghen V. Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease. J Hepatol 2016;65:570-8. [PMID: 27151181 DOI: 10.1016/j.jhep.2016.04.023] [Cited by in Crossref: 247] [Cited by in F6Publishing: 251] [Article Influence: 35.3] [Reference Citation Analysis]
527 Galal SM, Abdel Aal FH, Mohammed AE, Mohamed MZ, Abd El-rahman YG. Chronic viral hepatitis C in pediatric age group; assessment of viral activity and hepatic fibrosis by 1H magnetic resonance spectroscopy and diffusion weighted imaging in asymptomatic patient. The Egyptian Journal of Radiology and Nuclear Medicine 2016;47:739-748. [DOI: 10.1016/j.ejrnm.2016.05.022] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
528 Ku NO, Strnad P, Bantel H, Omary MB. Keratins: Biomarkers and modulators of apoptotic and necrotic cell death in the liver. Hepatology 2016;64:966-76. [PMID: 26853542 DOI: 10.1002/hep.28493] [Cited by in Crossref: 77] [Cited by in F6Publishing: 77] [Article Influence: 11.0] [Reference Citation Analysis]
529 Bruno C, Minniti S, Bucci A, Pozzi Mucelli R. ARFI: from basic principles to clinical applications in diffuse chronic disease-a review. Insights Imaging 2016;7:735-46. [PMID: 27553006 DOI: 10.1007/s13244-016-0514-5] [Cited by in Crossref: 43] [Cited by in F6Publishing: 48] [Article Influence: 6.1] [Reference Citation Analysis]
530 Yoo H, Lee JM, Yoon JH, Lee DH, Chang W, Han JK. Prospective Comparison of Liver Stiffness Measurements between Two Point Shear Wave Elastography Methods: Virtual Touch Quantification and Elastography Point Quantification. Korean J Radiol. 2016;17:750-757. [PMID: 27587964 DOI: 10.3348/kjr.2016.17.5.750] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
531 Morishita K, Hiramoto A, Osuga T, Lim SY, Khoirun N, Sasaki N, Nakamura K, Ohta H, Yamasaki M, Takiguchi M. Contrast-enhanced ultrasonography of the hepatic vein in normal dogs. J Vet Med Sci 2017;78:1753-8. [PMID: 27534912 DOI: 10.1292/jvms.16-0062] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
532 Gallego-Durán R, Cerro-Salido P, Gomez-Gonzalez E, Pareja MJ, Ampuero J, Rico MC, Aznar R, Vilar-Gomez E, Bugianesi E, Crespo J, González-Sánchez FJ, Aparcero R, Moreno I, Soto S, Arias-Loste MT, Abad J, Ranchal I, Andrade RJ, Calleja JL, Pastrana M, Iacono OL, Romero-Gómez M. Imaging biomarkers for steatohepatitis and fibrosis detection in non-alcoholic fatty liver disease. Sci Rep 2016;6:31421. [PMID: 27514671 DOI: 10.1038/srep31421] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
533 Chen S, Liao B, Zhong Z, Zheng Y, Liu B, Shan Q, Xie X, Zhou L. Supersonic shearwave elastography in the assessment of liver fibrosis for postoperative patients with biliary atresia. Sci Rep. 2016;6:31057. [PMID: 27511435 DOI: 10.1038/srep31057] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
534 Koon CM, Zhang X, Chen W, Chu ES, San Lau CB, Wáng YX. Black blood T1rho MR imaging may diagnose early stage liver fibrosis: a proof-of-principle study with rat biliary duct ligation model. Quant Imaging Med Surg 2016;6:353-63. [PMID: 27709071 DOI: 10.21037/qims.2016.08.11] [Cited by in Crossref: 16] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
535 Sivgin S, Baldane S, Deniz K, Zararsiz G, Kaynar L, Cetin M, Unal A, Eser B. Increased Hepatic Iron Content Predicts Poor Survival in Patients With Iron Overload Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation. Clin Lymphoma Myeloma Leuk 2016;16 Suppl:S10-8. [PMID: 27521305 DOI: 10.1016/j.clml.2016.02.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
536 Dugum MF, McCullough AJ. Acute Alcoholic Hepatitis, the Clinical Aspects. Clin Liver Dis 2016;20:499-508. [PMID: 27373612 DOI: 10.1016/j.cld.2016.02.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
537 Yang JC, Lu MY, Jaw FS, Peng SS, Shih TT. Breath-hold spin echosequence for assessing liver iron content. Magn Reson Imaging 2016;34:1256-63. [PMID: 27451406 DOI: 10.1016/j.mri.2016.07.005] [Reference Citation Analysis]
538 Kuroda H, Abe T, Kakisaka K, Fujiwara Y, Yoshida Y, Miyasaka A, Ishida K, Ishida H, Sugai T, Takikawa Y. Visualizing the hepatic vascular architecture using superb microvascular imaging in patients with hepatitis C virus: A novel technique. World J Gastroenterol 2016; 22(26): 6057-6064 [PMID: 27468197 DOI: 10.3748/wjg.v22.i26.6057] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
539 Kubo K, Kawakami H, Kuwatani M, Nishida M, Kawakubo K, Kawahata S, Taya Y, Kubota Y, Amano T, Shirato H, Sakamoto N. Liver elasticity measurement before and after biliary drainage in patients with obstructive jaundice: a prospective cohort studya prospective cohort study. BMC Gastroenterol 2016;16:65. [PMID: 27391646 DOI: 10.1186/s12876-016-0479-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
540 Corey KE, Klebanoff MJ, Tramontano AC, Chung RT, Hur C. Screening for Nonalcoholic Steatohepatitis in Individuals with Type 2 Diabetes: A Cost-Effectiveness Analysis. Dig Dis Sci 2016;61:2108-17. [PMID: 26825843 DOI: 10.1007/s10620-016-4044-2] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 7.1] [Reference Citation Analysis]
541 Ekiz F, Yuksel İ, Arikök AT, Yilmaz B, Altinbas A, Aktas B, Deveci M, Basar O, Coban S, Yuksel O. Will a second biopsy sample affect treatment decisions in patients with chronic hepatitis B? Hepatol Int 2016;10:602-5. [PMID: 26416085 DOI: 10.1007/s12072-015-9666-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
542 Ebrahimi H, Naderian M, Sohrabpour AA. New Concepts on Pathogenesis and Diagnosis of Liver Fibrosis; A Review Article. Middle East J Dig Dis. 2016;8:166-178. [PMID: 27698966 DOI: 10.15171/mejdd.2016.29] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
543 Ohkoshi S, Hirono H, Watanabe K, Hasegawa K, Kamimura K, Yano M. Natural regression of fibrosis in chronic hepatitis B. World J Gastroenterol 2016; 22(24): 5459-5466 [PMID: 27350724 DOI: 10.3748/wjg.v22.i24.5459] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
544 Wang M, Liu R, Liang Y, Yang G, Huang Y, Yu C, Sun K, Lai Y, Xia Y. Iron overload correlates with serum liver fibrotic markers and liver dysfunction: Potential new methods to predict iron overload-related liver fibrosis in thalassemia patients. United European Gastroenterol J 2017;5:94-103. [PMID: 28405327 DOI: 10.1177/2050640616646525] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
545 D'Ambrosio R, Degasperi E, Aghemo A, Fraquelli M, Lampertico P, Rumi MG, Facchetti F, Grassi E, Casazza G, Rosenberg W, Bedossa P, Colombo M. Serological Tests Do Not Predict Residual Fibrosis in Hepatitis C Cirrhotics with a Sustained Virological Response to Interferon. PLoS One 2016;11:e0155967. [PMID: 27304619 DOI: 10.1371/journal.pone.0155967] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
546 Lee HW, Park SY, Kim SU, Jang JY, Park H, Kim JK, Lee CK, Chon YE, Han KH. Discrimination of Nonalcoholic Steatohepatitis Using Transient Elastography in Patients with Nonalcoholic Fatty Liver Disease. PLoS One. 2016;11:e0157358. [PMID: 27284700 DOI: 10.1371/journal.pone.0157358] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 6.4] [Reference Citation Analysis]
547 S M S, G V, Kumar P S, A R, Chander P K, K V. CIRRHOSIS: NON-INVASIVE PARAMETERS FOR PREDICTING THE OCCURRENCE OF OOESOPHAGEAL VARICES. jemds 2016;5:2460-2465. [DOI: 10.14260/jemds/2016/574] [Reference Citation Analysis]
548 Kinner S, Reeder SB, Yokoo T. Quantitative Imaging Biomarkers of NAFLD. Dig Dis Sci 2016;61:1337-47. [PMID: 26848588 DOI: 10.1007/s10620-016-4037-1] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 7.7] [Reference Citation Analysis]
549 Mobarak L, Nabeel MM, Hassan E, Omran D, Zakaria Z. Real-time elastography as a noninvasive assessment of liver fibrosis in chronic hepatitis C Egyptian patients: a prospective study. Ann Gastroenterol. 2016;29:358-362. [PMID: 27366038 DOI: 10.20524/aog.2016.0033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
550 Góis E Cunha JR, de Oliveira IR, Lima MP, Júnior AA. Transumbilical videolaparoscopic (single site) liver biopsy with laparoscopy equipment. J Minim Access Surg 2016;12:135-8. [PMID: 27073305 DOI: 10.4103/0972-9941.158953] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
551 Babaei Z, Parsian H. Hyaluronic acid algorithm-based models for assessment of liver fibrosis: translation from basic science to clinical application. Hepatobiliary Pancreat Dis Int 2016;15:131-40. [PMID: 27020628 DOI: 10.1016/s1499-3872(16)60062-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
552 Papatheodoridis G, Dalekos G, Sypsa V, Yurdaydin C, Buti M, Goulis J, Calleja JL, Chi H, Manolakopoulos S, Mangia G, Gatselis N, Keskin O, Savvidou S, de la Revilla J, Hansen BE, Vlachogiannakos I, Galanis K, Idilman R, Colombo M, Esteban R, Janssen HL, Lampertico P. PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy. J Hepatol 2016;64:800-6. [PMID: 26678008 DOI: 10.1016/j.jhep.2015.11.035] [Cited by in Crossref: 267] [Cited by in F6Publishing: 284] [Article Influence: 38.1] [Reference Citation Analysis]
553 Tada T, Kumada T, Toyoda H, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, Kitabatake S, Yama T, Tanaka J. Long-term prognosis of patients with chronic hepatitis C who did not receive interferon-based therapy: causes of death and analysis based on the FIB-4 index. J Gastroenterol 2016;51:380-9. [PMID: 26342600 DOI: 10.1007/s00535-015-1117-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
554 Sandrasegaran K, Thayalan N, Thavanesan R, Kohli M, Berry W, Shah A, Kwo P. Risk factors for bleeding after liver biopsy. Abdom Radiol (NY) 2016;41:643-9. [PMID: 26847020 DOI: 10.1007/s00261-016-0655-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
555 Heo JY, Kim SU, Kim BK, Park JY, Kim DY, Ahn SH, Park YN, Ahn SS, Han KH, Kim HS. Use of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B Virus. Medicine (Baltimore) 2016;95:e3328. [PMID: 27057911 DOI: 10.1097/MD.0000000000003328] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
556 Kaspar MB, Sterling RK. Hyperbilirubinaemia in HIV-HCV co-infected patients on antiretroviral therapy: drug effect or liver disease severity? BMJ Open Gastroenterol 2016;3:e000072. [PMID: 26966552 DOI: 10.1136/bmjgast-2015-000072] [Reference Citation Analysis]
557 Huang R, Jiang N, Yang R, Geng X, Lin J, Xu G, Liu D, Chen J, Zhou G, Wang S, Luo T, Wu J, Liu X, Xu K, Yang X. Fibroscan improves the diagnosis sensitivity of liver fibrosis in patients with chronic hepatitis B. Exp Ther Med. 2016;11:1673-1677. [PMID: 27168788 DOI: 10.3892/etm.2016.3135] [Cited by in Crossref: 15] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
558 Zhang GM, Xia YJ. Reference Intervals of Fibrosis Index Based on Four Indicators in Healthy Elderly Chinese. J Clin Lab Anal 2016;30:645-8. [PMID: 26953257 DOI: 10.1002/jcla.21916] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
559 Seo YS, Kim MN, Kim SU, Kim SG, Um SH, Han KH, Kim YS. Risk Assessment of Hepatocellular Carcinoma Using Transient Elastography Vs. Liver Biopsy in Chronic Hepatitis B Patients Receiving Antiviral Therapy. Medicine (Baltimore) 2016;95:e2985. [PMID: 27015173 DOI: 10.1097/MD.0000000000002985] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
560 Touré PS, Diop MM, Lô G, Sow-sall A, Da Veiga JA, Sarr MM, Berthé A, Dioussé P, Ndiaye BP, Tall CT, Diop BM, Touré-kane NC, Ka MM, Mboup S. Intêret du FibroScan® et des marqueurs biologiques de la fibrose hépatique, chez des sénégalais porteurs chroniques du virus de l’hépatite B faiblement réplicatifs. J Afr Hepato Gastroenterol 2016;10:14-20. [DOI: 10.1007/s12157-015-0634-4] [Reference Citation Analysis]
561 Hukkinen M, Kivisaari R, Lohi J, Heikkilä P, Mutanen A, Merras-Salmio L, Pakarinen MP. Transient elastography and aspartate aminotransferase to platelet ratio predict liver injury in paediatric intestinal failure. Liver Int 2016;36:361-9. [PMID: 26058319 DOI: 10.1111/liv.12887] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
562 Coral GP, Antunes AD, Serafini AP, Araujo FB, Mattos AA. LIVER BIOPSY: IMPORTANCE OF SPECIMEN SIZE IN THE DIAGNOSIS AND STAGING OF CHRONIC VIRAL HEPATITIS. Rev Inst Med Trop Sao Paulo 2016;58:10. [PMID: 26910447 DOI: 10.1590/S1678-9946201658010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
563 Tapper EB, Hunink MG, Afdhal NH, Lai M, Sengupta N. Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score. PLoS One 2016;11:e0147237. [PMID: 26905872 DOI: 10.1371/journal.pone.0147237] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 4.9] [Reference Citation Analysis]
564 Hussain HK. Imaging methods for screening of hepatic steatosis. Clinical Dilemmas in Non-Alcoholic Fatty Liver Disease 2016. [DOI: 10.1002/9781118924938.ch16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
565 Pineda JJ, Diehl DL, Miao CL, Johal AS, Khara HS, Bhanushali A, Chen EZ. EUS-guided liver biopsy provides diagnostic samples comparable with those via the percutaneous or transjugular route. Gastrointest Endosc 2016;83:360-5. [PMID: 26301407 DOI: 10.1016/j.gie.2015.08.025] [Cited by in Crossref: 71] [Cited by in F6Publishing: 73] [Article Influence: 10.1] [Reference Citation Analysis]
566 Sey MS, Al-Haddad M, Imperiale TF, McGreevy K, Lin J, DeWitt JM. EUS-guided liver biopsy for parenchymal disease: a comparison of diagnostic yield between two core biopsy needles. Gastrointest Endosc 2016;83:347-52. [PMID: 26278654 DOI: 10.1016/j.gie.2015.08.012] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 5.6] [Reference Citation Analysis]
567 Valva P, Ríos DA, De Matteo E, Preciado MV. Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damage. World J Gastroenterol 2016; 22(4): 1367-1381 [PMID: 26819506 DOI: 10.3748/wjg.v22.i4.1367] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
568 Wong RJ, Ahmed A. Complications of liver biopsy. Gastrointestinal emergencies 2016. [DOI: 10.1002/9781118662915.ch13] [Reference Citation Analysis]
569 Fu Y, Peng HJ, Zhang X, Peng WJ, Wu J, Wang SP, Du M, Li RM. Assessment of fibrotic tissue and microvascular architecture by in-line phase-contrast imaging in a mouse model of liver fibrosis. Eur Radiol 2016;26:2947-55. [PMID: 26787604 DOI: 10.1007/s00330-015-4173-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
570 Song P, Mellema DC, Sheedy SP, Meixner DD, Karshen RM, Urban MW, Manduca A, Sanchez W, Callstrom MR, Greenleaf JF, Chen S. Performance of 2-Dimensional Ultrasound Shear Wave Elastography in Liver Fibrosis Detection Using Magnetic Resonance Elastography as the Reference Standard: A Pilot Study. J Ultrasound Med 2016;35:401-12. [PMID: 26782164 DOI: 10.7863/ultra.15.03036] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
571 Ozaki K, Matsui O, Kobayashi S, Minami T, Kitao A, Gabata T. Morphometric changes in liver cirrhosis: aetiological differences correlated with progression. Br J Radiol. 2016;89:20150896. [PMID: 26765832 DOI: 10.1259/bjr.20150896] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
572 Stankovic Z. Four-dimensional flow magnetic resonance imaging in cirrhosis. World J Gastroenterol 2016; 22(1): 89-102 [PMID: 26755862 DOI: 10.3748/wjg.v22.i1.89] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
573 Esposito E, Campolo M, Cordaro M, Casili G, Cuzzocrea S. Autophagy and Liver Diseases. Autophagy Networks in Inflammation 2016. [DOI: 10.1007/978-3-319-30079-5_17] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
574 Singh S, Venkatesh SK, Keaveny A, Adam S, Miller FH, Asbach P, Godfrey EM, Silva AC, Wang Z, Murad MH, Asrani SK, Lomas DJ, Ehman RL. Diagnostic accuracy of magnetic resonance elastography in liver transplant recipients: A pooled analysis. Ann Hepatol 2016;15:363-76. [PMID: 27049490 DOI: 10.5604/16652681.1198808] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
575 Taslakian B. Core Biopsy of the Liver. Procedural Dictations in Image-Guided Intervention 2016. [DOI: 10.1007/978-3-319-40845-3_32] [Reference Citation Analysis]
576 Sugihara T, Koda M, Okamoto T, Miyoshi K, Matono T, Hosho K, Okano J, Isomoto H, Yata S, Ohuchi Y. The efficacy of transjugular liver biopsy (TJLB); a retrospective analysis. Acta hepatologica Japonica 2016;57:280-286. [DOI: 10.2957/kanzo.57.280] [Reference Citation Analysis]
577 Hirose K, Kanefuji T, Suda T, Sugitani S, Nagasaki K, Kubota T, Igarashi M, Terai S. Formulation for Effective Screening and Management of Nonalcoholic Steatohepatitis: Noninvasive NAFLD Management Strategy. Gastroenterol Res Pract 2016;2016:6343656. [PMID: 27382367 DOI: 10.1155/2016/6343656] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
578 Geng XX, Huang RG, Lin JM, Jiang N, Yang XX. Transient elastography in clinical detection of liver cirrhosis: A systematic review and meta-analysis. Saudi J Gastroenterol 2016;22:294-303. [PMID: 27488324 DOI: 10.4103/1319-3767.187603] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
579 Lefkowitch JH. The Liver in Systemic Disease and Pregnancy. Scheuer's Liver Biopsy Interpretation 2016. [DOI: 10.1016/b978-0-7020-5548-5.00015-3] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
580 Rodrigues S. Real-Time Elastography in the Assessment of Advanced Fibrosis in Chronic Hepatitis C: Is It Here to Stay? GE Portuguese Journal of Gastroenterology 2016;23:4-5. [DOI: 10.1016/j.jpge.2015.12.010] [Reference Citation Analysis]
581 Chen B, Schreiber RA, Human DG, Potts JE, Guttman OR. Assessment of Liver Stiffness in Pediatric Fontan Patients Using Transient Elastography. Can J Gastroenterol Hepatol 2016;2016:7125193. [PMID: 27656638 DOI: 10.1155/2016/7125193] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
582 Fitzpatrick E. Nonalcoholic Fatty Liver Disease. Textbook of Pediatric Gastroenterology, Hepatology and Nutrition 2016. [DOI: 10.1007/978-3-319-17169-2_66] [Reference Citation Analysis]
583 Dhyani M, Anvari A, Samir AE. Ultrasound elastography: liver. Abdom Imaging 2015;40:698-708. [PMID: 25690689 DOI: 10.1007/s00261-015-0373-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
584 Venkatesh SK, Yin M, Takahashi N, Glockner JF, Talwalkar JA, Ehman RL. Non-invasive detection of liver fibrosis: MR imaging features vs. MR elastography. Abdom Imaging. 2015;40:766-775. [PMID: 25805619 DOI: 10.1007/s00261-015-0347-6] [Cited by in Crossref: 67] [Cited by in F6Publishing: 57] [Article Influence: 8.4] [Reference Citation Analysis]
585 Kose S, Ersan G, Tatar B, Adar P, Sengel BE. Evaluation of Percutaneous Liver Biopsy Complications in Patients with Chronic Viral Hepatitis. Eurasian J Med. 2015;47:161-164. [PMID: 26644763 DOI: 10.5152/eurasianjmed.2015.107] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
586 Amarapurkar D, Amarapurkar A. Indications of Liver Biopsy in the Era of Noninvasive Assessment of Liver Fibrosis. J Clin Exp Hepatol 2015;5:314-9. [PMID: 26900273 DOI: 10.1016/j.jceh.2015.08.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
587 Li W, Zhu C, Wu Y, Wang Z, Zhu C. Increased Pygo2 expression in liver of patients with hepatitis B virus-related fibrosis. Liver Int 2015;35:2522-9. [PMID: 26013055 DOI: 10.1111/liv.12877] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
588 Zhao H, Chen J, Meixner DD, Xie H, Shamdasani V, Zhou S, Robert JL, Urban MW, Sanchez W, Callstrom MR, Ehman RL, Greenleaf JF, Chen S. Noninvasive assessment of liver fibrosis using ultrasound-based shear wave measurement and comparison to magnetic resonance elastography. J Ultrasound Med 2014;33:1597-604. [PMID: 25154941 DOI: 10.7863/ultra.33.9.1597] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
589 Kalafateli M, Gurusamy KS, Noel-storr AH, Burroughs AK, Tsochatzis E. Forns index and 'FIB4' for staging of fibrosis in adults with chronic hepatitis C. Cochrane Database of Systematic Reviews 2015. [DOI: 10.1002/14651858.cd011929] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
590 Bannas P, Kramer H, Hernando D, Agni R, Cunningham AM, Mandal R, Motosugi U, Sharma SD, Munoz del Rio A, Fernandez L, Reeder SB. Quantitative magnetic resonance imaging of hepatic steatosis: Validation in ex vivo human livers. Hepatology 2015;62:1444-55. [PMID: 26224591 DOI: 10.1002/hep.28012] [Cited by in Crossref: 102] [Cited by in F6Publishing: 107] [Article Influence: 12.8] [Reference Citation Analysis]
591 Yarnykh VL, Tartaglione EV, Ioannou GN. Fast macromolecular proton fraction mapping of the human liver in vivo for quantitative assessment of hepatic fibrosis. NMR Biomed 2015;28:1716-25. [PMID: 26503401 DOI: 10.1002/nbm.3437] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
592 Shen Y, Shi G, Huang C, Zhu X, Chen S, Sun H, Zhou J, Fan J. Prediction of Post-Operative Liver Dysfunction by Serum Markers of Liver Fibrosis in Hepatocellular Carcinoma. PLoS One 2015;10:e0140932. [PMID: 26501145 DOI: 10.1371/journal.pone.0140932] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
593 Lombardi R, Buzzetti E, Roccarina D, Tsochatzis EA. Non-invasive assessment of liver fibrosis in patients with alcoholic liver disease. World J Gastroenterol 2015; 21(39): 11044-11052 [PMID: 26494961 DOI: 10.3748/wjg.v21.i39.11044] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
594 Verloh N, Utpatel K, Haimerl M, Zeman F, Fellner C, Fichtner-Feigl S, Teufel A, Stroszczynski C, Evert M, Wiggermann P. Liver fibrosis and Gd-EOB-DTPA-enhanced MRI: A histopathologic correlation. Sci Rep 2015;5:15408. [PMID: 26478097 DOI: 10.1038/srep15408] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 6.4] [Reference Citation Analysis]
595 Sripahol P, Niyomnaitham S, Huang K. Incidental Detection of Normal-Sized Liver Cirrhosis During Laparoscopic Surgery. Journal of Gynecologic Surgery 2015;31:283-284. [DOI: 10.1089/gyn.2014.0139] [Reference Citation Analysis]
596 Seo YS, Kim MY, Kim SU, Hyun BS, Jang JY, Lee JW, Lee JI, Suh SJ, Park SY, Park H, Jung EU, Kim BS, Kim IH, Lee TH, Um SH, Han KH, Kim SG, Paik SK, Choi JY, Jeong SW, Jin YJ, Lee KS, Yim HJ, Tak WY, Hwang SG, Lee YJ, Lee CH, Kim DG, Kang YW, Kim YS; Korean Transient Elastography Study Group. Accuracy of transient elastography in assessing liver fibrosis in chronic viral hepatitis: A multicentre, retrospective study. Liver Int 2015;35:2246-55. [PMID: 25682719 DOI: 10.1111/liv.12808] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 7.0] [Reference Citation Analysis]
597 Petta S, Maida M, Macaluso FS, Di Marco V, Cammà C, Cabibi D, Craxì A. The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease. Hepatology 2015;62:1101-10. [PMID: 25991038 DOI: 10.1002/hep.27844] [Cited by in Crossref: 159] [Cited by in F6Publishing: 166] [Article Influence: 19.9] [Reference Citation Analysis]
598 Ito T, Kumada T, Toyoda H, Tada T, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, Kitabatake S. Utility of the FIB-4 Index for hepatocarcinogenesis in hepatitis C virus carriers with normal alanine aminotransferase levels. J Viral Hepat 2015;22:777-83. [PMID: 25608086 DOI: 10.1111/jvh.12389] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
599 Remenieras J, Bastard C, Miette V, Perarnau J, Patat F. New inverse problem for viscoelastic characterization of fatty liver using vibration controlled transient elastography. 2015 IEEE International Ultrasonics Symposium (IUS) 2015. [DOI: 10.1109/ultsym.2015.0474] [Reference Citation Analysis]
600 DeWitt J, Cho CM, Lin J, Al-Haddad M, Canto MI, Salamone A, Hruban RH, Messallam AA, Khashab MA. Comparison of EUS-guided tissue acquisition using two different 19-gauge core biopsy needles: a multicenter, prospective, randomized, and blinded study. Endosc Int Open 2015;3:E471-8. [PMID: 26528504 DOI: 10.1055/s-0034-1392222] [Cited by in Crossref: 34] [Cited by in F6Publishing: 43] [Article Influence: 4.3] [Reference Citation Analysis]
601 Ekiz F, Yuksel İ, Arikök AT, Yilmaz B, Altinbas A, Aktas B, Deveci M, Basar O, Coban S, Yuksel O. Will a second biopsy sample affect treatment decisions in patients with chronic hepatitis B? Hepatol Int 2016;10:602-5. [PMID: 26416085 DOI: 10.1007/s12072-015-9666-5] [Reference Citation Analysis]
602 Skoczylas K, Pawełas A. Ultrasound imaging of the liver and bile ducts - expectations of a clinician. J Ultrason 2015;15:292-306. [PMID: 26673784 DOI: 10.15557/JoU.2015.0026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
603 Kim YD, Song D, Heo JH, Kim SU, Kim BK, Park JY, Kim DY, Ahn SH, Kim KJ, Han KH. Relationship between Cerebral Microbleeds and Liver Stiffness Determined by Transient Elastography. PLoS One 2015;10:e0139227. [PMID: 26421848 DOI: 10.1371/journal.pone.0139227] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
604 Koh H, Kim S, Kim MJ, Kim HG, Shin HJ, Lee MJ. Hepatic fat quantification magnetic resonance for monitoring treatment response in pediatric nonalcoholic steatohepatitis. World J Gastroenterol 2015; 21(33): 9741-9748 [PMID: 26361421 DOI: 10.3748/wjg.v21.i33.9741] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
605 Chen SZ, Yuan J, Deng M, Wei J, Zhou J, Wáng YX. Chemical exchange saturation transfer (CEST) MR technique for in-vivo liver imaging at 3.0 tesla. Eur Radiol 2016;26:1792-800. [PMID: 26334509 DOI: 10.1007/s00330-015-3972-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
606 Lin CL, Liu CH, Wang CC, Liang CC, Su TH, Liu CJ, Kao JH. Serum Biomarkers Predictive of Significant Fibrosis and Cirrhosis in Chronic Hepatitis B. J Clin Gastroenterol 2015;49:705-13. [PMID: 25319739 DOI: 10.1097/MCG.0000000000000250] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 3.5] [Reference Citation Analysis]
607 El-sherbiny WA, Farag RE, El-baiomy AAE, El-erian RA. Relation of cytokeratin 18-Apoptosense M30 to activity and fibrosis in chronic HCV patients. Egyptian Journal of Basic and Applied Sciences 2015;2:153-158. [DOI: 10.1016/j.ejbas.2015.04.005] [Reference Citation Analysis]
608 Davoudi Y, Layegh P, Sima H, Tatari S, Faghani R. Diagnostic Value of Conventional and Doppler Ultrasound Findings in Liver Fibrosis in Patients with Chronic Viral Hepatitis. Journal of Medical Ultrasound 2015;23:123-128. [DOI: 10.1016/j.jmu.2014.10.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
609 Dillman JR, Heider A, Bilhartz JL, Smith EA, Keshavarzi N, Rubin JM, Lopez MJ. Ultrasound shear wave speed measurements correlate with liver fibrosis in children. Pediatr Radiol 2015;45:1480-8. [PMID: 25851300 DOI: 10.1007/s00247-015-3345-5] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 6.6] [Reference Citation Analysis]
610 Singh S, Venkatesh SK, Loomba R, Wang Z, Sirlin C, Chen J, Yin M, Miller FH, Low RN, Hassanein T, Godfrey EM, Asbach P, Murad MH, Lomas DJ, Talwalkar JA, Ehman RL. Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysis. Eur Radiol. 2016;26:1431-1440. [PMID: 26314479 DOI: 10.1007/s00330-015-3949-z] [Cited by in Crossref: 148] [Cited by in F6Publishing: 129] [Article Influence: 18.5] [Reference Citation Analysis]
611 Kim HJ, Lee HK, Cho JH, Yang HJ. Quantitative comparison of transient elastography (TE), shear wave elastography (SWE) and liver biopsy results of patients with chronic liver disease. J Phys Ther Sci 2015;27:2465-8. [PMID: 26357427 DOI: 10.1589/jpts.27.2465] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
612 Yeom SK, Lee CH, Cha SH, Park CM. Prediction of liver cirrhosis, using diagnostic imaging tools. World J Hepatol 2015;7:2069-79. [PMID: 26301049 DOI: 10.4254/wjh.v7.i17.2069] [Cited by in Crossref: 70] [Cited by in F6Publishing: 70] [Article Influence: 8.8] [Reference Citation Analysis]
613 Tachi Y, Hirai T, Toyoda H, Tada T, Hayashi K, Honda T, Ishigami M, Goto H, Kumada T. Predictive Ability of Laboratory Indices for Liver Fibrosis in Patients with Chronic Hepatitis C after the Eradication of Hepatitis C Virus. PLoS One 2015;10:e0133515. [PMID: 26214180 DOI: 10.1371/journal.pone.0133515] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
614 Heba ER, Desai A, Zand KA, Hamilton G, Wolfson T, Schlein AN, Gamst A, Loomba R, Sirlin CB, Middleton MS. Accuracy and the effect of possible subject-based confounders of magnitude-based MRI for estimating hepatic proton density fat fraction in adults, using MR spectroscopy as reference. J Magn Reson Imaging. 2016;43:398-406. [PMID: 26201284 DOI: 10.1002/jmri.25006] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 5.0] [Reference Citation Analysis]
615 Xu X, Su Y, Song R, Sheng Y, Ai W, Wu X, Liu H. Performance of transient elastography assessing fibrosis of single hepatitis B virus infection: a systematic review and meta-analysis of a diagnostic test. Hepatol Int. 2015;9:558-566. [PMID: 26187292 DOI: 10.1007/s12072-015-9643-z] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
616 Pradhan B, Hadengue A, Chappuis F, Chaudhary S, Baral D, Gache P, Karki P, Rijal S. Alcoholic liver disease in Nepal: identifying homemade alcohol as a culprit. Clin Exp Gastroenterol 2015;8:183-9. [PMID: 26203269 DOI: 10.2147/CEG.S81321] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
617 Sagir A, Glaubach B, Sahin K, Graf D, Erhardt A, Oette M, Häussinger D. Transient Elastography for the Detection of Liver Damage in Patients with HIV. Infect Dis Ther 2015;4:355-64. [PMID: 26143457 DOI: 10.1007/s40121-015-0073-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
618 Toyoda H, Kumada T, Tada T, Kiriyama S, Tanikawa M, Hisanaga Y, Kanamori A, Kitabatake S, Ito T. Risk factors of hepatocellular carcinoma development in non-cirrhotic patients with sustained virologic response for chronic hepatitis C virus infection. J Gastroenterol Hepatol 2015;30:1183-9. [PMID: 25678094 DOI: 10.1111/jgh.12915] [Cited by in Crossref: 71] [Cited by in F6Publishing: 67] [Article Influence: 8.9] [Reference Citation Analysis]
619 European Association for Study of Liver, Asociacion Latinoamericana para el Estudio del Higado. EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol 2015;63:237-64. [PMID: 25911335 DOI: 10.1016/j.jhep.2015.04.006] [Cited by in Crossref: 1177] [Cited by in F6Publishing: 1197] [Article Influence: 147.1] [Reference Citation Analysis]
620 Dhole SD, Kher AS, Ghildiyal RG, Tambse MP. Chronic Liver Diseases in Children: Clinical Profile and Histology. J Clin Diagn Res 2015;9:SC04-7. [PMID: 26393179 DOI: 10.7860/JCDR/2015/13383.6250] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
621 Sekiguchi T, Umemura T, Fujimori N, Shibata S, Ichikawa Y, Kimura T, Joshita S, Komatsu M, Matsumoto A, Tanaka E, Ota M. Serum cell death biomarkers for prediction of liver fibrosis and poor prognosis in primary biliary cirrhosis. PLoS One 2015;10:e0131658. [PMID: 26110613 DOI: 10.1371/journal.pone.0131658] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
622 Ahmed M. Non-alcoholic fatty liver disease in 2015. World J Hepatol 2015;7:1450-9. [PMID: 26085906 DOI: 10.4254/wjh.v7.i11.1450] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
623 Ahmed M. Non-alcoholic fatty liver disease in 2015. World J Hepatol 2015;7:1450-9. [PMID: 26085906 DOI: 10.4254/wjh.v7.i11.1450] [Cited by in Crossref: 133] [Cited by in F6Publishing: 137] [Article Influence: 16.6] [Reference Citation Analysis]
624 Dugum M, McCullough A. Diagnosis and Management of Alcoholic Liver Disease. J Clin Transl Hepatol 2015;3:109-16. [PMID: 26356792 DOI: 10.14218/JCTH.2015.00008] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 5.5] [Reference Citation Analysis]
625 Kim MN, Kim SU, Kim BK, Park JY, Kim DY, Ahn SH, Song KJ, Park YN, Han KH. Increased risk of hepatocellular carcinoma in chronic hepatitis B patients with transient elastography-defined subclinical cirrhosis. Hepatology 2015;61:1851-9. [PMID: 25643638 DOI: 10.1002/hep.27735] [Cited by in Crossref: 109] [Cited by in F6Publishing: 111] [Article Influence: 13.6] [Reference Citation Analysis]
626 Radmard AR, Poustchi H, Dadgostar M, Yoonessi A, Kooraki S, Jafari E, Hashemi Taheri AP, Malekzadeh R, Merat S. Liver enzyme levels and hepatic iron content in Fatty liver: a noninvasive assessment in general population by T2* mapping. Acad Radiol 2015;22:714-21. [PMID: 25754799 DOI: 10.1016/j.acra.2015.01.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
627 Efe C, Cengiz M, Kahramanoğlu-Aksoy E, Yilmaz B, Özşeker B, Beyazt Y, Tanoğlu A, Purnak T, Kav T, Turhan T, Ozenirler S, Ozaslan E, Wahlin S. Angiotensin-converting enzyme for noninvasive assessment of liver fibrosis in autoimmune hepatitis. Eur J Gastroenterol Hepatol 2015;27:649-54. [PMID: 25860719 DOI: 10.1097/MEG.0000000000000355] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
628 Umemura T, Joshita S, Sekiguchi T, Usami Y, Shibata S, Kimura T, Komatsu M, Matsumoto A, Ota M, Tanaka E. Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein Level Predicts Liver Fibrosis and Prognosis in Primary Biliary Cirrhosis. Am J Gastroenterol 2015;110:857-64. [PMID: 25916223 DOI: 10.1038/ajg.2015.118] [Cited by in Crossref: 101] [Cited by in F6Publishing: 90] [Article Influence: 12.6] [Reference Citation Analysis]
629 Orăşan OH, Sava M, Iancu M, Cozma A, Saplonţai-Pop A, Sarlea Ţărmure S, Lungoci C, Orăşan RA, Patiu IM, Dumitraşcu DL. Serum hyaluronic acid in chronic viral hepatitis B and C: a biomarker for assessing liver fibrosis in chronic hemodialysis patients. Int Urol Nephrol 2015;47:1209-17. [PMID: 26025064 DOI: 10.1007/s11255-015-1017-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
630 Parekh PJ, Majithia R, Diehl DL, Baron TH. Endoscopic ultrasound-guided liver biopsy. Endosc Ultrasound. 2015;4:85-91. [PMID: 26020041 DOI: 10.4103/2303-9027.156711] [Cited by in Crossref: 35] [Cited by in F6Publishing: 40] [Article Influence: 4.4] [Reference Citation Analysis]
631 Wu CH, Ho MC, Jeng YM, Liang PC, Hu RH, Lai HS, Shih TT. Assessing hepatic fibrosis: comparing the intravoxel incoherent motion in MRI with acoustic radiation force impulse imaging in US. EurRadiol. 2015;25:3552-3559. [PMID: 25991478 DOI: 10.1007/s00330-015-3774-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
632 Kim KY, Song JS, Kannengiesser S, Han YM. Hepatic fat quantification using the proton density fat fraction (PDFF): utility of free-drawn-PDFF with a large coverage area. Radiol Med 2015;120:1083-93. [PMID: 25952293 DOI: 10.1007/s11547-015-0545-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
633 Tapper EB, Afdhal NH. Vibration-controlled transient elastography: a practical approach to the noninvasive assessment of liver fibrosis. Curr Opin Gastroenterol 2015;31:192-8. [PMID: 25730177 DOI: 10.1097/MOG.0000000000000169] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
634 Rogier J, Roullet S, Cornélis F, Biais M, Quinart A, Revel P, Bioulac-Sage P, Le Bail B. Noninvasive assessment of macrovesicular liver steatosis in cadaveric donors based on computed tomography liver-to-spleen attenuation ratio. Liver Transpl 2015;21:690-5. [PMID: 25761371 DOI: 10.1002/lt.24105] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 4.6] [Reference Citation Analysis]
635 Mansoor S, Yerian L, Kohli R, Xanthakos S, Angulo P, Ling S, Lopez R, Christine CK, Feldstein AE, Alkhouri N. The evaluation of hepatic fibrosis scores in children with nonalcoholic fatty liver disease. Dig Dis Sci 2015;60:1440-7. [PMID: 25540086 DOI: 10.1007/s10620-014-3494-7] [Cited by in Crossref: 52] [Cited by in F6Publishing: 56] [Article Influence: 6.5] [Reference Citation Analysis]
636 Kukuk GM, Hittatiya K, Sprinkart AM, Eggers H, Gieseke J, Block W, Moeller P, Willinek WA, Spengler U, Trebicka J, Fischer HP, Schild HH, Träber F. Comparison between modified Dixon MRI techniques, MR spectroscopic relaxometry, and different histologic quantification methods in the assessment of hepatic steatosis. Eur Radiol 2015;25:2869-79. [PMID: 25903702 DOI: 10.1007/s00330-015-3703-6] [Cited by in Crossref: 77] [Cited by in F6Publishing: 85] [Article Influence: 9.6] [Reference Citation Analysis]
637 Arulanandan A, Loomba R. Non-invasive Testing for NASH and NASH with Advanced Fibrosis: Are We There Yet? Curr Hepatol Rep 2015;14:109-18. [PMID: 26500833 DOI: 10.1007/s11901-015-0263-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
638 Pembroke T, Gallimore A, Godkin A. Tracking the kinetics of intrahepatic immune responses by repeated fine needle aspiration of the liver. J Immunol Methods 2015;424:131-5. [PMID: 25914090 DOI: 10.1016/j.jim.2015.04.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
639 Sharma P, Altbach M, Galons JP, Kalb B, Martin DR. Measurement of liver fat fraction and iron with MRI and MR spectroscopy techniques. Diagn Interv Radiol 2014;20:17-26. [PMID: 24047718 DOI: 10.5152/dir.2013.13124] [Cited by in Crossref: 4] [Cited by in F6Publishing: 19] [Article Influence: 0.5] [Reference Citation Analysis]
640 Enomoto H, Aizawa N, Nakamura H, Takata R, Sakai Y, Iwata Y, Tanaka H, Ikeda N, Aoki T, Hasegawa K, Yoh K, Hashimoto K, Ishii A, Takashima T, Saito M, Imanishi H, Iijima H, Nishiguchi S. A new metabolism-related index correlates with the degree of liver fibrosis in hepatitis C virus-positive patients. Gastroenterol Res Pract 2015;2015:926169. [PMID: 25861264 DOI: 10.1155/2015/926169] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
641 Jia J, Hou J, Ding H, Chen G, Xie Q, Wang Y, Zeng M, Zhao J, Wang T, Hu X, Schuppan D. Transient elastography compared to serum markers to predict liver fibrosis in a cohort of Chinese patients with chronic hepatitis B. J Gastroenterol Hepatol 2015;30:756-62. [PMID: 25353058 DOI: 10.1111/jgh.12840] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 7.0] [Reference Citation Analysis]
642 Sadler MD, Crotty P, Fatovich L, Wilson S, Rabin HR, Myers RP. Noninvasive methods, including transient elastography, for the detection of liver disease in adults with cystic fibrosis. Can J Gastroenterol Hepatol 2015;29:139-44. [PMID: 25855877 DOI: 10.1155/2015/138530] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
643 Boursier J, de Ledinghen V, Poynard T, Guéchot J, Carrat F, Leroy V, Wong GL, Friedrich-Rust M, Fraquelli M, Plebani M, Sebastiani G, Myers R, Angulo P, Bertrais S, Wendum D, Bricault I, Calès P; ARDENT group, AFEF. An extension of STARD statements for reporting diagnostic accuracy studies on liver fibrosis tests: the Liver-FibroSTARD standards. J Hepatol 2015;62:807-15. [PMID: 25450206 DOI: 10.1016/j.jhep.2014.10.042] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 5.6] [Reference Citation Analysis]
644 Sun B, Li YG, Lan YH. Fibroscan for diagnosis and treatment of chronic liver disease. Shijie Huaren Xiaohua Zazhi 2015; 23(9): 1433-1439 [DOI: 10.11569/wcjd.v23.i9.1433] [Reference Citation Analysis]
645 Gomyo M, Kondo K, Yamakawa M, Shiina T. Mapping viscoelastic properties by multi-line (ML) acoustic radiation force. Medical Imaging 2015: Ultrasonic Imaging and Tomography 2015. [DOI: 10.1117/12.2082456] [Reference Citation Analysis]
646 Pacana T, Sanyal AJ. Recent advances in understanding/management of non-alcoholic steatohepatitis. F1000Prime Rep. 2015;7:28. [PMID: 25926979 DOI: 10.12703/p7-28] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
647 Singh S, Venkatesh SK, Wang Z, Miller FH, Motosugi U, Low RN, Hassanein T, Asbach P, Godfrey EM, Yin M, Chen J, Keaveny AP, Bridges M, Bohte A, Murad MH, Lomas DJ, Talwalkar JA, Ehman RL. Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data. Clin Gastroenterol Hepatol 2015;13:440-451.e6. [PMID: 25305349 DOI: 10.1016/j.cgh.2014.09.046] [Cited by in Crossref: 359] [Cited by in F6Publishing: 374] [Article Influence: 44.9] [Reference Citation Analysis]
648 Fernandes FF, Ferraz ML, Andrade LE, Dellavance A, Terra C, Pereira G, Pereira JL, Campos F, Figueiredo F, Perez RM. Enhanced liver fibrosis panel as a predictor of liver fibrosis in chronic hepatitis C patients. J Clin Gastroenterol 2015;49:235-41. [PMID: 24714186 DOI: 10.1097/MCG.0000000000000128] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
649 Dezsőfi A, Baumann U, Dhawan A, Durmaz O, Fischler B, Hadzic N, Hierro L, Lacaille F, McLin VA, Nobili V, Socha P, Vajro P, Knisely AS; ESPGHAN Hepatology Committee. Liver biopsy in children: position paper of the ESPGHAN Hepatology Committee. J Pediatr Gastroenterol Nutr 2015;60:408-20. [PMID: 25383787 DOI: 10.1097/MPG.0000000000000632] [Cited by in Crossref: 132] [Cited by in F6Publishing: 113] [Article Influence: 16.5] [Reference Citation Analysis]
650 Bonnard P, Elsharkawy A, Zalata K, Delarocque-Astagneau E, Biard L, Le Fouler L, Hassan AB, Abdel-Hamid M, El-Daly M, Gamal ME, El Kassas M, Bedossa P, Carrat F, Fontanet A, Esmat G. Comparison of liver biopsy and noninvasive techniques for liver fibrosis assessment in patients infected with HCV-genotype 4 in Egypt. J Viral Hepat 2015;22:245-53. [PMID: 25073725 DOI: 10.1111/jvh.12285] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.5] [Reference Citation Analysis]
651 Abdollahi M, Pouri A, Ghojazadeh M, Estakhri R, Somi M. Non-invasive serum fibrosis markers: A study in chronic hepatitis. Bioimpacts. 2015;5:17-23. [PMID: 25901293 DOI: 10.15171/bi.2015.05] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
652 Liang LB, Zhu X, Yan LB, Du LY, Liu C, Chen LY, Liao J, Tang H. Serum hepatitis B surface antigen titer and transient elastography in screening for insignificant fibrosis in HBeAg-positive chronic hepatitis B patients. Ther Clin Risk Manag 2015;11:229-35. [PMID: 25709465 DOI: 10.2147/TCRM.S73827] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
653 Saito M, Yano Y, Hirano H, Momose K, Yoshida M, Azuma T. Serum NX-DCP as a New Noninvasive Model to Predict Significant Liver Fibrosis in Chronic Hepatitis C. Hepat Mon 2015;15:e22978. [PMID: 25788955 DOI: 10.5812/hepatmon.22978] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
654 Nassef YE, Shady MM, Galal EM, Hamed MA. Performance of diagnostic biomarkers in predicting liver fibrosis among hepatitis C virus-infected Egyptian children. Mem Inst Oswaldo Cruz 2013;108:887-93. [PMID: 24141960 DOI: 10.1590/0074-0276130139] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
655 Wang JY, Mao RC, Zhang YM, Zhang YJ, Liu HY, Qin YL, Lu MJ, Zhang JM. Serum microRNA-124 is a novel biomarker for liver necroinflammation in patients with chronic hepatitis B virus infection. J Viral Hepat 2015;22:128-36. [PMID: 25131617 DOI: 10.1111/jvh.12284] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
656 Baik SK, Kim MY, Jeong WK. Diagnostic imaging modalities. Cirrhosis: A practical guide to management 2015. [DOI: 10.1002/9781118412640.ch03] [Reference Citation Analysis]
657 Castera L. Non-invasive diagnosis tests. Cirrhosis: A practical guide to management 2015. [DOI: 10.1002/9781118412640.ch06] [Reference Citation Analysis]
658 Göbel T, Schadewaldt-Tümmers J, Greiner L, Poremba C, Häussinger D, Erhardt A. Transient elastography improves detection of liver cirrhosis compared to routine screening tests. World J Gastroenterol 2015; 21(3): 953-960 [PMID: 25624730 DOI: 10.3748/wjg.v21.i3.953] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
659 Wang X, Xie G, Wang X, Zhou M, Yu H, Lin Y, Du G, Luo G, Liu P. Urinary metabolite profiling offers potential for differentiation of liver-kidney yin deficiency and dampness-heat internal smoldering syndromes in posthepatitis B cirrhosis patients. Evid Based Complement Alternat Med 2015;2015:464969. [PMID: 25667596 DOI: 10.1155/2015/464969] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
660 Carvalho-Filho RJ, Feldner ACC, Silva AEB, Ferraz MLG. Management of hepatitis C in patients with chronic kidney disease. World J Gastroenterol 2015; 21(2): 408-422 [PMID: 25593456 DOI: 10.3748/wjg.v21.i2.408] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
661 Quezada N, León F, Martínez J, Jarufe N, Guerra JF. Emergency right hepatectomy after laparoscopic tru-cut liver biopsy. Int J Surg Case Rep 2015;8C:42-4. [PMID: 25618399 DOI: 10.1016/j.ijscr.2015.01.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
662 Tapper EB, Castera L, Afdhal NH. FibroScan (vibration-controlled transient elastography): where does it stand in the United States practice. Clin Gastroenterol Hepatol 2015;13:27-36. [PMID: 24909907 DOI: 10.1016/j.cgh.2014.04.039] [Cited by in Crossref: 99] [Cited by in F6Publishing: 105] [Article Influence: 12.4] [Reference Citation Analysis]
663 Toshima T, Shirabe K, Ikegami T, Yoshizumi T, Kuno A, Togayachi A, Gotoh M, Narimatsu H, Korenaga M, Mizokami M, Nishie A, Aishima S, Maehara Y. A novel serum marker, glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA(+)-M2BP), for assessing liver fibrosis. J Gastroenterol 2015;50:76-84. [PMID: 24603981 DOI: 10.1007/s00535-014-0946-y] [Cited by in Crossref: 129] [Cited by in F6Publishing: 129] [Article Influence: 16.1] [Reference Citation Analysis]
664 Huang SY, Paulson EK. Techniques of Percutaneous Tissue Acquisition. Textbook of Gastrointestinal Radiology, 2-Volume Set 2015. [DOI: 10.1016/b978-1-4557-5117-4.00071-4] [Reference Citation Analysis]
665 Castro R, Perazzo H, Grinsztejn B, Veloso VG, Hyde C. Chronic Hepatitis C: An Overview of Evidence on Epidemiology and Management from a Brazilian Perspective. Int J Hepatol 2015;2015:852968. [PMID: 26693356 DOI: 10.1155/2015/852968] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
666 Ogawa K, Uozumi S, Yu K, Wada N, Uraoka T, Shimojima N, Yahagi N, Kitagawa Y, Ohnishi K. A Method of Bio-tissue Hardness Measurement by Force Sensor-less Organ Palpation Device. JJSCAS 2015;17:91-100. [DOI: 10.5759/jscas.17.91] [Reference Citation Analysis]
667 O’neil M, Damjanov I, Taylor RM. Indications and Techniques of Liver Biopsy. Liver Pathology for Clinicians 2015. [DOI: 10.1007/978-3-319-20080-4_2] [Reference Citation Analysis]
668 Wakui N, Matsukiyo Y, Sumino Y. Use of Sonazoid-enhanced ultrasonography in histopathological staging of the liver. Jpn J Med Ultrasonics 2015;42:525-532. [DOI: 10.3179/jjmu.jjmu.r.45] [Reference Citation Analysis]
669 Erozan YS, Tatsas A. Liver. Cytopathology of Liver, Biliary Tract, Kidney and Adrenal Gland 2015. [DOI: 10.1007/978-1-4899-7513-3_3] [Reference Citation Analysis]
670 Qian Z, Yonggui Z, Chunyu Z, Ping Z, Jian J, Jiangbin W. Hydrogen 1 (1H) magnetic resonance spectroscopy (MRS) of 3.0T in assessment of steatosis to antiviral therapy for chronic hepatitis C. Afr J Biotechnol 2014;13:4753-4760. [DOI: 10.5897/ajb2014.13468] [Reference Citation Analysis]
671 Hong H, Li J, Jin Y, Li Q, Li W, Wu J, Huang Z. Performance of real-time elastography for the staging of hepatic fibrosis: a meta-analysis. PLoS One. 2014;9:e115702. [PMID: 25541695 DOI: 10.1371/journal.pone.0115702] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
672 Cho HJ, Kim SS, Ahn SJ, Park JH, Kim DJ, Kim YB, Cho SW, Cheong JY. Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B. Clin Mol Hepatol. 2014;20:347-354. [PMID: 25548740 DOI: 10.3350/cmh.2014.20.4.347] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
673 Park HS, Kim YJ, Yu MH, Choe WH, Jung SI, Jeon HJ. Three-Tesla magnetic resonance elastography for hepatic fibrosis: Comparison with diffusion-weighted imaging and gadoxetic acid-enhanced magnetic resonance imaging. World J Gastroenterol 2014; 20(46): 17558-17567 [PMID: 25516671 DOI: 10.3748/wjg.v20.i46.17558] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
674 Zou X, Chi X, Pan Y, Du D, Sun H, Matsuda A, Li W, Kuno A, Zhang X, Narimatsu H, Niu J, Zhang Y. LecT-Hepa facilitates estimating treatment outcome during interferon therapy in chronic hepatitis C patients. Clin Proteomics 2014;11:44. [PMID: 25593566 DOI: 10.1186/1559-0275-11-44] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
675 Lu YP, Wei J, Xu LR, Tang YY, Yuan Y, Zhang Y, Li YY. Assessment of fibrosis during the development of fatty liver in rabbits using real-time shear-wave elastography. J Huazhong Univ Sci Technolog Med Sci 2014;34:921-8. [PMID: 25480592 DOI: 10.1007/s11596-014-1375-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
676 Lu PX, Huang H, Yuan J, Zhao F, Chen ZY, Zhang Q, Ahuja AT, Zhou BP, Wáng YX. Decreases in molecular diffusion, perfusion fraction and perfusion-related diffusion in fibrotic livers: a prospective clinical intravoxel incoherent motion MR imaging study. P. LoS One. 2014;9:e113846. [PMID: 25436458 DOI: 10.1371/journal.pone.0113846] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 3.8] [Reference Citation Analysis]
677 Teshale E, Lu M, Rupp LB, Holmberg SD, Moorman AC, Spradling P, Vijayadeva V, Boscarino JA, Schmidt MA, Gordon SC; CHeCS Investigators. APRI and FIB-4 are good predictors of the stage of liver fibrosis in chronic hepatitis B: the Chronic Hepatitis Cohort Study (CHeCS). J Viral Hepat 2014;21:917-20. [PMID: 25131445 DOI: 10.1111/jvh.12279] [Cited by in Crossref: 72] [Cited by in F6Publishing: 57] [Article Influence: 8.0] [Reference Citation Analysis]
678 Jin YJ, Shim JH, Kim GA, Yu E, Kim KM, Lim YS, Lee HC. Clinicobiochemical prediction of biopsy-proven cases of severe hepatic fibrosis in patients with chronic hepatitis C infection. BMJ Open 2014;4:e006255. [PMID: 25431223 DOI: 10.1136/bmjopen-2014-006255] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
679 Sumida Y, Nakajima A, Itoh Y. Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol. 2014;20:475-485. [PMID: 24574716 DOI: 10.3748/wpg.v20.i2.475] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
680 Kemp SD, Zimmerman KL, Panciera DL, Monroe WE, Leib MS, Lanz OI. A comparison of liver sampling techniques in dogs. J Vet Intern Med 2015;29:51-7. [PMID: 25417960 DOI: 10.1111/jvim.12508] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
681 Yamasaki K, Tateyama M, Abiru S, Komori A, Nagaoka S, Saeki A, Hashimoto S, Sasaki R, Bekki S, Kugiyama Y, Miyazoe Y, Kuno A, Korenaga M, Togayachi A, Ocho M, Mizokami M, Narimatsu H, Yatsuhashi H. Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients. Hepatology 2014;60:1563-70. [PMID: 25042054 DOI: 10.1002/hep.27305] [Cited by in Crossref: 181] [Cited by in F6Publishing: 184] [Article Influence: 20.1] [Reference Citation Analysis]
682 Ble M, Procopet B, Miquel R, Hernandez-Gea V, García-Pagán JC. Transjugular liver biopsy. Clin Liver Dis 2014;18:767-78. [PMID: 25438282 DOI: 10.1016/j.cld.2014.07.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
683 Dvorak K, Stritesky J, Petrtyl J, Vitek L, Sroubkova R, Lenicek M, Smid V, Haluzik M, Bruha R. Use of non-invasive parameters of non-alcoholic steatohepatitis and liver fibrosis in daily practice--an exploratory case-control study. PLoS One 2014;9:e111551. [PMID: 25350286 DOI: 10.1371/journal.pone.0111551] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
684 Jeong JY, Kim TY, Sohn JH, Kim Y, Jeong WK, Oh YH, Yoo KS. Real time shear wave elastography in chronic liver diseases: Accuracy for predicting liver fibrosis, in comparison with serum markers. World J Gastroenterol 2014; 20(38): 13920-13929 [PMID: 25320528 DOI: 10.3748/wjg.v20.i38.13920] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 33] [Article Influence: 3.6] [Reference Citation Analysis]
685 Barr RG. Elastography of the Abdomen. Ultrasound Clinics 2014;9:625-640. [DOI: 10.1016/j.cult.2014.07.002] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
686 Wong GL. Prediction of fibrosis progression in chronic viral hepatitis. Clin Mol Hepatol 2014;20:228-36. [PMID: 25320725 DOI: 10.3350/cmh.2014.20.3.228] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 3.6] [Reference Citation Analysis]
687 Tang A, Desai A, Hamilton G, Wolfson T, Gamst A, Lam J, Clark L, Hooker J, Chavez T, Ang BD, Middleton MS, Peterson M, Loomba R, Sirlin CB. Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. Radiology 2015;274:416-25. [PMID: 25247408 DOI: 10.1148/radiol.14140754] [Cited by in Crossref: 165] [Cited by in F6Publishing: 169] [Article Influence: 18.3] [Reference Citation Analysis]
688 Motola DL, Caravan P, Chung RT, Fuchs BC. Noninvasive Biomarkers of Liver Fibrosis: Clinical Applications and Future Directions. Curr Pathobiol Rep 2014;2:245-56. [PMID: 25396099 DOI: 10.1007/s40139-014-0061-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
689 Hassan S, Syed S, Kehar SI. Glial Fibrillary Acidic Protein (GFAP) as a Mesenchymal marker of Early Hepatic Stellate Cells Activation in Liver Fibrosis in Chronic Hepatitis C Infection. Pak J Med Sci 2014;30:1027-32. [PMID: 25225520 DOI: 10.12669/pjms.305.5534] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
690 Hassan K, Bhalla V, Regal MEE, A-Kader HH. Nonalcoholic fatty liver disease: A comprehensive review of a growing epidemic. World J Gastroenterol 2014; 20(34): 12082-12101 [PMID: 25232245 DOI: 10.3748/wjg.v20.i34.12082] [Cited by in CrossRef: 127] [Cited by in F6Publishing: 137] [Article Influence: 14.1] [Reference Citation Analysis]
691 Sharma P, Dhawan S, Bansal R, Tyagi P, Bansal N, Singla V, Kumar A, Matin A, Arora A. Usefulness of transient elastography by FibroScan for the evaluation of liver fibrosis. Indian J Gastroenterol 2014;33:445-51. [PMID: 25138787 DOI: 10.1007/s12664-014-0491-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
692 Zhao H, Song P, Meixner DD, Kinnick RR, Callstrom MR, Sanchez W, Urban MW, Manduca A, Greenleaf JF, Chen S. Liver elasticity imaging using external Vibration Multi-directional Ultrasound Shearwave Elastography (EVMUSE). 2014 IEEE International Ultrasonics Symposium 2014. [DOI: 10.1109/ultsym.2014.0240] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
693 Lampela H, Kosola S, Heikkilä P, Lohi J, Jalanko H, Pakarinen MP. Native liver histology after successful portoenterostomy in biliary atresia. J Clin Gastroenterol 2014;48:721-8. [PMID: 24275708 DOI: 10.1097/MCG.0000000000000013] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 4.2] [Reference Citation Analysis]
694 Li Y, Chen Y, Zhao Y. The diagnostic value of the FIB-4 index for staging hepatitis B-related fibrosis: a meta-analysis. PLoS One. 2014;9:e105728. [PMID: 25165830 DOI: 10.1371/journal.pone.0105728] [Cited by in Crossref: 48] [Cited by in F6Publishing: 57] [Article Influence: 5.3] [Reference Citation Analysis]
695 Kobayashi K, Nakao H, Nishiyama T, Lin Y, Kikuchi S, Kobayashi Y, Yamamoto T, Ishii N, Ohashi T, Satoh K. Diagnostic accuracy of real-time tissue elastography for the staging of liver fibrosis: a meta-analysis. Eur Radiol. 2015;25:230-238. [PMID: 25149296 DOI: 10.1007/s00330-014-3364-x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 4.2] [Reference Citation Analysis]
696 Fitzpatrick E, Dhawan A. Noninvasive biomarkers in non-alcoholic fatty liver disease: Current status and a glimpse of the future. World J Gastroenterol 2014; 20(31): 10851-10863 [PMID: 25152587 DOI: 10.3748/wjg.v20.i31.10851] [Cited by in CrossRef: 75] [Cited by in F6Publishing: 77] [Article Influence: 8.3] [Reference Citation Analysis]
697 Liu YR, Lin BB, Zeng DW, Zhu YY, Chen J, Zheng Q, Dong J, Jiang JJ. Alpha-fetoprotein level as a biomarker of liver fibrosis status: a cross-sectional study of 619 consecutive patients with chronic hepatitis B. BMC Gastroenterol 2014;14:145. [PMID: 25128299 DOI: 10.1186/1471-230X-14-145] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
698 Li C, Hu J, Zhou D, Zhao J, Ma K, Yin X, Wang J. Differentiation of bland from neoplastic thrombus of the portal vein in patients with hepatocellular carcinoma: application of susceptibility-weighted MR imaging. BMC Cancer. 2014;14:590. [PMID: 25123782 DOI: 10.1186/1471-2407-14-590] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
699 Alkhouri N, Mansoor S, Giammaria P, Liccardo D, Lopez R, Nobili V. The development of the pediatric NAFLD fibrosis score (PNFS) to predict the presence of advanced fibrosis in children with nonalcoholic fatty liver disease. PLoS One. 2014;9:e104558. [PMID: 25121514 DOI: 10.1371/journal.pone.0104558] [Cited by in Crossref: 49] [Cited by in F6Publishing: 53] [Article Influence: 5.4] [Reference Citation Analysis]
700 Brescini L, Orsetti E, Gesuita R, Piraccini F, Marchionni E, Staffolani S, Castelli P, Drenaggi D, Barchiesi F. Evaluating Liver Fibrosis by Transient Elastometry in Patients With HIV-HCV Coinfection and Monoinfection. Hepat Mon 2014;14:e15426. [PMID: 25337140 DOI: 10.5812/hepatmon.15426] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
701 Silva Junior RG, Schmillevitch J, Nascimento Mde F, Miranda ML, Brant PE, Schulz PO, Vieira A, Szutan LA. Acoustic radiation force impulse elastography and serum fibrosis markers in chronic hepatitis C. Scand J Gastroenterol 2014;49:986-92. [PMID: 24742130 DOI: 10.3109/00365521.2014.909528] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
702 Miyaaki H, Ichikawa T, Kamo Y, Taura N, Honda T, Shibata H, Milazzo M, Fornari F, Gramantieri L, Bolondi L, Nakao K. Significance of serum and hepatic microRNA-122 levels in patients with non-alcoholic fatty liver disease. Liver Int 2014;34:e302-7. [PMID: 24313922 DOI: 10.1111/liv.12429] [Cited by in Crossref: 109] [Cited by in F6Publishing: 112] [Article Influence: 12.1] [Reference Citation Analysis]
703 Levine MH, Feng S. Clinical Allograft Rejection Syndromes in Liver Transplantation. Textbook of Organ Transplantation 2014. [DOI: 10.1002/9781118873434.ch70] [Reference Citation Analysis]
704 Zhao H, Song P, Meixner DD, Kinnick RR, Callstrom MR, Sanchez W, Urban MW, Manduca A, Greenleaf JF, Chen S. External vibration multi-directional ultrasound shearwave elastography (EVMUSE): application in liver fibrosis staging. IEEE Trans Med Imaging 2014;33:2140-8. [PMID: 25020066 DOI: 10.1109/TMI.2014.2332542] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 4.6] [Reference Citation Analysis]
705 Zhang BY, Li XG, Xu J. Assessment of hepatic fibrosis stage by real-time tissue elastography: A meta-analysis. Shijie Huaren Xiaohua Zazhi 2014; 22(19): 2774-2779 [DOI: 10.11569/wcjd.v22.i19.2774] [Reference Citation Analysis]
706 Attia D, Pischke S, Negm AA, Rifai K, Manns MP, Gebel MJ, Lankisch TO, Potthoff A. Changes in liver stiffness using acoustic radiation force impulse imaging in patients with obstructive cholestasis and cholangitis. Dig Liver Dis 2014;46:625-31. [PMID: 24666759 DOI: 10.1016/j.dld.2014.02.020] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
707 Sekhar A, Sun MR, Siewert B. A tissue phantom model for training residents in ultrasound-guided liver biopsy. Acad Radiol 2014;21:902-8. [PMID: 24928159 DOI: 10.1016/j.acra.2014.03.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.1] [Reference Citation Analysis]
708 Xu XY, Kong H, Song RX, Zhai YH, Wu XF, Ai WS, Liu HB. The effectiveness of noninvasive biomarkers to predict hepatitis B-related significant fibrosis and cirrhosis: a systematic review and meta-analysis of diagnostic test accuracy. PLoS One. 2014;9:e100182. [PMID: 24964038 DOI: 10.1371/journal.pone.0100182] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 2.9] [Reference Citation Analysis]
709 Ferraioli G, Tinelli C, Lissandrin R, Zicchetti M, Dal Bello B, Filice G, Filice C. Controlled attenuation parameter for evaluating liver steatosis in chronic viral hepatitis. World J Gastroenterol 2014; 20(21): 6626-6631 [PMID: 24914387 DOI: 10.3748/wjg.v20.i21.6626] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
710 Zaiton F, Dawoud H, El Fiki IM, Hadhoud KM. Diffusion weighted MRI and transient elastography assessment of liver fibrosis in hepatitis C patients: Validity of non invasive imaging techniques. The Egyptian Journal of Radiology and Nuclear Medicine 2014;45:279-287. [DOI: 10.1016/j.ejrnm.2014.02.007] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
711 Lu Y, Wei J, Tang Y, Yuan Y, Huang Y, Zhang Y, Li Y. Evaluation of fatty liver fibrosis in rabbits using real-time shear wave elastography. Exp Ther Med. 2014;8:355-362. [PMID: 25009583 DOI: 10.3892/etm.2014.1749] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
712 Schenk JP, Selmi B, Flechtenmacher C, Sakka SE, Teufel U, Engelmann G. Real-time tissue elastography (RTE) for noninvasive evaluation of fibrosis in liver diseases in children in comparison to liver biopsy. J Med Ultrason (2001). 2014;41:455-462. [PMID: 27278026 DOI: 10.1007/s10396-014-0542-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
713 Anania G, Gigante E, Piciucchi M, Pilozzi E, Pucci E, Pellicelli AM, Capotondi C, Rossi M, Baccini F, Antonelli G, Begini P, Fave GD, Marignani M. Liver biopsy: Analysis of results of two specialist teams. World J Gastrointest Pathophysiol 2014; 5(2): 114-119 [PMID: 24891983 DOI: 10.4291/wjgp.v5.i2.114] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
714 Chinnaratha MA, Jeffrey GP, MacQuillan G, Rossi E, de Boer BW, Speers DJ, Adams LA. Prediction of morbidity and mortality in patients with chronic hepatitis C by non-invasive liver fibrosis models. Liver Int 2014;34:720-7. [PMID: 24034439 DOI: 10.1111/liv.12306] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
715 Idilman IS, Keskin O, Elhan AH, Idilman R, Karcaaltincaba M. Impact of sequential proton density fat fraction for quantification of hepatic steatosis in nonalcoholic fatty liver disease. Scand J Gastroenterol 2014;49:617-24. [PMID: 24694249 DOI: 10.3109/00365521.2014.894118] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
716 Caetano AC, Lages J, Gonçalves B, Soares JB, Gonçalves R, Rolanda C. Será uma refeição ligeira fator de erro na avaliação da dureza hepática por elastografia hepática transitória? Um estudo prospetivo. GE Jornal Português de Gastrenterologia 2014;21:102-108. [DOI: 10.1016/j.jpg.2013.10.005] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
717 Ferraioli G, Tinelli C, Lissandrin R, Zicchetti M, Bello BD, Filice G, Filice C. Point shear wave elastography method for assessing liver stiffness. World J Gastroenterol 2014; 20(16): 4787-4796 [PMID: 24782633 DOI: 10.3748/wjg.v20.i16.4787] [Cited by in CrossRef: 97] [Cited by in F6Publishing: 97] [Article Influence: 10.8] [Reference Citation Analysis]
718 Levien AS, Weisse C, Donovan TA, Berent AC. Assessment of the efficacy and potential complications of transjugular liver biopsy in canine cadavers. J Vet Intern Med 2014;28:338-45. [PMID: 24765677 DOI: 10.1111/jvim.12305] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
719 Leissinger C, Kruse-jarres R. General Surgical Management of Patients with Hemophilia. Textbook of Hemophilia 2014. [DOI: 10.1002/9781118398258.ch28] [Reference Citation Analysis]
720 Kim MY, Jeong WK, Baik SK. Invasive and non-invasive diagnosis of cirrhosis and portal hypertension. World J Gastroenterol 2014; 20(15): 4300-4315 [PMID: 24764667 DOI: 10.3748/wjg.v20.i15.4300] [Cited by in CrossRef: 71] [Cited by in F6Publishing: 73] [Article Influence: 7.9] [Reference Citation Analysis]
721 Li JF, Qu F, Zheng SJ, Ren JY, Wu HL, Liu M, Liu H, Ren F, Chen Y, Zhang JL, Duan ZP. Plasma sphingolipids as potential indicators of hepatic necroinflammation in patients with chronic hepatitis C and normal alanine aminotransferase level. PLoS One 2014;9:e95095. [PMID: 24736528 DOI: 10.1371/journal.pone.0095095] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
722 Xie Q, Zhou X, Huang P, Wei J, Wang W, Zheng S. The performance of enhanced liver fibrosis (ELF) test for the staging of liver fibrosis: a meta-analysis. PLoS One. 2014;9:e92772. [PMID: 24736610 DOI: 10.1371/journal.pone.0092772] [Cited by in Crossref: 46] [Cited by in F6Publishing: 50] [Article Influence: 5.1] [Reference Citation Analysis]
723 Ma JJ, Ding H, Mao F, Sun HC, Xu C, Wang WP. Assessment of liver fibrosis with elastography point quantification technique in chronic hepatitis B virus patients: a comparison with liver pathological results. J Gastroenterol Hepatol 2014;29:814-9. [PMID: 24325607 DOI: 10.1111/jgh.12479] [Cited by in Crossref: 44] [Cited by in F6Publishing: 41] [Article Influence: 4.9] [Reference Citation Analysis]
724 Maklad S, Esmat G, Hassan E, Attalah M, Zeid AA. Liver Biopsy and FibroScan to Detect Early Histopathological Changes in Chronic HBV Patients Not Candidate for Treatment. Gastroenterology Res 2014;7:56-63. [PMID: 27785271 DOI: 10.14740/gr597w] [Reference Citation Analysis]
725 Wu CH, Ho MC, Jeng YM, Hsu CY, Liang PC, Hu RH, Lai HS, Shih TT. Quantification of hepatic steatosis: a comparison of the accuracy among multiple magnetic resonance techniques. J Gastroenterol Hepatol 2014;29:807-13. [PMID: 24224538 DOI: 10.1111/jgh.12451] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
726 Kuo YH, Lu SN, Chen CH, Chang KC, Hung CH, Tai WC, Tsai MC, Tseng PL, Hu TH, Wang JH. The changes of liver stiffness and its associated factors for chronic hepatitis B patients with entecavir therapy. PLoS One. 2014;9:e93160. [PMID: 24682088 DOI: 10.1371/journal.pone.0093160] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
727 Patel A, Gogna A, Irani FG, Teo TK, Yeow TN, Jain D, Lo RH, Tay KH, Tan BS, Azhar R, Chang JP, Taneja M. Single Centre Experience of Transjugular Liver Biopsy in 152 Patients. Ann Acad Med Singap 2014;43:160-165. [DOI: 10.47102/annals-acadmedsg.v43n3p160] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
728 Hernando D, Levin YS, Sirlin CB, Reeder SB. Quantification of liver iron with MRI: state of the art and remaining challenges. J Magn Reson Imaging. 2014;40:1003-1021. [PMID: 24585403 DOI: 10.1002/jmri.24584] [Cited by in Crossref: 163] [Cited by in F6Publishing: 174] [Article Influence: 18.1] [Reference Citation Analysis]
729 Kim MN, Kim SU, Park JY, Kim DY, Han KH, Chon CY, Ahn SH. Risk assessment of liver-related events using transient elastography in patients with chronic hepatitis B receiving entecavir. J Clin Gastroenterol 2014;48:272-8. [PMID: 23811938 DOI: 10.1097/MCG.0b013e31829a7247] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
730 Lim JK, Tate JP, Fultz SL, Goulet JL, Conigliaro J, Bryant KJ, Gordon AJ, Gibert C, Rimland D, Goetz MB, Klein MB, Fiellin DA, Justice AC, Lo Re V 3rd. Relationship between alcohol use categories and noninvasive markers of advanced hepatic fibrosis in HIV-infected, chronic hepatitis C virus-infected, and uninfected patients. Clin Infect Dis 2014;58:1449-58. [PMID: 24569533 DOI: 10.1093/cid/ciu097] [Cited by in Crossref: 60] [Cited by in F6Publishing: 67] [Article Influence: 6.7] [Reference Citation Analysis]
731 Verloh N, Haimerl M, Zeman F, Schlabeck M, Barreiros A, Loss M, Schreyer AG, Stroszczynski C, Fellner C, Wiggermann P. Assessing liver function by liver enhancement during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MRI at 3 Tesla. Eur Radiol. 2014;24:1013-1019. [PMID: 24531844 DOI: 10.1007/s00330-014-3108-y] [Cited by in Crossref: 102] [Cited by in F6Publishing: 92] [Article Influence: 11.3] [Reference Citation Analysis]
732 Morling JR, Fallowfield JA, Guha IN, Nee LD, Glancy S, Williamson RM, Robertson CM, Strachan MW, Price JF; Edinburgh Type 2 Diabetes Study investigators. Using non-invasive biomarkers to identify hepatic fibrosis in people with type 2 diabetes mellitus: the Edinburgh type 2 diabetes study. J Hepatol 2014;60:384-91. [PMID: 24512822 DOI: 10.1016/j.jhep.2013.10.017] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 5.9] [Reference Citation Analysis]
733 Zaccardi F, Pitocco D, Martini F, Caputo S, Miele L, Grieco A, Ghirlanda G. A case of esomeprazole-induced transient diabetes and hepatitis: the role of liver inflammation in the pathogenesis of insulin resistance. Acta Diabetol 2014;51:151-3. [PMID: 22389003 DOI: 10.1007/s00592-012-0382-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
734 Sumida Y, Nakajima A, Itoh Y. Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol 2014; 20(2): 475-485 [PMID: 24574716 DOI: 10.3748/wjg.v20.i2.475] [Cited by in CrossRef: 347] [Cited by in F6Publishing: 357] [Article Influence: 38.6] [Reference Citation Analysis]
735 Lee S, Kim DY. Non-invasive diagnosis of hepatitis B virus-related cirrhosis. World J Gastroenterol 2014; 20(2): 445-459 [PMID: 24574713 DOI: 10.3748/wjg.v20.i2.445] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
736 Aithal GP, Das K, Chowdhury A. Epidemiology of Nonalcoholic Fatty Liver Disease (NAFLD). GI Epidemiology 2014. [DOI: 10.1002/9781118727072.ch32] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
737 Zhao F, Yuan J, Deng M, Lu PX, Ahuja AT, Wang YX. Further exploration of MRI techniques for liver T1rho quantification. Quant Imaging Med Surg 2013;3:308-15. [PMID: 24404445 DOI: 10.3978/j.issn.2223-4292.2013.12.10] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
738 Dohan A, Guerrache Y, Boudiaf M, Gavini J, Kaci R, Soyer P. Biopsie hépatique par voie transjugulaire : indications, technique et résultats. Journal de Radiologie Diagnostique et Interventionnelle 2014;95:13-18. [DOI: 10.1016/j.jradio.2013.05.011] [Reference Citation Analysis]
739 Mcclaran J, Buote N. Liver and biliary tract. Feline Soft Tissue and General Surgery 2014. [DOI: 10.1016/b978-0-7020-4336-9.00031-7] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
740 Gwak G. Diagnosis of Non-alcoholic Fatty Liver Disease. J Korean Diabetes 2014;15:82. [DOI: 10.4093/jkd.2014.15.2.82] [Reference Citation Analysis]
741 Venkatesh SK. Clinical Applications of Liver Magnetic Resonance Elastography: Chronic Liver Disease. Magnetic Resonance Elastography 2014. [DOI: 10.1007/978-1-4939-1575-0_4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
742 Martín-Rodríguez JL, Arrebola JP, Jiménez-Moleón JJ, Olea N, González-Calvin JL. Sonographic quantification of a hepato-renal index for the assessment of hepatic steatosis in comparison with 3T proton magnetic resonance spectroscopy. Eur J Gastroenterol Hepatol 2014;26:88-94. [PMID: 23921844 DOI: 10.1097/MEG.0b013e3283650650] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
743 Gor N, Salem SB, Jakate S, Patel R, Shah N, Patil A. Histological adequacy of EUS-guided liver biopsy when using a 19-gauge non-Tru-Cut FNA needle. Gastrointest Endosc 2014;79:170-2. [PMID: 23916397 DOI: 10.1016/j.gie.2013.06.031] [Cited by in Crossref: 38] [Cited by in F6Publishing: 45] [Article Influence: 4.2] [Reference Citation Analysis]
744 John A, Al Kaabi S, Soofi ME, Mohannadi M, Kandath SM, Derbala M, Yakoub R, Al-Ahdal EM, Sharma M, Wani H, Dweik N, John A, Butt MT. Liver biopsy for parenchymal liver disease - is routine real time image guidance unnecessary? Indian J Gastroenterol 2014;33:50-4. [PMID: 24048678 DOI: 10.1007/s12664-013-0393-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
745 Hoad C, Marciani L, Francis S, Gowland P. Whole body magnetic resonance imaging (MRI). Biomedical Imaging 2014. [DOI: 10.1533/9780857097477.2.266] [Reference Citation Analysis]
746 Narita Y, Genda T, Tsuzura H, Sato S, Kanemitsu Y, Ishikawa S, Kikuchi T, Hirano K, Iijima K, Wada R, Ichida T. Prediction of liver stiffness hepatocellular carcinoma in chronic hepatitis C patients on interferon-based anti-viral therapy. J Gastroenterol Hepatol 2014;29:137-43. [PMID: 24117602 DOI: 10.1111/jgh.12401] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
747 Thabet A, Gervais DA. Liver Biopsy. Percutaneous Image-Guided Biopsy 2014. [DOI: 10.1007/978-1-4614-8217-8_13] [Reference Citation Analysis]
748 Allison RP, Belli AM, Chun J, Chung R, Das R, England A, Flood K, Giroux M, Mcwilliams RG, Morgan R, Papadakos N, Patel JV, Patel R, Patel U, Ratnam L, Yadavali RP, Rose J. Hemorrhage After Transjugular Liver Biopsy. Managing Common Interventional Radiology Complications 2014. [DOI: 10.1007/978-1-4471-5502-7_33] [Reference Citation Analysis]
749 Sira MM, Behairy BE, Abd-Elaziz AM, Abd Elnaby SA, Eltahan EE. Serum Inter-Alpha-Trypsin Inhibitor Heavy Chain 4 (ITIH4) in Children with Chronic Hepatitis C: Relation to Liver Fibrosis and Viremia. Hepat Res Treat 2014;2014:307942. [PMID: 25295185 DOI: 10.1155/2014/307942] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
750 Moon KM, Kim G, Baik SK, Choi E, Kim MY, Kim HA, Cho MY, Shin SY, Kim JM, Park HJ. Ultrasonographic scoring system score versus liver stiffness measurement in prediction of cirrhosis. Clin Mol Hepatol. 2013;19:389-398. [PMID: 24459644 DOI: 10.3350/cmh.2013.19.4.3890] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
751 Moon KM, Kim G, Baik SK, Choi E, Kim MY, Kim HA, Cho MY, Shin SY, Kim JM, Park HJ, Kwon SO, Eom YW. Ultrasonographic scoring system score versus liver stiffness measurement in prediction of cirrhosis. Clin Mol Hepatol 2013;19:389-98. [PMID: 24459644 DOI: 10.3350/cmh.2013.19.4.389] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 3.4] [Reference Citation Analysis]
752 Wong GL, Chan HL, Yu Z, Chan HY, Tse CH, Wong VW. Liver fibrosis progression is uncommon in patients with inactive chronic hepatitis B: a prospective cohort study with paired transient elastography examination. J Gastroenterol Hepatol 2013;28:1842-8. [PMID: 23829381 DOI: 10.1111/jgh.12327] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
753 Noureddin M, Lam J, Peterson MR, Middleton M, Hamilton G, Le TA, Bettencourt R, Changchien C, Brenner DA, Sirlin C, Loomba R. Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials. Hepatology 2013;58:1930-40. [PMID: 23696515 DOI: 10.1002/hep.26455] [Cited by in Crossref: 342] [Cited by in F6Publishing: 354] [Article Influence: 34.2] [Reference Citation Analysis]
754 Inoue Y, Kokudo N. Elastography for hepato-biliary-pancreatic surgery. Surg Today. 2014;44:1793-1800. [PMID: 24292652 DOI: 10.1007/s00595-013-0799-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
755 Luo ZH, Zou J, Mi L, Liu Y, Tong YL, Yu XF. Evaluation of hepatic fibrosis stage (≥ F2) by fibroscan in patients with chronic viral hepatitis: A Meta-analysis. Shijie Huaren Xiaohua Zazhi 2013; 21(33): 3724-3735 [DOI: 10.11569/wcjd.v21.i33.3724] [Reference Citation Analysis]
756 Armstrong MJ, Barton D, Gaunt P, Hull D, Guo K, Stocken D, Gough SC, Tomlinson JW, Brown RM, Hübscher SG. Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trial. BMJ Open. 2013;3:e003995. [PMID: 24189085 DOI: 10.1136/bmjopen-2013-003995] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
757 Wong GL, Chan HL, Yu Z, Chan HY, Tse CH, Wong VW. Liver fibrosis progression in chronic hepatitis B patients positive for hepatitis B e antigen: a prospective cohort study with paired transient elastography examination. J Gastroenterol Hepatol 2013;28:1762-9. [PMID: 23808759 DOI: 10.1111/jgh.12312] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
758 Goto Y, Okuda K, Akasu G, Kinoshita H, Tanaka H. Noninvasive diagnosis of compensated cirrhosis using an analysis of the time-intensity curve portal vein slope gradient on contrast-enhanced ultrasonography. Surg Today 2014;44:1496-505. [PMID: 24136649 DOI: 10.1007/s00595-013-0750-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
759 Kim DY, Song KJ, Kim SU, Yoo EJ, Park JY, Ahn SH, Han KH. Transient elastography-based risk estimation of hepatitis B virus-related occurrence of hepatocellular carcinoma: development and validation of a predictive model. Onco Targets Ther. 2013;6:1463-1469. [PMID: 24204161 DOI: 10.2147/ott.s51986] [Cited by in Crossref: 7] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
760 Emara MH, Ibrahim IM, Radwan MI, Elbast MR. Hemobilia and Melena After Liver Biopsy: A Case Report and Review of Literature. Gastroenterology Res 2013;6:200-3. [PMID: 27785254 DOI: 10.4021/gr569w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
761 Gutkowski K, Hartleb M, Kacperek-Hartleb T, Kajor M, Mazur W, Zych W, Walewska-Zielecka B, Habior A, Sobolewski M. Laboratory-based scoring system for prediction of hepatic inflammatory activity in patients with autoimmune hepatitis. Liver Int 2013;33:1370-7. [PMID: 23651331 DOI: 10.1111/liv.12198] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
762 Shah N, Nelson JE, Kowdley KV. MicroRNAs in Liver Disease: Bench to Bedside. J Clin Exp Hepatol 2013;3:231-42. [PMID: 25755505 DOI: 10.1016/j.jceh.2013.09.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
763 Cakmakci E, Caliskan KC, Tabakci ON, Tahtabasi M, Karpat Z. Percutaneous liver biopsies guided with ultrasonography: a case series. Iran J Radiol 2013;10:182-4. [PMID: 24348609 DOI: 10.5812/iranjradiol.13184] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
764 Venkatesh SK, Wang G, Lim SG, Wee A. Magnetic resonance elastography for the detection and staging of liver fibrosis in chronic hepatitis B. Eur Radiol. 2014;24:70-78. [PMID: 23928932 DOI: 10.1007/s00330-013-2978-8] [Cited by in Crossref: 121] [Cited by in F6Publishing: 116] [Article Influence: 12.1] [Reference Citation Analysis]
765 Armstrong MJ, Corbett C, Hodson J, Marwah N, Parker R, Houlihan DD, Rowe IA, Hazlehurst JM, Brown R, Hübscher SG. Operator training requirements and diagnostic accuracy of Fibroscan in routine clinical practice. Postgrad Med J. 2013;89:685-692. [PMID: 23924687 DOI: 10.1136/postgradmedj-2012-131640] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
766 Recio E, Cifuentes C, Macías J, Mira JA, Parra-Sánchez M, Rivero-Juárez A, Almeida C, Pineda JA, Neukam K. Interobserver concordance in controlled attenuation parameter measurement, a novel tool for the assessment of hepatic steatosis on the basis of transient elastography. Eur J Gastroenterol Hepatol 2013;25:905-11. [PMID: 23459105 DOI: 10.1097/MEG.0b013e32835f4c3d] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
767 D'Ambrosio R, Aghemo A, Fraquelli M, Rumi MG, Donato MF, Paradis V, Bedossa P, Colombo M. The diagnostic accuracy of Fibroscan for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological response. J Hepatol 2013;59:251-6. [PMID: 23528378 DOI: 10.1016/j.jhep.2013.03.013] [Cited by in Crossref: 109] [Cited by in F6Publishing: 113] [Article Influence: 10.9] [